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ABSTRACT
Distal Determinants of Cardiovascular Disease Risk Factors
Amna Umer
Introduction: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in
the world. West Virginia (WV) has one of the highest prevalence of CVD in the United States.
The first two studies examined the association between perinatal risk factors (birth weight (BTW)
and breastfeeding) and subsequent childhood and maternal CVD risk factors 11 years postpartum. The purpose of the third study was to conduct a systematic review and meta-analysis to
examine the evidence regarding the relationship between childhood obesity and adult CVD risk
factors.
Method: We used longitudinally linked data from three cross-sectional datasets in WV for the
first (N=19,583) and second study (N=10,457). The outcome variables included blood pressure
for children and lipid levels for both mothers and children. The exposures were BTW of the
infant (study 1) and reported history of breastfeeding obtained retrospectively when the child was
in fifth grade (study 2). Mean differences, correlations, and simple regression analyses were
performed to examine the unadjusted associations. Multiple regression analysis was performed
adjusting for current body mass index (BMI) and additional covariates. For the third study, the
search strategy included (1) electronic searches in multiple databases (PubMed (MEDLINE),
Web of Science, and Scopus) on June 5, 2015, and (2) citation tracking (N=4,840 citations).
Studies were included if they met the following criteria (1) longitudinal study-design, (2)
childhood exposure and adult outcomes collected on the same individual over time, (3) childhood
obesity, as defined by the authors, (4) English language articles, (5) studies published by June,
2015, (6) the primary outcome measures included: systolic blood pressure (SBP), diastolic blood
pressure (DBP), total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density
lipoprotein cholesterol (LDL), non-high-density lipoprotein cholesterol (non-HDL), triglycerides
(TG), and (7) outcome not self-reported.
Results: BTW was significantly associated with HDL (b= 0.14mg/dL; 95% CI: 0.11, 0.18), LDL
(b = -0.1mg/dL; 95% CI: -0.19, -0.016), non-HDL (b = -0.18mg/dL; 95% CI: -0.28, -0.09), and
log-TGs (b=-0.007 (-0.008, -0.005) per 1000 g increase in BTW in the adjusted analyses. There
was a positive association between BTW and maternal TC levels, which became non-significant
in the adjusted analysis [b= 0.4 mg/dL (95% CI: -0.01, 0.90) per1000 g increase in BTW]. None
of the other maternal lipids were significant in the unadjusted or the adjusted analysis. For the
second study, there was a significant association between reported history of breastfeeding and
child’s TGs (beta=-0.04; 95% CI: -0.06, -0.01) when adjusted for the child’s current BMI and
additional covariates. Maternal lipids were not significantly related to their breastfeeding history.
For the third study, a total of 23 studies were included in the systematic review and 21 in the
meta-analysis. The findings suggest that childhood obesity is significantly and positively
associated with adult SBP (Zr = 0.11; 95% CI: 0.07, 0.14), DBP (Zr = 0.11; 95% CI: 0.07, 0.14),
and TG (Zr =0.08; 95% CI: 0.03, 0.13), and inversely associated with adult HDL (Zr =-0.06; 95%
CI: -0.10, -0.02). For those studies that adjusted for adult BMI, associations were reversed.
Conclusion: Low BTW was associated with poor lipid levels (LDL, HDL, non-HDL, and TG)
and breastfeeding was protective for TGs in fifth grade children independent of their current
BMI. As CVD risk factors persist from childhood into adulthood, the small effect sizes observed
in the first two studies can have potential unfavorable consequence on lipid levels in later
adulthood. The results of the systematic review with meta-analysis suggest that childhood obesity
is significantly and positively associated with adult SBP, DBP, and TG and negatively associated
with adult HDL. Well-designed, longitudinal studies with improved reporting as well as data
analysis that include both unadjusted and adjusted associations for adult adiposity are needed
before any definitive conclusions can be made.
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CHAPTER 1: Project overview
Introduction

Cardiovascular Disease (CVD)
Cardiovascular Disease is the leading cause of death in the world and also in the United
States (U.S.). According to the Global Burden of Disease Study, more than 17.3 million people
died from CVD in 2013, representing 31% of all global deaths1,2 and nearly 50% of deaths from
chronic diseases worldwide.3 The number of CVD mortalities is projected to rise to more than
23.6 million by 2030.4,5 Based on U.S. mortality data, CVD accounted for 34.3% deaths in 2006,6
32.8% deaths in 2008,7 31.9% deaths in 2010,8 and 30.8% of all deaths in 2013.4 Although CVD
mortality rate is declining, it is still the leading cause of death in the U.S. and accounts for nearly
1 out of 3 deaths.4 According to the 2016 Heart Disease and Stroke Statistics update, more than
one third of U.S. adults have one or more than one types of CVD.4 For 2011-12, the estimated
cost of CVD (direct and indirect) was $316.6 billion, which is projected to increase to $918
billion by 2030.4 There are geographic disparities in the CVD prevalence in the U.S. The
Appalachian region in the southeastern U.S. has among the highest rates of CVD compared to
rest of the nation.9-11 West Virginia (WV), a state entirely within the Appalachian region, has one
of the highest CVD mortality rates in the U.S.4 In 2013, the age adjusted CVD mortality rate in
WV was 270.6 per 100,000, ranking 47th in the nation (U.S.: 225.2 per 100,000 population).4
With such a high prevalence of CVD, it becomes important to assess the risk factors of CVD in
order to implement preventative measures. Some of the known risk factors for CVD include high
blood pressure (hypertension), abnormal lipid profile, obesity, diabetes mellitus, and family
history of heart disease, which are linked to known risky health behaviors such as smoking,
physical inactivity, poor diet, and excessive alcohol intake.12-15 Previously these risk factors were
thought to be prevalent in adulthood only, but are now detected during early childhood and
adolescence as well.16,17 These risk factors have the propensity to track from childhood into
adulthood and thus are considered predictors of adult CVD risk factors.18 As current adolescents
enter adulthood, the prevalence of CVD is expected also to rise,19 as projected that more than
43% of men and 45% of women in the U.S. will have some form of CVD and 41.4% will have
hypertension by 2030.4,20

CVD Risk Factors
For this study we focus on three CVD risk factors: (1) blood pressure measured by
systolic blood pressure (SBP) and diastolic blood pressure (DBP), (2) lipids including total
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cholesterol (TC), low-density lipoprotein cholesterol (LDL), high-density lipoprotein cholesterol
(HDL), non-high-density lipoprotein cholesterol (non-HDL), and triglycerides (TG), and (3)
obesity.
High Blood Pressure. High blood pressure can be due to high SBP ≥140 mmHg or high
DBP ≥90 mmHg or both. Hypertension is defined as SBP and DBP ≥140/90 mmHg for adults’
≥20 years, and ≥95th percentile for age and sex for children and adolescents.21 High SBP, high
DBP, and hypertension are all independent risk factors for CVD.22-24 Hypertension is responsible
for approximately two-thirds of stroke and one-half of ischemic heart diseases.25,26 According to
National Health and Nutrition Examination Survey (NHANES) 2009-2012 data, nearly one third
(32.6%) of U.S. adults’ ≥20 years have hypertension.27 Among children and adolescents ages 8 17, 11.0% have pre-hypertension (SBP or DBP ≥90 but less than 95 percentile) or hypertension
(SBP or DBP ≥95th percentile), which remained unchanged since 1999-2000.4,27 A systematic
review with meta-analysis concluded that high blood pressure tracks strongly from childhood into
adulthood with the average tracking correlation coefficients of 0.38 and 0.28 for SBP and DBP
respectively.28 Not only is hypertension in adulthood one of the leading causes of heart diseases
in the U.S.29,30, but children with hypertension may also have evidence of cardiovascular endorgan damage such as increased left ventricular mass and thickness of carotid artery intima media
(potential markers of hypertensive vascular damage).31-33 According to the United States Center
for Disease Control and Prevention (CDC)’s 2013 Behavioral Risk Factor Surveillance System
(BRFSS), the state-specific prevalence of adult hypertension in the U.S. ranges from 24%-41%.
WV has the highest prevalence of adult hypertension in the nation (rank 50).34 Additionally,
results from the WV CARDIAC project 2014-2015 found nearly 23% fifth grade children in WV
to have hypertension (SBP and/or DBP ≥95% percentile).35
Abnormal serum lipid and lipoprotein concentrations. Abnormal serum lipid and
lipoprotein cholesterol levels (high TC, LDL, TG, non-HDL, and low HDL) are another
established risk factor for CVD.14,15,36 Adults with high TC have nearly twice the risk of heart
disease compared to those with normal cholesterol levels.37 High cholesterol in early life has also
been associated with preclinical atherosclerosis that contributes to adult atherosclerosis.38-41 The
criteria for high risk for each component of lipid profile in children and adolescents vary by age
and gender but are based on having an individual lipid component ≥95th percentile.42 For 10-19
year old children the individual components ≥95th percentile corresponds to approximately: TC
≥200mg/dL, LDL ≥130 mg/dL, TG ≥130 mg/dL HDL <40 mg/dL, and non-HDL ≥145 mg/dL.4244

For adults the criteria for high risk for each component of lipid profile is: TC ≥240 mg/dL,

LDL ≥160 mg/dL, TG ≥200 mg/dL, and HDL <40 mg/dL.45,46 According to the 2016 Heart
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Disease and Stroke Statistics update,4 mainly based on NHANES 2009-2012 data showed that the
prevalence of high TC was 13% in U.S. adults ≥20 years and 8.5% in adolescents ages 12-19.
High LDL was prevalent in 27% of U.S. adults’ ≥20 years and nearly 7% in adolescents ages 1219. The proportion of low HDL varied significantly by gender. Nearly 25% of men and less than
10% of women ≥20 years had low HDL47 and 19.5% of boys and 11% of girls (ages 12-19) had
low HDL.4 For TG nearly a quarter (25.1%) of adults’ ≥20 years had high TG and the proportion
in children and adolescents 12-19 years old, 10% males and 6.5% females had high TG.4 Based
on CDC’s BRFSS 2013, WV ranks 48th in the nation with the prevalence of high TC among
adults.34 Additionally, results from the WV CARDIAC project 2014-2015 showed that nearly 5%
of children in fifth grade have high LDL (≥130 mg/dL) and 17% have low HDL (<40 md/dL).35
Although nationally the prevalence of high total cholesterol and low HDL is declining in children
ages 8-17;27 it is still an important CVD risk factor. Furthermore, as observed with high blood
pressure, abnormal serum lipid and lipoprotein also track from childhood into adulthood as
well.48-51
Overweight and obesity. Overweight and obesity is another major risk factor for CVD.52
Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in
meters used to establish the weight status of an individual. However, at a population level it is
one of the most commonly used measures to assess body fatness. BMI correlates well with the
individual’s adiposity status, and is also a convenient and an inexpensive method.53,54 Overweight
is defined as 25.0 ≤ BMI ≤ 29.9 kg/m2, and obese is defined as BMI ≥30.0 kg/m2 in adults.55 In
children overweight is defined as BMI ranging from 85th to <95th percentile, and obesity is
defined as ≥95th percentile using sex-specific BMI-for-age 2000 CDC growth charts.56
Overweight and obesity during childhood and adolescence is a major public health problem.
According to the most recent national study (NHANES 2011-2012), nearly 32% children and
adolescents between the ages of 2 to 19 were either overweight or obese, of which 17% were
obese. The study stratified the results by different age groups and found that nearly 8% of 2-5year-olds were obese compared to 18% of 6-11-year-olds and 21% of 12-19-year-olds.57 Data
from the WV Healthy Lifestyles Act Evaluations 2008-2009 shows that 18.5% of children in
kindergarten were obese, compared with 22.1% of second graders and 29.6% of fifth graders.58
According to the 2007 National Survey of Children’s Health (NSCH) nearly 36% of WV
adolescents ages 10-17 years were overweight or obese compared to the national average of
32%.59 Results from the WV CARDIAC project 2014-2015 showed that nearly 47% of children
in fifth grade were either overweight or obese (BMI ≥85th percentile).35
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Overweight adolescents have a 40%-80% chance of becoming overweight or obese
adults60,61 and adult adiposity is a well-known risk factor for developing adult CVD.62-64 Some of
the immediate heath implications of pediatric obesity include development of other CVD risk
factors during childhood and adolescence.65-70 Adult CVD risk factors found during childhood
(such as high blood pressure, poor lipid profile, impaired glucose tolerance, and metabolic
syndrome71-73) are amplified in the presence of pediatric obesity and referred by Ford and
colleagues as ‘obesity-associated CVD risk factors’.71 A population-based study estimated that
70% of obese children and adolescents between the ages of 5 to 17 have at least one risk factor
for CVD.65 Data from the longitudinal Bogalusa Heart Study shows that overweight children
were 4.5 and 2.4 times as likely to have elevated SBP and DBP, compared to normal weight
children respectively.74 Moreover, overweight children were 2.4 times as likely to have high TC,
3 times likely to have high LDL, 3.4 times as likely to have low HDL, and 7 times as likely to
have high TG compared to normal weight children.74 A recent systematic review with metaanalysis concluded that obese children, when compared to normal weight children, have raised
SBP by 7.49 mmHg, DBP by 4.45 mmHg, and TC by 0.15 mmol/L.70
Moreover, data from NHANES 2011-12 showed that two-third of adults are either
overweight or obese (68.5%) in the U.S. The prevalence of extreme obesity (6.3%; BMI ≥40.0
kg/m2) was higher in women (8.3%; 95% CI: 6.9, 9.8) compared to men (4.4%; 95% CI: 2.8,
6.8).57 According to the 2014 BRFSS data, the state specific obesity rates ranged from 21.3%
percent in Colorado to 35.9% in Arkansas. In the past decade the obesity rates in WV has
increased from 27.6% in 2004 to 35.7% in 2014, ranking the second highest rate of adult obesity
in the nation.75
Adult obesity is also associated with numerous comorbid conditions such as
hypertension, dyslipidemia, diabetes, insulin resistance, and metabolic syndrome and all these
conditions increases the risk for CVD.76 Obese individuals have an increased risk of developing
hypertension. Some studies have suggested that 60–75% of hypertension can be attributed to
adult overweight or obesity.62,77,78 Furthermore, obesity is a predictor of higher TG, LDL, and
lower HDL.62 Results from a meta-analysis of 21 cohort studies concluded that overweight was
an independent risk factor for heart diseases, but the association was partially mediated by the
effects of overweight on blood pressure and cholesterol levels, which accounted for nearly 45%
of the increased risk of heart disease.79 Data from NHANES III showed a strong association of
adult body mass index (BMI) with hypertension and abnormal lipid profile. The report showed
that the prevalence of high blood pressure was 15% for underweight/normal weight men and
women, and 38% for obese women and 42% for obese men.80
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Link between childhood obesity and adult CVD risk factors. In summary, research
suggests that childhood obesity is an independent risk factor for developing childhood CVD risk
factors,65-68 and obese children also have higher risk of becoming overweight/obese adults,60,61,81
which is an independent risk factor for developing adult CVD risk factors.62,64,76-78 However,
studies that have examined the direct relationship between childhood obesity and adult CVD have
yielded inconsistent results.63,71,82-84 Recent systematic reviews suggest that the relationship
between childhood obesity and adult high blood pressure or poor lipid profile is weak, possibly
because the results are confounded by adult obesity.84,85 Thus, it remains unclear whether
childhood obesity is an independent risk factor for adult CVD risk factors or whether childhood
obesity persists as adult obesity and indirectly increases the risk of adult CVD.86,87

Early Life Exposure and Origins of Childhood and Maternal CVD Risk Factors
There is growing evidence that early-life risk factors may influence the development of
fatty streaks and vascular endothelial dysfunction in children to atherosclerotic plaques in early
adulthood and subsequent CVD in later life.88-91 For example, research shows an association
between birth weight and obesity,92 hypertension,93 and dyslipidemia.94 Conversely, early-life
protective factors (such as breastfeeding) have been shown to reduce the risk of overweight and
obesity,95 hypertension96,97 and improve cholesterol concentrations in later life.98
These relationships may start to occur prior to birth. The Barker hypothesis (also called
the ‘in utero fetal programming hypothesis’ or the ‘developmental origins of adult disease
hypothesis’) proposed that intrauterine malnutrition leads to low birth weight (LBW) infants,
which predisposes infants to develop CVD in later life.99-102 Although this hypothesis has been a
topic of great controversy, evidence seems to be accumulating on various associations between
perinatal risk factors and the development of CVD risk factors in subsequent years.103 Although,
Barker and colleagues focused primarily on LBW and adult CVD, recent literature has focused on
other perinatal risk factors such as high birth weight (HBW), maternal pre-pregnancy adiposity,
excessive gestational weight gain (GWG), and gestational diabetes as early determinants for the
origins of childhood and adulthood CVD.92,94,104-108 Some studies have shown that it is not only in
the periods of gestation but also in the critical period of lactation (e.g., breastfeeding) that the
type of nutrition can have long lasting effects on the offspring’s development of CVD risk factors
in later life.109,110
Surprisingly, perinatal risk factors not only impact the health of the offspring, but also are
associated with maternal CVD morbidity and mortality in later years.111-115 Data shows that
mothers who deliver LBW infants have significantly higher risk of maternal CVD morbidity and
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mortality116-120 and CVD related risk factors such as hypertension121 and metabolic syndrome.122
Furthermore, recent literature indicates that mothers who breastfeed their newborns have a
significant positive impact on their own cardiovascular health115 including lower prevalence of
CVD risk factors (e.g., high blood pressure and poor lipid profile).123

Distal Determinants of CVD Risk Factors
There is an ongoing debate on using the term ‘distal’ and ‘proximal’ causes of
disease/outcome in the field of public health research. Social and behavioral sciences, a branch of
public health research that focuses on social determinants of health use the term ‘distal’ for social
and economic risk factors and ‘proximal’ for individual and biological factors.124,125 Others
suggest that proximal are more direct or ‘downstream’ factors and distal are indirect or
‘upstream’ health determinant for the outcome of interest.124 For the purpose of this current
dissertation, distal determinant of CVD risk factors are predictor variables, which are temporally
distal (far in relation to time) from when the health outcomes are being assessed. We focused on
two distal perinatal factors (birth weight of the infant and breastfeeding) and later childhood and
maternal CVD risk factors for study 1 and study 2 (aims 1 and 2 respectively). For the third study
we focused on childhood obesity as the distal determinant of adult CVD risk factors.

Summary
CVD morbidity and mortality accounts for nearly one-third of all diseases and death
nationally and worldwide. Although the mortality from CVD is declining in the U.S. since the
past decade, CVD morbidity is expected to increase from nearly 33% to more than 43% by
2030.4,20 Several well-established adult CVD risk factors (i.e. high blood pressure, high
cholesterol, and obesity) are now prevalent during childhood as well. Childhood obesity in itself
is an independent risk factor for other childhood CVD risk factors including high blood pressure
and abnormal lipid profile.
Additionally, the development of CVD risk factors may start as early as in utero and
infancy, and these early life exposures can impact the cardiovascular health in later years. CVD
risk factors such as childhood obesity, high blood pressure, and dyslipidemia share common early
life exposures such as birth weight and breastfeeding. However, there is limited data focusing on
these associations during childhood independent of child’s obesity status. Surprisingly, these
perinatal risk factors (birth weight and breastfeeding) have been linked to maternal CVD risk
factors in subsequent years.120,122,126-128 However, this topic is a recent and an active area of
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research with limited number of studies have explored these associations for maternal
cardiovascular health in subsequent years. Most relevant to our study, no studies examined these
associations longitudinally across the lifespan in the state of WV; where there is a vital need to
assess these risk factors and implement early preventative measures to reduce the high burden of
CVD in this state. Data shows that WV has some of the highest rates of obesity, hypertension,
high cholesterol levels, LBW infants, and one of the lowest breastfeeding rates in the nation.
Thus, we intended to fill this gap in the literature with the first two studies/aims.
For the third aim we moved our focus from perinatal exposures (birth weigh and
breastfeeding) and its associations with childhood and maternal CVD risk factors to childhood
exposure (over weight and obesity) and its association with adult CVD risk factors. Despite the
high prevalence of both childhood obesity and CVD, studies examining the relationship between
childhood adiposity and adult CVD have yielded conflicting results.63,71,82-84 However, adult
adiposity is an established risk factor for developing adult CVD62,76-78 and there is much evidence
to suggest that overweight children and adolescents have a higher risk of becoming overweight or
obese adults.60,61,81 Thus, it remains unclear whether childhood obesity is an independent risk
factor for adult CVD risk factors or whether the association is mediated through adult obesity.84-87
Given that childhood obesity as an independent risk factor for CVD in adults is not well
established, for the third aim/study we examined the association between childhood obesity and
adult CVD risk factors.
The overall objective of this project was to determine the associations between two distal
perinatal factors (birth weight and breastfeeding) and childhood and maternal cardiovascular
health, and determine the relationship between childhood obesity as the distal determinant of
adult CVD risk factors. The central hypothesis of this project is that early life exposures are
independently associated with childhood CVD risk factors and childhood obesity is an
independent risk factor for adult CVD risk factors. Specifically, the proposed project looks to
investigate the following specific aims.

Specific Aim 1
Investigate the association between infant’s birth weight on childhood CVD risk factors
(SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of age (controlling for child’s
current body mass index (BMI), and the subsequent risk of developing maternal CVD risk factors
(TC, LDL, HDL, non-HDL, and TG) 11 years post partum.
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Objective 1.1. Determine the association between infant’s birth-weight on childhood
CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of age independent
of childhood adiposity.
Working Hypotheses 1.1. Low or/and high birth weight infants will have significantly
higher SBP, DBP, TC, LDL, HDL, and TG, and lower HDL at 11 years of age independent of
childhood adiposity.
Objective 1.2. Determine the association between infant’s birth-weight on maternal CVD
risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post-partum.
Working Hypothesis 1.2. Mothers who gave birth to low or/and high birth weight
infants will have significantly higher TC, LDL, non-HDL, and TG, and lower HDL, 11 years
post-partum.

Specific Aim 2
Investigate the association between infant breastfeeding and childhood CVD risk factors
(SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of age (controlling for child’s
current BMI, and the subsequent risk of developing maternal CVD risk factors (TC, LDL, HDL,
non-HDL, and TG) 11 years post partum.
Objective 2.1. Determine the association between infant breastfeeding and childhood
CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of age independent
of childhood adiposity.
Working Hypotheses 2.1. Infants who were breastfed have significantly lower SBP,
DBP, TC, LDL, non-HDL, and TG and higher HDL at 11 years of age independent of childhood
adiposity.
Objective 2.2. Determine the association between infant breastfeeding and maternal
CVD risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post-partum.
Working Hypothesis 2.2. Mothers who breastfed their infants will have significantly
lower TC, LDL, non-HDL, and TG and higher HDL after 11 years post-partum.

Specific Aim 3
Conduct a comprehensive systematic review (SR) and meta-analysis (MA) to critically
evaluate the available evidence regarding the relationship between childhood obesity and adult
CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, and TG).
Objective 3.1. Determine the overall effect of childhood and adolescence obesity and its
association with adult blood pressure and lipid profile.
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Objective 3.2. Identify sources of between-study heterogeneity in relation to changes in
adult blood pressure and lipid profile as a result of childhood and adolescence obesity. Where
significant between study variation exists in research methodology, study design, study
population, sample size, analysis and context, we will determine covariates responsible for such
heterogeneity for the primary outcome variables (SBP, DBP, TC, LDL, HDL, non-HDL, and TG)
of interest.

The three specific aims/studies correspond to chapters two, three, and four. Chapter 5
presents a summary of key findings of individual studies, strengths, limitations, and significance
of the studies, potential public health implications as well as potential direction and
recommendations for future research. There are wide-ranging factors that contribute to the high
burden of CVD across the life course. Thus examining the associations of these distal
determinants of CVD will aid in the understanding of these factors and their potential role. This
can potentially lead to planning and implementation of ideal preventive strategies for promoting
cardiovascular health during various life stages.
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CHAPTER 2: Birth weight and childhood and maternal cardiovascular disease risk factors

Abstract
Introduction: The reported associations between birth weight and childhood
cardiovascular disease (CVD) risk factors have been inconsistent. The relationship between
infants’ birth weight and later maternal CVD is also a more recent and active area of research. We
aimed to examine the association between birth weight and subsequent childhood and maternal
CVD risk factors 11 years post-partum.
Methods: The study used longitudinally linked data from three cross-sectional datasets
[West Virginia Birth Certificates, the Working in Appalachia to Track High Birth Score, Critical
Congenital Heart Disease and Hearing Loss (WATCH)/Birth Score project, and the Coronary
Artery Risk Detection in Appalachian Communities (CARDIAC) project] in West Virginia and
restricted to full term infants only. The outcome variables included blood pressure measures
(systolic blood pressure (SBP), diastolic blood pressure (DBP)) for children and lipid levels for
both mothers and children (total cholesterol (TC), low-density lipoprotein cholesterol (LDL),
high-density lipoprotein cholesterol (HDL), non-high-density lipoprotein cholesterol (non-HDL),
and triglycerides (TG). The exposure was birth weight of the infant assessed as continuous and
categorical variable using conventional cut-offs. Low birth weight (LBW) and high birth weight
(HBW) was defined as birth weight of <2,500 grams and >4000 grams respectively. The role of
child’s current body mass index (BMI) was assessed as a potential mediator.
Results: The final study sample after excluding infants born pre-term (i.e., <37 weeks of
gestation: N=2,097, 9.67%) was 19,583. In this sample, nearly 3% of the infants were LBW and
11% were HBW. Unadjusted analyses showed a positive association between birth weight and the
SBP, DBP, HDL, and a negative association between birth weight and TGs. When adjusted for
the child’s BMI, the association became negative but non-significant for SBP, and remained
positive but became non-significant for DBP. The association between birth weigh and HDL [b=
0.14 mg/dL (95% CI: 0.11, 0.18) per 1000 g increase in birth weight] and between birth weight
and log-TG [b=-0.007 (-0.008, -0.005) per 1000 g increase in birth weight] remained significant
after adjustments were made for the child’s BMI. LDL and non-HDL became significant and
negatively associated with birth weight in the adjusted analysis [LDL (b = -0.1 mg/dL (-0.19, 0.16) per 1000 g increase in birth weight; non-HDL (b = - 0.18 mg/dL (-0.28, -0.09) per 1000 g
increase in birth weight]. There was a positive association between birth weight and maternal TC
levels, which became non-significant in the adjusted analysis [b= 0.4 mg/dL (95% CI: -0.01,
0.90) per 1000 g increase in birth weight]. None of the other maternal lipids levels (LDL, HDL,
non-HDL, and TG) were significant in the unadjusted or the adjusted analysis.
Conclusion: In this young Appalachian population, birth weight was associated with
lipid levels in children. LBW was associated with higher LDL, non-HDL, and TGs and lower
HDL levels in fifth grade children independent of the current weight status. As CVD risk factors
persist from childhood into adulthood, these small effect sizes can have potential unfavorable
consequence on lipid levels in later adulthood. HBW seemed to show a trend towards poor
maternal lipid levels 11 years post-partum. Well-designed longitudinal studies are needed to
understand the complex pathways examining these associations at different life stages.
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Introduction
Cardiovascular Disease (CVD) is the leading cause of death globally, nationally, and also
in the state of West Virginia (WV).1-3 WV, a state entirely within the Appalachian region, has one
of the highest CVD mortality rates in the U.S.3 In 2013, the age adjusted CVD mortality rate in
the United States was 225.2 per 100,000 population whereas in WV the age adjusted CVD
mortality rate was 270.6 per 100,000, ranking 47th in the nation.3 High blood pressure and poor
cholesterol are well-established risk factors for CVD.4-8 These risk factors are not only found in
adulthood but are prevalent during childhood as well and have been linked with numerous
perinatal exposures such as birth weight.9-17
The fetal origins hypothesis proposed by Barker and colleagues states that early life
exposures such as under nutrition in utero could potentially increase susceptibility to poor health
outcomes in later life.18 Briefly, the hypothesis suggests that this poor nutrition in utero can
potentially trigger a response where the fetus may slow down its own growth to adapt to the
unfavorable conditions (restricted nutrients and poor fetal oxygenation). This potentially leads to
inadequate fetal growth (intrauterine growth restriction (IUGR)),19 as a short-term strategy for
survival. This strategy leads to having low birth weight (LBW) but in the long term can have
adverse health consequences.20
LBW is defined as birth weight of <2,500 grams (5.5 lbs) and high birth weight (HBW)
is defined as a birth weight of >4000 grams (8.8 lbs).21-23 LBW (<2,500 grams) at birth can result
from either IUGR in a full-term infant (≥37 weeks of gestation), or from premature/preterm birth
(<37 weeks of gestation).19 According to National Vital Statistics System the national average
incidence of LBW is 8.0% of all live births, based on 2013 birth certificates data. The statespecific incidences vary from 5.8% in Alaska to 11.5% in Mississippi. WV ranks 45 in the nation,
with an incidence of 9.4%.24 Based on 2011 Pregnancy Surveillance System (PNSS) and Pediatric
Nutrition Surveillance System (PedNSS) the national prevalence of LBW and HBW is 8.9% and
6.4% respectively in low-income children enrolled in federally funded programs.23
A child’s LBW is an indicator of suboptimal fetal growth and an important predictor for
several long-term health outcomes including morbidity and mortality from CVD.25-27 However,
others have argued that birth weight is a strong predictor of infant mortality in the first year of life
and not a predictor for the development of chronic diseases during childhood or adulthood.28,29
Finally, recent literature also shows that mothers who deliver LBW or HBW infants have a higher
risk of having CVD morbidity and mortality.30,31,58
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The detailed literature review presented below first outlines associations between birth
weight and child CVD risk factors including blood pressure (systolic blood pressure (SBP),
diastolic blood pressure (DBP)), and lipid profile ((total cholesterol (TC), low-density lipoprotein
cholesterol (LDL), high-density lipoprotein cholesterol (HDL), non-high-density lipoprotein
cholesterol (non-HDL), and triglycerides (TG)), and then expands on associations between birth
weight and maternal CVD risk factors.

Child Birth Weight and Child CVD Risk Factors
LBW has shown to be an independent risk factor for childhood CVD risk factors such as
obesity,32 high blood pressure,33,34 and poor lipid profile.35 For example, Gademan and colleagues
found that birth weight was significant and inversely associated with SBP and DBP independent
of the child’s current body mass index (BMI) at 6 years of age.33 However, Zhang and colleagues
observed the inverse association only with SBP but a positive (linear) association with DBP. The
study demonstrated that among children 6-15 years, SBP levels decreased 0.9 mmHg (b = -0.9; p
= 0.002) and DBP increased 0.9 mmHg (b = 0.9; p = 0.006) for each 1,000 g increase in birth
weight.36 Other studies also found a positive (linear) relationship between birth weight and high
blood pressure.9,37,38 Filler and colleagues observed that birth weight was significantly and
positively correlation with DBP z score (r = 0.037, p = 0.044), BMI z score (r = 0.123, p <0.0001)
but not with SBP (r = -0.006, p = 0.729).37 Sousa and colleagues found that HBW adolescents (14
years old) had a significantly higher prevalence ratio for high SBP of 3.3 (95% CI: 1.7, 6.4)
compared with normal birth weight adolescents.38 As suggested by these conflicting relationships
between blood pressure and birth weight, another study that examined the association at 7 years
and 16 years (2 different cohorts) found a non-linear relationship and concluded that both LBW
and HBW were associated with high SBP.39 A recent systematic review concluded that children
and adults who were born preterm or very LBW (<1500 g) have moderately higher SBP later in
life,26 and a recent meta-analysis also demonstrated an inverse linear association between birth
weight and later risk of high SBP.40 However, other studies have found a weak association or no
association between birth weight and subsequent risk of developing high blood pressure.41-43 This
also includes a recent systematic review that found no significant association between LBW and
childhood obesity or childhood hypertension.44 This relationship may be further obscured by the
child’s current weight status. For example, Berge and colleagues found an association between
LBW and SBP only among overweight children between the ages of 5-9 years.45
These conflicting relationships are also found when examining the association between
birth weight and cholesterol levels in childhood. For example, when examining the association
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between birth weight and serum lipid profile, Donker and colleagues found an inverse association
between birth weight and elevated TG concentrations in later childhood (ages 9-11 years).35
Another longitudinal study found that among children (ages 4-11 years) LBW was associated
with lower mean HDL, higher LDL, and TG levels irrespective of age or gender.34 However,
Azadbakht and colleagues demonstrated that both LBW and HBW were significantly associated
with low levels of HDL.9 Similarly, a recent study found no significant association between birth
weight (when analyzed as a continuous variable) and lipid profiles, but when birth weight was
categorized as low, normal, and high, the results showed that HBW subjects had higher TC levels
(b = 0.971; p <0.001) and higher non-HDL levels (b = 0.960; p = 0.001) compared to children
who had normal birth weight.36 A study using WV Coronary Artery Risk Detection In
Appalachian Communities (CARDIAC) data on 11 years old children found that infants who
were born preterm had higher levels of TGs compared to term infants. The study also categorized
gestational age categories, as small for gestational age (SGA), appropriate for gestational age
(AGA), and large for gestational age (LGA) based on Fenton’s weight graphs,46 and found that
SGA infants were less likely to be obese in fifth grade, but those who were obese had higher TG
levels compared to AGA or LGA obese children.47 Other studies have found no significant
association between HBW and serum lipid profile in children (6 years of age) or between LBW
and serum cholesterol levels at 8 years of age,10,48 in adolescents,38 or in early adulthood.49
Consistent with these conflicting results, a recently published systematic review and metaanalysis concluded that the current birth weight standards are poor predictors for later
development of adverse health outcomes.44

Child Birth Weight and Maternal CVD Risk Factors
Mothers who deliver LBW infants (BTW<2500 g vs. >3500 g) have 7-11 times the risk
of maternal CVD mortality in later years.30,50-53 Preterm delivery and delivery of a SGA infant has
also been associated with an increase risk of maternal CVD.54-56 Catov and colleagues found that
women who gave birth to preterm babies (independent of hypertension during pregnancy) had
higher blood pressure several years after pregnancy compared to women who gave birth to term
babies.57 Results from a large retrospective cohort study (N=129,290) found that mothers who
delivered babies in the lowest birth weight quintile for gestational age had higher risks of
maternal CVD morbidity 15–19 years later compared to mothers who delivered babies in the
highest four quintiles grouped together.53 One study found that mothers of infants with HBW
were more likely to be obese and have higher rates of metabolic syndrome 8 years after
delivery.58 The study found no significant relationship between the infant birth weight and
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maternal TC, LDL and HDL but found significant positive association for TGs only (Odds Ratio
= 2.17; 95% CI: 1.01, 4.70).58 Thus, suggesting that HBW was associated with higher TGs.
Another study demonstrated a positive association between delivering a LBW infant and maternal
hypertension in later life.59 Yet another study that examined the relationship between offspring
birth weight and parental carotid artery intima media thickness found that the relationship was
significant and inversely associated.60 The researchers state two plausible explanations: 1)
Maternal environmental factors (e.g., poor diet) can potentially increase maternal risk of
atherosclerosis and impact the infant’s birth weight or 2) a potential common genetic factor could
be related to both LBW and higher risk of atherosclerosis in subsequent years.60

Low Birth Weight, Preterm Births, and Small for Gestational Age
Birth weight of the infant is the weight of the infant at the time of delivery. Preterm birth
is defined as birth at less than 37 weeks of gestational age, which can be due to several factors
such as infection and/or fetal growth restriction. SGA is defined as an infant who is less than the
10th percentile of birth weight for gestational age. SGA is most often used as a marker of intra
uterine growth restriction (IUGR). A LBW may be due to preterm birth or due to IUGR.19
Although there seems to be an overlap between these terms, Behrman and colleagues suggest that
“They are not interchangeable, however, as each has distinct etiologies and risk factors. Among
low birth weight infants, approximately two-thirds are born preterm, whereas less than 20
percent of SGA age infants are born preterm.”61 LBW and HBW babies are found in both preterm
and full term babies. However, preterm infants are at a greater risk of infant mortality as well as
adverse health outcomes compared to term birth infants.61-64 Many researchers believe that birth
weight categories (LBW, normal birth weight, HBW) and birth weight for gestational age
categories (SGA, AGA, and LGA), both combines preterm and term births and are thus unreliable
predictor of population risk. They further suggest that these two populations should be examined
independently; for example, Wilcox notes, “Once the percent of preterm births is known, the
analysis of birth weight can be simplified by restricting the sample to term births. Among term
births, the influence of gestational age is minor and can be ignored.” 28 Lastly, some of the critics
of Barker hypothesis have argued that Barker and colleagues failed to account for infants born
prematurely.65 They argue that not only the determinants of preterm birth and fetal growth
differ;66 IUGR, rather than prematurity is associated with later chronic diseases.67
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Statement of the Problem
As presented in the literature review on the current topic above, most studies found an
inverse association between birth weight and CVD risk factors without excluding preterm infants
or only focusing on preterm infants as demonstrated by earlier systematic reviews.26,68 Our study
population included nearly 10% preterm birth infants. Furthermore, the LBW in the overall
population was 7%, which accounts for 3% among full-term infants, and nearly 50% in preterm
infants (49.36%). Thus, in agreement with the literature that suggests that preterm and term
babies are two distinct populations, we aimed to examine the association of birth weight and
CVD risk factors in full-term birth infants only. The association of birth weight in full-term births
with CVD risk factors is less clear and our study is intended to fill this gap.
Moreover, we can also observe from the literature that the associations between birth
weight and childhood CVD risk factors show inconsistent results. While some studies have found
a significant association33-35 others have found a weak association or no association between birth
weight and poor lipid profile or blood pressure in subsequent years.41-43,69,70 Child’s birth weight
has also shown to be associated either linearly (negatively or positively) or non-linearly (Ushaped) with childhood obesity, 32,38,71-74 which is an independent risk factor for childhood CVD
risk factors. Thus many argue that child’s current weight may be a potential mediator between
these associations, while others argue that socio-demographic factors and maternal history of
CVD may increase the risk of LBW, as well as increase the risk of CVD risk factors in the
offspring.75,76 Thus this study aims to examine this association adjusting for important confounder
variables as well as examine the role of childhood BMI as a potential mediator. There is also a
paucity of information on the influence of infant’s birth weight and the subsequent risk of
maternal hypertension and only one study in India looked at the association for maternal lipid
profile postpartum.58 Most importantly, we did not find any study examining these associations
(for both children and mothers) longitudinally in the state of WV; where there is a critical need to
identify risk factors that can potentially reduce the high burden of CVD through early prevention
and intervention. For the purpose of this study we focused on two CVD risk factors: (1) blood
pressure (SBP and DBP) and, (2) and lipids and lipoprotein levels (TC, LDL, HDL, non-HDL,
and TG). The main objective of the study was to determine the association between infant’s birth
weight and childhood CVD risk factors (SBP, DBP, TC, LDL, HDL, non HDL, and TG) at 11
years of age controlling for child’s current BMI, and the subsequent risk of developing maternal
CVD risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post partum.
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Methods and Materials

Data Sources
The study used data from three projects, including WV Birth Certificates, the Working in
Appalachia to Track High Birth Score, Critical Congenital Heart Disease and Hearing Loss
(WATCH)/Birth Score project, and the Coronary Artery Risk Detection in Appalachian
Communities (CARDIAC) project. The WV Birth-Score Project began in 1985 and is an infant
risk-screening tool.47,77 Health care professionals collect data on every newborn within 24-48
hours or prior to discharge, in order to identify infants who are at a high risk of morbidity or
mortality in the first year of life, for referral to primary care management.47,77,78 In this study,
children participating in the Birth-Score project (all of whom are merged with the Birth
Certificate data) born between in 1994 to 2000 were merged with data collected by the
CARDIAC Project in years 2004-2010. The CARDIAC project collects data on fifth grade public
school children in 55 counties in WV with informed consent by parents/guardians and assent by
the child.79 Area coordinators employed by the project, along with health science student
volunteers, local school nurses, and volunteer phlebotomists conduct blood pressure,
anthropometric measurements, and blood lipid testing. The blood sample is obtained from fifth
grade children in the CARDIAC project and analyzed by local area hospitals or by LabCorp Inc.
(Burlington, NC). Parents of participating children were sent a voucher for screening of their
fasting blood lipid profile and reports were submitted to the CARDIAC project. Further details of
the data collection procedure are described elsewhere.80-83 The West Virginia University
Institutional Review Board (Protocol number 1504666639) approved merged analysis based on
the child’s identification number. We include only those observations where data was available
from all three projects.
Matching Process. The WV Vital Statistics department (in Charleston, WV) sends the
Birth Certificate data to the Birth Score project each month. This is done to ensure the number of
Birth Score project forms completed by each hospital for every child born in the state. The Birth
Score project data manager performed the matching process by linking maternal social security
numbers using SAS software. The remaining unmatched babies are printed out and hand matched
against the Vital Statistics Birth certificate data. The first and last name of the infant, birth
hospital, mother’s first, last, and maiden names, and date of birth are used to obtain the highest
probable match.
This combined Birth Certificate/Birth Score data file was then used for linkage to the
CARDIAC data. The CARDIAC office provided the CARDIAC data file, which consists of the
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CARDIAC identification number, the first and last name of the child, date of birth and the
mother’s name for years 2004-2010 (N=46,198). The Birth Score applications programmer
performed the matching process for all years. Overall, nearly 50% data match was achieved
(N=22,136) between the CARDIAC and the Birth Score data. One of the main reasons for the
unmatched data is the fact that not all children in the fifth grade in WV were necessarily born in
WV and thus their information is not available in the Birth Score database.

Variables
Dependent variables. The main outcome variables for the study were available from the
CARDIAC data, and include blood pressure (SBP and DBP) and lipid profile (TC, LDL, HDL,
non-HDL, and TG) for the child and only lipid profile (TC, LDL, HDL, non-HDL, and TG) for
the mother. Blood pressure was taken after the child had rested for five minutes. The first
Korotkoff sound was used to record SBP and the fifth Korotkoff sound (K5, the last sound heard)
was used to record DBP, measured in mm Hg. Lipids were both fasting and non-fasting, and
measured in mg/dL; LabCorp estimated LDL using the Friedwald equation. All the outcomes
were used as continuous variables. Some implausible values due to data coding error (e.g. SBP of
5mm Hg) were set to missing. This included 8 observations for SBP, 28 observations for DBP, 10
observations for TC, 27 observations for LDL, 7 observations for TG, 5 observations for maternal
TC, and 1 observation for maternal LDL.
Independent variable. The main exposure was defined as birth weight of the child in
grams at the time of delivery. The continuous variable was obtained from the Birth Certificate
data. The birth weight is also captured by the Birth Score Project with the following categories:
<1501 grams, 1501-2000 grams, 2001-2500 grams, 2501-3000 grams, and >3000 grams. For the
purpose of this project, we will use birth weight data for full-term infant only; i.e., for infants
born ≥37 weeks of gestation. This variable was used as both a continuous and a categorical
variable depending on the type of analysis. Child’s birth weight has been shown to be both
linearly (positively72,73 and inversely 33, 38,74) and non-linearly (i.e., U-shape 9,84) associated with
childhood CVD risk factor measures. Because of this plausible U-shaped relationship, birth
weight was categorized using conventional cut-offs categories as LBW (<2,500 grams), normal
birth weight (2500-4000 grams), and HBW (>4000 grams).
Mediator. Trained area coordinators, nurses, and health science students measure the
children’s height and weight using SECA Road Rod stadiometer (78”/200 cm) and the SECA 840
Personal Digital Scale respectively (Seca Corp, Hanover, MD, USA). Body Mass Index (BMI) is
a measure of weight adjusted for height and is calculated by CDC EpiInfo using the following
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equation: BMI (kg/m2) = weight (kg)/height (m2). The study used BMI percentiles as a proxy for
the child’s current adiposity measure.85 The BMI for children ages 2 to 20 are plotted on a gender
specific growth chart (the 2000 CDC growth chart).86 BMI percentiles are thus a measure of
relative weight adjusted for the child’s height, age and sex that corresponds to the 2000 CDC
growth charts.86
Covariates. We controlled for socio-demographic variables and other confounder
variables that have shown to be associated with both the exposure (birth weight) and the
outcomes of interest (CVD risk factors) or only with the outcomes of interest based on current
literature.
Socio-demographic variables. The socio-demographic variables included the child’s age,
sex, race, maternal age, maternal race, education (at birth and later when child in fifth grade), and
health insurance status at time of delivery. The age of the child in fifth grade was calculated from
the CARDIAC screening date and parent-reported child birthdate in the CARDIAC project. The
sex of the child was recorded at birth and at fifth grade by all three projects. This study used the
sex (male or female), recorded by the CARDIAC project in fifth grade. The race/ethnicity of the
child was parent-reported in fifth grade. For this study we dichotomized the race as “white” and
“other” based on the population distribution of WV (i.e., 94% white).87 The Birth Certificate as
well the Birth Score Project captured data on maternal race, which was dichotomized as “white”
and “other” as well.
Current literature shows inconsistent results of the association between maternal age and
childhood CVD risk factors88,89 and between maternal age and maternal CVD risk factors.90,91 The
association between maternal age at birth and childhood birth weight has been shown in
numerous studies; 92,93 thus maternal age (continuous) at the time of infant’s birth was included as
a confounder and recorded by the WV Birth Certificate data. For the maternal outcomes, the
maternal age at birth was added to the child’s age in fifth grade to generate maternal age when the
child was in fifth grade. Current literature also shows that maternal socio-economic status such as
maternal education and maternal health insurance are not only associated with giving birth to
LBW babies,94-96 but are also associated with CVD risk factors in childhood,97 and with maternal
CVD health as well.98 The maternal education at time of birth was recorded as a continuous
variable and included the number of years of education received ranging from 1 to 17. Maternal
education was also recorded when the child was in fifth grade and was dichotomized as less than
or equal to 12 grade and more than 12 grades of education. Maternal health insurance at the time
of delivery was categorized as a binary variable (Medicaid and non-Medicaid).
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Family history of risk factors. The CARDIAC project collects information on family
history of heart disease, coronary heart disease, heart attack, open-heart surgery, angioplasty, and
death from heart disease; thus, we made a new variable called family history of CVD based on
having family history of any one of these six variables. Family history of hypertension or high
cholesterol is associated with having high blood pressure and abnormal lipid level in later
life;99,100 the CARDIAC project collects information on family history of cholesterol (yes or no).
Family history of diabetes (yes or no) was also available from the CARDIAC project.
Other infant and maternal characteristics. Additional covariates include number of
previous pregnancies (0 or ≥1), smoking during pregnancy (yes or no), smoking in the house
when the child was in fifth grade (yes or no), weight gain during pregnancy (measured in
pounds), gestational age (range 37 - 44 weeks) and infant feeding intention (breastfeed or both
breastfeed and bottle). The literature shows that children from mothers with increasing parity
(i.e., with one or more than one number of previous pregnancies; multiparous) have lower blood
pressure, TC and LDL compared to children of mothers with no prior pregnancies (nulliparous).
101,102

There is also an association between nulliparity vs. multiparity and low birth weight.103

Furthermore, there is also an association between parity and maternal CVD risk.104,105
Smoking is a well-established risk factor for CVD. Maternal smoking during pregnancy
has also been shown to be associated with childhood CVD risk factors106 107 as well as delivering
LBW babies.108,109 Maternal smoking during pregnancy (yes or no) was obtained via self-report
by the Birth Score project at birth. The CARDIAC project inquired if anyone smoked in the
house when the child was in fifth grade as well. Current literature shows inconsistent association
between gestational weight gain and higher risk of childhood CVD risk factors.110,111 Data on
maternal gestational weight gain was available at birth and was assessed for its role as a
covariate. Although this study only examined full-term birth infants (born ≥37 weeks of
gestation), children born full term can also have low birth weight; therefore the potential role
gestational age (ranging from 37-44 weeks) as a confounder was assessed as well. The Birth
Score Project collects information on mother’s intention to breastfeed. Breastfeeding has shown
to be protective for childhood CVD risk factors.112,113 Recent research also suggests that
breastfeeding is significantly associated with positive CVD health outcomes for the mother as
well.114-116 In our previous study we have demonstrated that intention to breastfeed is correlated (r
= 0.66) with actual breastfeeding practices in WV children.117 Therefore, we used intent to
breastfeed as a surrogate for actual breastfeeding practices.
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Statistical Analysis
All statistical analyses were conducted in SAS version 9.3 (SAS Institute, Cary NC). TG
was log transformed in all analyses. The one-way analysis of variance (ANOVA) was used to
determine whether there were significant differences between the means of all the outcomes of
interest and three birth weight groups (LBW, normal birth weight, and HBW). Post hoc tests (i.e.,
Tukeys) were performed when there was significant omnibus F-tests to explore which means
were significantly different from each other. Bivariate relationships between the birth weight
(continuous) and the CVD risk factors (continuous variables) were assessed using Pearson
correlation. Seven separate multiple-regression analyses were performed for the 7 continuous
dependent variables (SBP, DBP, TC, LDL, HDL, non-HDL, and TG). All CVD outcomes were
first regressed on birth weight (main independent variable) as a continuous variable as also as
categorical variable using conventional cut-offs [LBW (<2,500 grams), normal birth weight
(2500-4000 grams), and HBW (>4000 grams)] to determine for both the linear as well as the nonlinear relationship of birth weight and CVD risk factors (model 1). Two dummy variables were
made for LBW and HBW categories and normal birth weight was utilized as the referent
category. In separate models BMI percentile of the child in fifth grade was included in order to
assess its role as a mediator (model 2). For all outcomes, additional covariates were added to
model 2 (model 3). The decision to include the additional covariates was based on a priori
hypotheses, existing literature, and associations that were found significant with the outcome
variable at the bivariate level using Pearson (for continuous variables) or Spearman (for
categorical variables) correlations. The covariates were dropped one at a time from the regression
model if they were not significant (with highest p-value greater than p >0.05). However, if the
main independent variable (birth weight) was not significant it was retained in the model
regardless of its significance.
Ordinary Least Squares (OLS) regression was utilized, which is the most common type of
multiple regression model where: y = a + bx1 + bx2+ bx3+ bx4…bx15, where y is the criterion
DV, ‘a’ is the constant, ‘b’ is the slope weight values, and x1 through x15 are the values for the
predictors (IVs). The slope ‘b’ gives us the change in the predicted value of Y, on average, for
each unit increase in X. Regression assumptions were assessed for all variables. The regression F
statistic was used to determine the overall significance of the regression model and a
corresponding p-value of ≤0.05 was used for statistical significant. The association of each
independent variable to the outcome variable was also assessed for significance (alpha ≤0.05) by
examining the parameter estimates and their corresponding t-test values in addition to the 95%
confidence intervals (CI) of the t-statistic.
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We report both standardized and unstandardized regression coefficients in order to assist
in interpretation of the findings. The squared multiple correlations, R², and adjusted R² were
interpreted as the effect sizes of the regression model (magnitude of the association). The study
also performed the regression analysis with and without the main predictor variable (i.e., birth
weight) in order to calculate the unique amount of variance shared between birth weight and
CVD risk factors by calculating the change in R² for outcomes assessed in model 3 only.
Furthermore, the interactions between age and sex were also assessed and dropped from the
model if they were not significant. (Note: the only significant interaction (age*sex) was present
for LDL).
For the maternal CVD risk factors (TC, LDL, HDL, non-HDL, and TG), the same
analyses were performed. The one-way analysis of variance (ANOVA) was used to determine
whether there were significant differences between the means of all the outcomes of interest and
three birth weight groups (LBW, normal birth weight, and HBW). Bivariate relationships
between the birth weight (continuous) and the CVD risk factors (continuous variables) were
assessed using Pearson correlation. Five separate multiple-regression analyses were performed
for the 5 continuous dependent variables (TC, LDL, HDL, non HDL, and TG). If the bivariate
relationships were significant, then multiple regression analysis was planned to regress the
outcome variable on birth weight variable adjusting for additional covariates.
Sensitivity analyses. To explore whether there were gender differences we included the
interaction term between gender and birth weight in the regression analysis. If the interaction
term was significant we performed separate regression models by gender for that outcome. In
order to use birth weight as a continuous variable and assess for the U-shape relationship, we
used splines modeling technique that takes into consideration the relationship between the birth
weight and the outcome within and between levels of the predictor variable (i.e. birth
weight).118,119 A linear spline is a continuous function formed by connecting linear segments.
They are piecewise polynomial segments in one variable of some degree D with function values,
which is continuous and the function has D-1 derivatives that agree at the points where they join.
The joining points are called knots that mark one transition to the next and allowing the curve the
freedom to change direction and follow the data more accurately to model the relationship
between the independent and the dependent variable.118,119 We used 2 knots at the two
conventional cut-off points for birth weight distribution (<2,500 grams and >4000 grams) and
additional knots were also explored. This allows the slope of the regression to change at these two
knots, thus allowing flexibility of the continuous birth weight to fit the non-linear segments (three
segments). Lastly, we performed a post hoc sensitivity analysis by adjusting for pre-screening
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fasting levels in the regression analysis. Nearly 5% of the study population was not fasting before
screening. Recent data shows that cholesterol levels test for fasting and non-fasting children are
minor and do not have clinical relevance.140
Results
A total of 22,136 participants were available for analysis with the merged data. After
excluding the infants born preterm (i.e. <37 weeks of gestation: 2,097 (9.67%)), the final number
of participants for this study was 19,583. From the CARDIAC project data, the mean age of the
children in fifth grade was 10.95 (±0.48), 56% were female, 95% infants were white. The mean
BMI percentile of fifth graders was 73.05 (±27.84). Nearly 3% of the infants were LBW and 11%
were HBW in full-term birth infants. The CVD risk factor data was available for approximately
85% of children. However, the maternal lipid data was available for only 6% of the mothers
(N=1,121). The population characteristics of children and mothers are available in Table 1.
The means of all the outcomes of interest by the three birth weight groups (LBW, normal
birth weight, and HBW) are given in Table 2. Only SBP and DBP showed significant overall
results. Further exploration using post-hoc comparisons showed that the mean SBP and DBP for
infants with HBW were significantly higher than infants born with normal birth weight. For the
mothers, none of the mean lipid levels were significantly different for the three groups. Consistent
with the ANOVA results, the correlations between birth weight (continuous) and SBP (N=19,397,
r = 0.03, p = 0.0002), and between birth weight and DBP (N=19,344, r = 0.03, p <0.0001), were
significant and positive (Table 3). For the lipid levels, the correlations between birth weight and
HDL (N=16,066, r = 0.02, p = 0.0035) were significant and positive, and between birth weight
and TG (N=15,951, r = -0.03, p = 0.0005) were significant and negative. For the mothers there
was significant and positive correlation of birth weight with maternal TC (N=1,116, r = 0.06, p =
0.0386) only (Table 3).
The results of the multiple linear regression analysis using birth weight as a continuous
variable showed the same pattern as observed in the correlations above for childhood CVD risk
factors (Table 4a model 1). When using birth weight categories, only HBW was significantly
higher than normal birth weight for child’s SBP and DBP only and showed a trend towards
significance for TC, LDL, and non-HDL cholesterol levels (p = 0.07) in children (Table 4a model
1). When the child’s current BMI was added to the model the association between birth weight
and SBP and DBP became non-significant. Moreover, the association between birth weight and
SBP, TC, and LDL reversed but were not significant (Table 4a model 2). HDL was positively,
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and non-HDL and TG were negatively associated with the birth weight. Children born LBW had
significantly lower HDL, and those born with HBW had significantly higher HDL levels, where
as the reverse was true for non-HDL and TG in fifth grade (Table 4a model 2). Moreover, when
additional covariates were adjusted for in the regression model, the association between
continuous birth weight and LDL was significant with a 1.1 mg/dL decrease in LDL per 1000 g
increase in birth weight (b= -1.1 md/dL; (95% CI: -1.9, -0.2) per 1000 g increase in birth weight,
p = 0.02). The association between birth weight and non-HDL [(b= -0.2 mg/dL (95% CI: -0.3, 0.1) per 1000 g increase in birth weight, p = 0.0002)], and between birth weight and TG [(b= 0.005 (95% CI: -0.007, -0.004) per 1000 g increase in birth weight, p = 0.0001] remained
significant and negative (Table 4a model 3). For HDL the association remained significant and
positively associated with birth weight in the fully adjusted model [(b = 0.1 mg/dL (95% CI: 0.06,
0.13) per 1000 g increase in birth weight, p = 0.0001)] (Table 4a model 3). The list of additional
covariates and their relationship with the outcomes are detailed in Table 5. The unique variance
shared between birth weight and the significant outcomes were determined by calculating the
change in R-square, which ranged from 0.02% to 0.2% (Table 5).
For the maternal lipid levels the unadjusted regression results showed that with every
1000 g increase in the child’s birth weight the maternal TC increased by 0.5 mg/dL (95%CI: 0.02,
0.90) (Table 4b model 1). However, the association became non-significant when adjustments
were made for additional covariates [(b = 0.4 mg/dL (95% CI: -0.01, 0.87) per 1000 g increase in
birth weight] (Table 4b model 2).
No gender differences were observed in the additional sensitivity analysis that examined
the interaction of birth weight by gender on blood pressure and lipid levels of children. The
results of the sensitivity analyses that used spline regression models for children are presented in
supplemental Tables S1. For the models that included the child’s current BMI and additional
covariates (Table S1-model 3) showed that with every one-unit increase in the birth weight the
child’s TC, LDL, and non-HDL levels decreased significantly in the <2500-gram segment only.
DBP demonstrated a U-shaped relationship in both the crude and adjusted spline models.
However, none of the segments were statistically significant. The results of the sensitivity
analyses that used spline regression model for the mother data are presented in supplemental
Table S2. The results were not significant for any of the spline birth weight segments and
maternal lipids. The post hoc sensitivity analysis adjusting for children pre-screening fasting
status showed no differences in the results of the multiple regression analysis that did not adjust
for the pre-screening fasting status of the child.
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Discussion
Overall, the results showed a linear positive association between birth weight and
maternal TC levels and between birth weight and childhood SBP, DBP, and HDL and a negative
association of birth weight with child’s TG at the bivariate level (based on the results of the
Pearson correlation and linear regression (unadjusted) results). When adjusted for the child’s
current BMI percentile in fifth grade, the association between birth weight and SBP and DBP
became non-significant. However, the association between birth weight and HDL and TG not
only remained significant but also strengthened. Additionally, non-HDL was negatively but not
significantly associated with birth weight in the crude analysis, and became significantly and
negatively associated with birth weight after adjusting for the child’s current BMI. Surprisingly,
when additional covariates were added to the models, the association between birth weight and
LDL also became significant, demonstrating a negative association as well.

Blood Pressure in Children
Our results are consistent with studies that found a positive association between birth
weight and childhood SBP for the crude analysis that reversed in direction for the adjusted
association.45,120 Although the direction of our study is consistent with previous studies, unlike
most studies the adjusted association was not significant.34,36,40,68,121 However a recent study that
examined this association in WV fifth grade found no significant differences in SBP in fifth grade
by gestational group (SGA, AGA, LGA) or comparing preterm to term birth infants.47 As our
study focused on term birth infants only, it is difficult to compare the findings to the earlier work
done on WV fifth grade children. The results of our study suggest that the association between
birth weight and childhood is potentially mediated by the child’s current BMI. The direction of
the association between birth weight and SBP is consistent with the Barker’s hypothesis for the
adjusted analysis only. However, the non-significant findings suggest that the association is not
independent of the child’s current BMI.
Our results are similarly consistent with studies that found a significant positive
association between birth weight and childhood DBP for the unadjusted analysis37,120 that became
non-significant (but remained positive) after adjusting for the child’s current BMI.42 Azadbakht
and collegues also found significant mean differences in DBP levels according to birth weight
categories and also a positive crude association as observed in our study. However unlike the
results of our study their findings remained signifiant after adjusting for child’s current BMI,9 as
demostrated by other studies as well.33, 36 Our study demonstated a significant positive linear
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association between birth weight and DBP (b = 0.06 mmHg; 95% CI: 0.03 - 0.08; p <0.0001 for
1,000 g increase in birth weight) that attenuated and became non-significant when adjusted for
the child’s current BMI (b = 0.01 mmHg; 95% CI: -0.01, 0.04; p = 0.4916 for 1,000 g increase in
birth weight). The results from the spline regression models (sensitivity analysis) for DBP
demonstrated a U-shaped relationship in both the crude and adjusted spline regression models.
However, none of the segments were statistically significant. The direction of the association
between birth weight and DBP is not consistent with the Barker’s hypothesis for both the crude
and the adjusted analyses. However, it is important to note that DBP is a less reliable measure
compared to SBP in children.122,123 Furthermore, numerous studies have shown SBP to be a
stronger predictor of CVD compared to DBP.124

Lipids in Children
Our results are consistent with studies that have found a significant association between
birth weight and childhood HDL (positive),9,34 and between birth weight and TGs (negative).35
Adjustments for the child’s current BMI strengthened the relationship between birth weight and
HDL and between birth weight and TG levels in children. LDL and non-HDL were not
significant in the crude analysis but became significant and negatively associated with birth
weight after accounting for the child’s BMI and additional covariates. Our results for non-HDL
and LDL are consistent with the findings of other studies as well.34,36 For TC; our results are not
consistent with the systematic review that found a weak inverse relationship between birth weight
and childhood TC levels.125 Another study that used WV CARDIAC data for 11 years old
children found that infants who were born preterm had higher levels of TGs compared to term
infants. The study also found that SGA infants were less likely to be obese in fifth grade, but
those who were obese had higher TG levels compared to AGA or LGA obese children.47 The
study did not find an association with other lipid levels. However, the population in our study was
limited to term infants only, which differed from the study by Mullett and colleagues that
included preterm infants as well.47
Our results demonstrated that LBW was associated with lower mean HDL and higher
LDL, non-HDL, and TG levels independent of the child’s current BMI and additional covariates.
When birth weight was categorized, LBW vs. normal birth weight subjects had higher LDL and
non-HDL levels, and HBW subjects had higher HDL and lower TG compared to normal birth
weight children. These results suggest that association between birth weight and lipid levels is
linear and not U-shaped as demonstrated by some studies.35,84,126 Based on these results, we
hypothesize that the association between birth weight and lipids is independent of the child’s
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current BMI levels. However, the change in R2 showed that birth weight accounted for less than
1% of unique variance in lipid levels of fifth grade WV children, suggesting a small effect size.
Interpreting significant covariates included in the study may be of some interest as well
(Table 5). The results suggest that girls had significantly higher LDL, higher TG and lower HDL
compared to boys as observed in other studies as well.127,128 The interaction between sex and age
was significant for LDL only, which suggested that there was an increase in LDL levels with an
increase in age and the increase was much larger for girls than for boys. Although the age range
in our study was only 5 years (9 to 14), we observed that there was a significant increase in the
level of TGs129 and a decrease in HDL130 and non-HDL with age during childhood as observed in
other studies as well.131 Race (white vs. others) was a significant factor for HDL (lower) and TG
(higher) only, which is also consistent in the literature.129,132 Family history of CVD or cholesterol
was positively associated with the child LDL, non-HDL, and TG levels and negatively associated
with HDL as expected based on current literature.99,100,133 Previous literature has shown
inconsistent association between maternal education and child’s TG levels, 134,135 our study
demonstrates that the increase in mothers’ education at birth was associated with lower child’s
TG levels (b= -0.01 mg/dL decrease in TG per 1 year increase in maternal education, 95% CI: 0.02, -0.01). Maternal age at time of birth was not significantly related to childhood lipid levels as
observed in other studies as well, 89 except for HDL levels, which increased as the maternal age at
birth increased. Maternal smoking during pregnancy was associated with lower HDL during
childhood as observed in another study examining lipid level in 8-year-old children.106 However,
previous literature has shown this association with other lipid levels as well106,107 not observed in
this study. Mother who intended to ‘breastfeed only’ had children with significantly lower nonHDL compared to mothers who ‘intended to breastfeed and bottle-feed’ their infants. Lastly, and
most importantly the BMI percentile was significantly associated with all lipid levels. The
standardized regression coefficients for the outcomes ranged from 0.14 to 0.35 (negative for
HDL) for every one unit standardized increase in the BMI percentile of children (Table 5).

Adjusting for Current BMI
Our study results showed that the positive association between birth weight and SBP, TC,
and LDL became negative (reversed) when current BMI was added in the model. However the
change in direction from positive to negative after adjusting for current BMI is an area of great
controversy. Some believe that adjusting for current BMI may produce spurious inverse
association.136,137 Tu and colleagues performed a simulation study where the true positive
association between birth weight and adult blood pressure attenuated and even reversed when the
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correlation between birth weight and the current weight was increased.137 However, Gillman and
colleagues demonstrate that adjusting for current body size is not only appropriate but can also
help us understand the inverse birth weight and CVD risk factors association.138 The systematic
review by Lauren and colleagues concluded that there was no consistent relationship between
birth weight and later lipid levels and most studies that adjusted for the current size were the ones
that supported the Barkers hypothesis only.84 Other researchers have also recommended not
adjusting for current body size.39,69 Menezes and colleagues found the positive association
between birth weight and blood pressure that reversed direction after adjusting for current BMI.
However the authors state that regardless of their findings they do not support the inverse
association because birth weight adjusted for current weight is a proxy measure of post-natal
growth and not a measure of birth weight.120 In our study the direction of association between
birth weight and SBP, TC, and LDL changed from positive to negative when adjusted for current
BMI. However, based on our unadjusted results (model 1) we can clearly see that LBW was
significantly associated with higher TG and lower HDL levels and adjustment for current BMI
only strengthened the associations. Overall, our results suggest that BMI is a key predictor of
CVD risk factors (Table 5) and a potential mediator for the relationship between birth weight and
CVD risk factors and therefore should be accounted for in the regression models. (Note in our
study: Pearson correlations between BMI and birth weight (r = 0.10), SBP (r = 0.34), DBP (r =
0.26), TC (r = 0.10), LDL (r = 0.15), HDL (r = -0.33), non-HDL (r = 0.23), and log-TG (r =
0.35), p <0.0001).

Lipids in Mothers
The results of our study found no significant mean difference in any of the lipid levels of
mothers by birth weight categories of the child. However, the correlation between birth weight
and maternal TC was significant and positive. The nature of the association was further revealed
when the birth weight was categorized in the regression analysis, which demonstrated that
mothers who gave birth to HBW babies had higher TC compared to mothers who gave birth to
normal birth weight babies. However, the association became non-significant when additional
covariates were added in the model. None of the other lipid levels were significant associated
with the birth weight of infant. Although, not significant the direction of association suggests that
mothers who give birth to HBW babies have a trend towards increased risk of poor lipid levels 11
years post-partum as demonstrated by a positive association between birth weight and TC, LDL,
non-HDL, TG and a negative association with HDL. A study by Yajnik and colleagues found no
significant relationship between the infant birth weight and maternal TC, LDL, and HDL but
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found significant positive association for TG levels in India.58 Our results are consistent with
Yajnik et al., findings for the direction of association between birth weight and lipid levels but not
significant for TG as found in this earlier work.58 This may be due to differences in the birth
weight distribution of the two populations. Furthermore, we did not have information on maternal
lipid levels or maternal BMI, which has been associated with infants birth weight.139 We also did
not have information on the birth weight of the mothers when they were born. Whether mother’s
abnormal lipid levels are associated with giving birth to low or high birth weight babies, or
whether the birth weight of the infant is a potential risk factor for maternal lipid level in later
years, or whether the mother’s own birth weight impacts their lipid profile is difficult to establish
at this point. The research on this topic is still in its infancy and needs further exploration.

Limitations of the Study
Some of the limitations of the study include lack of information on possible important
confounder variables such as parental adiposity status, maternal pre-pregnancy weight, maternal
lipid status before and during pregnancy, maternal birth weight, rapid weight gain during the first
year of life, pubertal status of the child, family history of hypertension, physical activity, and
dietary behaviors. Furthermore, the CARDIAC project only collects parental lipid data and thus
the maternal CVD risk factors were limited to lipid profile only, which was available for a small
sample of the population. Only a small percent of mothers of participating CARDIAC students
took advantage of the free vouchers for lipid testing, thus limiting the generalizability of the
sample. Due to the unique characteristics of the Appalachian state of WV, results may not be
generalizable beyond the participants included in this study.

Strengths of the Study
Despite these limitations, this study demonstrates a significant linear association between
birth weight and child’s lipid levels in fifth grade using a large longitudinal dataset with
information available for important covariates. The direction of association of all outcomes
(except DBP) was consistent with the Barker’s hypothesis. To our knowledge this is the first
study that has examined these associations in the state of WV for both mothers and the children
born full-term at birth. These results provide an important contribution for expanding the research
examining the association between birth weight of the infant and maternal CVD health.
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Conclusion
Our earlier work has shown that HBW is associated with higher childhood BMI in fifth
grade WV children.117 This study provides information on the relationship between birth weight
and other CVD risk factors as well, demonstrating that LBW is associated with higher risk of
abnormal lipid levels (higher LDL, non-HDL, and TGs and lower HDL levels) in fifth grade
children independent of current weight status in this young Appalachian population. As there is
tracking of CVD risk factors from childhood into adulthood, there is a potential that these small
effect sizes can have detrimental effect on CVD in later adulthood in WV. For the mothers CVD
risk factors, HBW of the infant seemed to demonstrate a trend towards poor maternal lipid levels
11 years post-partum. Well-designed longitudinal studies are needed to understand the complex
biological pathways for both the mother and the child and examine these associations at different
stages of life. Furthermore, future research should also focus on working with diverse populations
to establish different birth weight cut-offs that can increase the sensitivity of identifying infants
with higher risk of future CVD as suggested by the recent systematic review as well.44
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Chapter 3: Breastfeeding and childhood and maternal cardiovascular risk factors

Abstract
Introduction: The Appalachian state of West Virginia (WV) has a higher prevalence of
cardiovascular disease (CVD) and lower breastfeeding rates compared to the national averages.
There is paucity of research examining the relationship of breastfeeding to subsequent childhood
and maternal CVD risk factors, an issue of particular relevance in this rural state.
Methods: The study used longitudinally linked data from three cross-sectional datasets in
WV datasets [West Virginia Birth Certificates, the Working in Appalachia to Track High Birth
Score, Critical Congenital Heart Disease and Hearing Loss (WATCH)/Birth Score project, and
the Coronary Artery Risk Detection in Appalachian Communities (CARDIAC) project]. The
information on the main exposure “history of breastfeeding” was obtained retrospectively via
parental recall when the child was in fifth grade. The outcome variables included blood pressure
measures (systolic blood pressure (SBP), diastolic blood pressure (DBP)) for children and lipid
profile for both the mother and child (total cholesterol (TC), low-density lipoprotein cholesterol
(LDL), high-density lipoprotein cholesterol (HDL), non-high-density lipoprotein cholesterol
(non-HDL), and triglycerides (TG)). Mean differences, correlations, and simple regression
analyses were performed to examine the crude associations. Multiple regression analysis was
performed adjusting for current body mass index (BMI) and additional covariates.
Results: The final study sample after excluding infants born pre-term (i.e. <37 weeks of
gestation: N=1,190, 10.2%) was 10,457. Nearly, 43% of the mothers self-reported breastfeeding
their index child. The results showed a significant negative correlation between reported history
of breastfeeding and childhood SBP (r =-0.06), DBP (r = -0.04), and TGs (r = -0.07), and a
positive correlation between breastfeeding history and child’s HDL levels (r = 0.04). When
adjusted for the child’s current BMI and socio-demographic variables in the regression analysis,
the association was statistically significant for TGs only (beta = -0.04 mg/dL; 95% CI: -0.06, 0.01; p = 0.01). Maternal mean lipid levels were not significantly different between the two
groups nor were significantly correlated to their reported history of breastfeeding.
Conclusion: The observed protective effect of breastfeeding on the child’s TGs level in
fifth grade was small but significant. This supports the promotion of breastfeeding as a possible
preventive measure for future CVD risk factors in the rural Appalachian state of WV.
Nonetheless future research should focus on designing large prospective studies to assess and
understand the association of breastfeeding with both maternal and child CVD risks factors at
various life stages.
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Introduction
Cardiovascular disease (CVD) mortality accounts for nearly 50% of mortality, or 17.5
million out of 38 million chronic disease mortality worldwide.1,2 CVD is also the leading cause of
mortality and morbidity in the United States (U.S.)3 with nearly one third of adults having at least
one type of CVD.4,5 CVD mortality rates are nearly 20% higher in the rural Appalachian
population compared to the rest of the nation.6 West Virginia (WV), a state entirely within the
Appalachian region, has one of the highest rates of CVD mortality (ranks 45) in the nation and
also one of the highest prevalence of CVD risk factors ranking number 50th in high blood
pressure and 48th in high total cholesterol level.7 Data on early life determinants of CVD risk
suggests that breastfeeding is protective for cardiovascular health of an individual and also has a
protective effect on mothers who choose to breastfeed their infant.8-11
American Academy of Pediatrics (AAP) suggests six months of exclusive breastfeeding
and continuation of breastfeeding until the infant is one year old while gradually introducing solid
foods after six months.12 However, results from the 2011 National Immunization Survey (NIS)
show that only 18.8% of mothers in the U.S. and 12.2% of the mothers in WV exclusively
breastfeed for the first six months. The percentage of mothers who breastfeed but not exclusively
for the first six months postpartum is also much lower in WV (29%) compared to the national
average of 49%.13 Pediatric Nutrition Surveillance System (PedNSS), is another survey that
monitors nutritional status of low-income children enrolled in federally funded maternal and child
health program (mainly WIC). The results from 2011 PedNSS shows the only 13.5% of women
in WV enrolled in these programs breastfeed for six months where as only 0.3% exclusively
breastfed their infant. The results from 2011 NIS and PedNSS survey for the state of WV as well
as national rates are shown in Table 1.13,14
Bartick and colleagues performed a pediatric cost analysis and concluded that the cost of
morbidity and mortality associated with suboptimal breastfeeding in the U.S. was approximately
$14 billion annually in 2011.15,16 The researchers also performed a cost analysis of maternal
morbidity and mortality associated with suboptimal breastfeeding. The study calculated the cost
to be approximately $17 billion from premature deaths and $733.7 million (direct) and $126.1
million (indirect) morbidity costs.17
The detailed literature review presented below outlines the associations between
breastfeeding and child CVD risk factors including blood pressure (systolic blood pressure (SBP),
diastolic blood pressure (DBP)), and lipid profile [(total cholesterol (TC), low-density lipoprotein
cholesterol (LDL), high-density lipoprotein cholesterol (HDL), non-high-density lipoprotein
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cholesterol (non-HDL), and triglycerides (TG)], and then expands on associations between
mothers who breastfeed their infant and maternal CVD risk factors.

Breastfeeding and Childhood CVD Risk Factors
Breastfeeding has shown to be protective against childhood obesity.18 Data shows that the
risk of childhood obesity decreases (ranging from 15% to 35%) significantly in children who
were breastfed compared to children who were not breastfed.19-21 In addition to childhood
adiposity, breastfeeding has been shown to have protective effects on other CVD risk factors
during childhood such as blood pressure, cholesterol, and diabetes.22
A study that examined the association between breastfeeding duration and child’s blood
pressure at 8 years of age found significant higher mean values of SBP (but not for DBP) for
children who were breastfed for <40 days (99 mmHg) compared to children who were breastfed
for ≥40 days (93 mmHg) 23 suggesting a dose-response relationship between breastfeeding
duration and later childhood blood pressure.24 In another study, SBP was 1.19 mmHg (95% CI:
0.40, 1.96) lower among 5-year-old children who were breastfed for at least 6 months compared
to those who were not, even after adjusting the child’s current weight status.25 In another larger
prospective cohort study, SBP was 1.2 mmHg lower (95% CI: 0.5, 1.9) and DBP was 0.9 mmHg
lower (95% CI: 0.3, 1.4) among breastfed children, compared with children who were never
breastfed after adjusting for covariates.26 Consistent with these results, a systematic review with
meta-analysis found the pooled mean difference in SBP was −1.10 mmHg (95% CI: -1.79, -0.42)
among infants who were breastfed during infancy but DBP was not significantly related to the
type of infant feeding.27 Another systematic review on the topic showed that breastfeeding was
associated with a 1.4 mmHg reduction in SBP and 0.5 mmHg reductions in DBP in later life.28
However, other studies have shown no association between blood pressure and breastfed
and non-breastfed children,29,30 or between breastfeeding duration and blood pressure in
adolescence and young adults.31-34 For example, results from a randomized controlled trial for a
breastfeeding promotion intervention found no differences in adiposity or blood pressure at age
6.5 years in the experimental group compared to the control group.35,36 In an observational study,
neither exclusive nor partial breastfeeding (compared to never breastfeeding) were significantly
associated with blood pressure in 13-year-old adolescents.30 Furthermore, a recent systematic
review also found no association between breastfeeding and blood pressure in children ages 1019.37
Breastfeeding has also been studied in relation to childhood and adolescence cholesterol
levels.22 A study found that cholesterol concentration was significantly lower in boys (but not in
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girls) who were breastfed for a median duration of <2 months compared to those who were
formula fed.38 Another study that examined the association between breastfeeding and BMI and
serum lipids concentrations at 6 years, found that boys who were breastfed for <6 months had
significantly higher BMI than those breastfed for >8 months and longer duration was also related
to higher HDL levels in girls but not in boys.39 These results may also be beneficial later in life:
one study demonstrated a significant association between breastfeeding and higher levels of TC
and LDL cholesterol in older women compared to men.40 Two systematic reviews on the topic
also found breastfeeding to be associated with decreased risk of blood cholesterol levels later in
child’s life22 or in adolescence and adult life.41
Although generally the literature notes a positive protective factor of breastfeeding
against abnormal lipid profiles, other studies showed no association between breastfeeding and
serum lipid concentrations in children42 or in adults.34 But even these results may be misleading
due to the time in which the lipid measurements were taken. For example, two studies found no
difference in mean TC and LDL levels between breast feeders and bottle feeders in adolescence
(ages 13-16 years), but demonstrated that breastfeeding was associated with higher TC and LDL
during infancy (<1 years) and lower mean TC and LDL levels in adults >17 years even after
adjustment for BMI.41,43 Moreover, some studies have found the negative association with one
lipoprotein but not with the other types of lipoproteins or only in one of the sexes. For example,
in a population based cohort study in Brazil, the LDL cholesterol was higher among never (mean
41.0 mg/dl; 95% CI: 39.4, 42.7) than among ever breast fed adolescent boys (38.6 mg/dl; 95%
CI: 38.6, 40.3), while the associations with all other lipoprotein concentrations were not
significant.44 Another study of 17-year-old adolescents found significantly higher TG levels in
boys only and the association was not significant for girls and for other lipoprotein
concentrations.45 Additionally, a recent systematic review with meta-analysis found no
association between breastfeeding and TC levels for all age groups including ages 10-19.37

Breastfeeding and Maternal CVD Risk Factors
Recent research suggests that breastfeeding is significantly associated with positive
cardiovascular health not only for the child but also for the mother.46-48 A recent study examining
the association between lactation and CVD mortality found that parous women <65 years who
had never breastfed had a higher CVD mortality than women who had breastfed 24 months or
more (Hazard ratio (HR): 2.77, 95% CI: 1.28, 5.99).49 Another study noted that women who
breastfed for a lifetime total of >2 years had a 23% lower risk of heart disease compared to
women who had never breastfed.11 The researchers also found a dose-response relationship

33

between duration of lactation and lower prevalence of hypertension and hyperlipidemia in
postmenopausal women (median age 63 years) even after adjusting for the maternal BMI.11 Thus,
the beneficial effect of breastfeeding for mothers may extend to CVD risk factors such as
metabolic syndrome, obesity, hypertension, and high cholesterol. For example, a cross-sectional
study demonstrated that women who breastfed had significantly lower odds of metabolic
syndrome in later life (OR = 0.79, 95% CI: 0.63; 0.99).48 Another study also found that women
who breastfed for <12 weeks had significantly greater weight gain over a 15 year follow up
period compared to women who breastfed for >12 weeks.50 Other researchers note that
breastfeeding lowered maternal blood pressure as early as one month to five months
postpartum10,51 and continued to have beneficial effects later in life (45-64 years of age).52 On
average, women who breastfed for <3 months have higher visceral fat content,53 along with
higher TC and TG levels compared to women who breastfed their children for at least three
months.54 However, McClure et al., noted that the association between breastfeeding and HDL
became non-significant after controlling for socio-demographic variables.54
Conversely, a randomized controlled trial showed that longer breastfeeding duration did
not lower maternal adiposity or blood pressure 11.5 years postpartum55 and a prospective cohort
study did not find an association between breastfeeding duration and any of the serum lipid
markers (TC, TG, HDL, and LDL) at 3 years postpartum.56

Biology of Breastfeeding and CVD
Children. The composition and constituents of human milk are specifically intended for
human babies and any other form of feeding preparations is markedly different from human
milk.57,58 One of the main differences in human milk and formula milk is the fat content, which
differs throughout the day and within a single milk expression, as well as across each stage of the
infant’s growth.59 Formula milk is not responsive to the nutritional needs of the infant as the
infant ages.60 Human milk also contains digestive enzymes that help in the digestion of milk and
absorption of fat.61 This enzyme is absent in formula milk, which makes the digestive process
difficult. Some researchers hypothesize that the differences in health outcomes observed in
children are due to the differences in the infant’s digestion of human milk or formula milk.62
Other researchers note that the fat content in human milk may provide satiety signal, which
protects against overfeeding, in addition to the assumption that breastfed infants better learn to
regulate the amount of milk consumed.63-65 Studies have shown that breastfeeding increases the
infant’s ability to self-regulate energy intake, which prevents them from overconsumption.67,68 In
addition to digestive enzymes, human milk also contains growth factors or hormones that could
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also have an effect on the lipid metabolism and growth and development of the infant.66 Lastly, Li
and colleagues examined the satiety responsiveness of 6 year old children found that infants who
were bottle fed had low satiety responsiveness compared to breastfed infants, probably due to
parental control in infancy to empty their bottles.69
Mother. Several experts in the field have summarized the biological explanation for the
association between lactation and maternal lipid levels. During pregnancy, lipid levels increase
and after delivery these levels decrease rapidly in lactating women. This is potentially due to
alteration in lipid metabolism, as lactation process requires mobilization and redistribution of
lipids from body fat storage for milk production.48,70 Lactation not only increases the mother's
metabolic expenditure (nearly 500 kcal/day),71 the process also improves the metabolic system by
making it more efficient.11,48,72 This metabolic efficiency can potentially reverse the gestational
increases in fat and lipid accumulation and have a long-term positive impact on women’s
cardiovascular health.70 The decrease in lipid levels have been observed as early as 6 to 13 weeks
after delivery and up to three years postpartum; others have noted these differences even postmenopause.11,73-75

Statement of the Problem
In summary, the literature examining the association between breastfeeding and later
childhood CVD risk presents some inconsistent results. While most studies have found a
significant protective effect of breastfeeding on child CVD risk factors23 others have not.30,35,41,43
Data shows that childhood adiposity is associated with blood pressure and cholesterol.76-78 While
some studies have controlled for childhood obesity and found that the association between
breastfeeding and blood pressure and lipid levels attenuates,42 others have found that even after
controlling for BMI, the association remains significant.23 These conflicting results suggest that
childhood obesity could potentially be a partial or a full mediator between the observed effects.
Furthermore, some studies have found this association to be gender specific,38,39,45 age specific
(adults only),40 or specific to one or two components of CVD risk factors.44,45
The association between maternal breastfeeding and maternal CVD risk factors also show
inconsistent results. Some studies suggest that mothers who breastfeed have lower CVD risk
factor in later life,11,50,52 while others did not find a significant association.55,56 Most importantly,
to the best of our knowledge, we did not find any study examining these associations
longitudinally in the state of WV; where focusing on improving the low breastfeeding rates in the
state could potentially have an impact on the future CVD burden. The purpose of this study was
to investigate the influence of infant breastfeeding and childhood CVD risk factors (SBP, DBP,
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TC, LDL, HDL, non-HDL, and TG) at 11 years of age (controlling for child’s current BMI), and
the subsequent risk of developing maternal CVD risk factors (TC, LDL, HDL, non-HDL, and
TG) 11 years post partum.

Methods and Materials

Data Sources.
The study used data from three projects, including WV Birth Certificates, the Working in
Appalachia to Track High Birth Score, Critical Congenital Heart Disease and Hearing Loss
(WATCH)/Birth Score project, and the Coronary Artery Risk Detection in Appalachian
Communities (CARDIAC) project. The WATCH/WV Birth Score project is an infant riskscreening instrument that was initiated in 1985.79,80 Trained health care professionals collect data
on every newborn within 24-48 hours or prior to discharge, in order to identify infants who are at
a high risk of poor health outcomes or mortality in the first year of life, for referral to primary
care management.79-81 In this study, children participating in the Birth-Score project (all of whom
are merged with the Birth Certificate data) born between in 1997 to 2004 were merged with data
collected by the CARDIAC Project in years 2008-2014. The CARDIAC project collects data on
fifth grade public school children in 55 counties in WV with informed consent by
parents/guardians and assent by the child.82 Area coordinators employed by the project, along
with health science student volunteers, local school nurses, and volunteer phlebotomists conduct
blood pressure, anthropometric measurements, and blood lipid testing. Blood sample is obtained
from fifth grade children in the CARDIAC project and analyzed by local area hospitals or by
LabCorp Inc. (Burlington, NC). Parents of participating children were sent a voucher for
screening of their fasting blood lipid profile and reports were submitted to the CARDIAC project.
Further details of the data collection procedure are described elsewhere.83-86 The WV University
Institutional Review Board (Protocol number 1504666639) approved the merged analysis based
on the child’s identification number. We include only those observations where data was
available from all three projects.
Matching Process. The WV Vital Statistics department (in Charleston, WV) sends the
Birth Certificate data to the Birth Score project each month. This is done to ensure the number of
Birth Score project forms completed by each hospital for every child born in the state. The Birth
Score project data manager performed the matching process by linking maternal social security
numbers using SAS software. The remaining unmatched babies are printed out and hand matched
against the Vital Statistics Birth Certificate data. The first and last name of the infant, birth
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hospital, mother’s first, last, and maiden names, and date of birth are used to obtain the highest
probable match.
This combined Birth Certificate/Birth Score data file was then used for linkage to the
CARDIAC data. The CARDIAC office provided the CARDIAC data file, which consists of the
CARDIAC identification number, the first and last name of the child, date of birth and the
mother’s name for years 2008-2014 (N=20,531). The Birth Score applications programmer
performed the matching process for all years. Overall, nearly 60% data match was achieved
(N=11,980, 58.4%) between the CARDIAC and the Birth Score data. One of the main reasons for
the unmatched data is the fact that not all children in the fifth grade in WV were necessarily born
in WV and thus their information are not available in the Birth Score database.

Variables.
Dependent variables. The main outcome variables for the proposed study are available
from the CARDIAC data, and include blood pressure and lipid profile (SBP, DBP, TC, LDL,
HDL, non-HDL, and TG) for the child and lipid profile for the mother (TC, LDL, HDL, nonHDL, and TG). If maternal lipid profile was available for stepmother, adoptive-mother or legal
guardian, the observations were excluded for the maternal analyses only. Blood pressure was
taken after the child had rested for five minutes. The first Korotkoff sound was used to record
SBP and the fifth Korotkoff sound was used to record DBP, measured in mm Hg. Lipids were
both fasting and non-fasting, and measured in mg/dL; LabCorp estimated LDL using the
Friedwald equation. All the outcomes were used as continuous variables. Some implausible
values due to data coding error (e.g. SBP of 0 mm Hg) were set to missing. This included 2
observations for SBP and 1 observation for DBP.
Independent variable. The main exposure variable was the reported history of
breastfeeding. Information related to breastfeeding was obtained using the CARDIAC
questionnaire retrospectively via parental/caregiver recall when the child was in fifth grade. The
question stated, “Was your child breastfed?” and the answer options included ‘yes’, ‘no’ and
‘don’t know’. The ‘don't know’ option was recoded to missing.
Mediator. Trained area coordinators, nurses, and health science students measure the
children’s height and weight using SECA Road Rod stadiometer (78”/200 cm) and the SECA 840
Personal Digital Scale respectively (Seca Corp, Hanover, MD, USA). Body Mass Index (BMI) is
a measure of weight adjusted for height and is calculated by CDC EpiInfo using the following
equation: BMI (kg/m2) = weight (kg)/height (m2). The study used BMI percentiles as a proxy for
the child’s current adiposity measure.87 The BMI for children ages 2 to 20 are plotted on a gender
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specific growth chart (the 2000 CDC growth chart).88 Established cut-off points were used to
identify underweight (less than 5th percentile); healthy weight (5th to 84.9th percentile);
overweight (85th to 94.9th percentile); obese (95th to 98.9th percentile); and morbidly obese
(greater than 99th percentile) weight categories.89 BMI percentiles are thus a measure of relative
weight adjusted for the child’s height, age and sex that corresponds to the 2000 CDC growth
charts.88
Covariates. We controlled for socio-demographic variables and other confounder
variables that have shown to be associated with both the exposure (breastfeeding) and the
outcomes of interest (CVD risk factors) or only with the outcomes of interest based on current
literature.
Socio-demographic variables. The socio-demographic variables included the child’s age,
sex, race, maternal age, education and health insurance status at time of delivery. The age of the
child at fifth grade was calculated from the CARDIAC screening date and parent-reported child
birthdate in the CARDIAC project. The sex of the child was recorded at birth and at fifth grade
by all three projects. This study used the sex (male or female), recorded by the CARDIAC project
in fifth grade. The race/ethnicity of the child was parent-reported in fifth grade. For our study we
dichotomized the race as ‘‘white’’ and ‘‘other’’ based on the population distribution of WV (i.e.,
94% white).90 Current literature shows inconsistent results of the association between maternal
age and childhood CVD risk factors;91,92 thus maternal age at the time of infant’s birth was
included as a confounder and recorded by the WV Birth Certificate data. Maternal education has
also been shown to be associated with CVD risk factors in childhood 93 and also a predictor of
maternal breastfeeding practices.94,95 Maternal education at time of birth was recorded as the
number of years of education received ranging from 1 to 17 and was included as a continuous
variable for the analysis. Current literature also shows that maternal socio-economic play an
important role in the mother’s decision and duration to breastfeed her child.94,96,97 Maternal health
insurance at the time of delivery was assessed as a confounder variable (as a measure of socioeconomic factor) and categorized as a binary variable (Medicaid and non-Medicaid).
Family history of risk factors. The CARDIAC project collects information on family
history of heart disease, coronary heart disease, heart attack, open-heart surgery, angioplasty, and
death from heart disease; thus, we made a new variable called family history of CVD based on
having family history of any one of these six variables. Family history of hypertension or high
cholesterol is associated with having high blood pressure and abnormal lipid level in later life;98,99
the CARDIAC project collects information on family history of cholesterol (yes or no).
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Other infant and maternal characteristics. Additional covariates include number of
previous pregnancies (0 or ≥1), smoking during pregnancy (yes or no), weight gain during
pregnancy (measured in pounds) and birth weight of the child (measured in grams). The literature
shows that children from mothers with increasing parity (i.e., with one or more than one number
of previous pregnancies; multiparous) have lower blood pressure, TC and LDL compared to
children of mothers with no prior pregnancies (nulliparous).100,101 Maternal smoking during
pregnancy has also been shown to be associated with childhood CVD risk factors,96,102 and
maternal smoking is also associated with breastfeeding initiation and duration.103 Current
literature shows inconsistent association between gestational weight gain and higher risk of
childhood CVD risk factors.104,105 We had information on maternal gestational weight gain and
assessed for its role as a covariate in our study. Birth weight of the child is also associated with
childhood CVD risk factor.102 The information on birth weight was available as a continuous
variable in grams from the WV Birth Certificate data.

Statistical Analysis.
All statistical analyses were conducted in SAS version 9.3 (SAS Institute, Cary NC). TG
was log transformed in all analyses. Independent samples t-tests were used to compare the means
of dependent variables for the two breastfeeding groups (reported history of breastfeeding and no
reported history of breastfeeding) and the magnitude of this association was calculated using
Cohen’s d effect size (Cohen’s d =

where SD pooled=

. .

. .

). Bivariate

relationships between reported history of breastfeeding (binary: yes vs. no) and the CVD risk
factors (continuous variables) were assessed using Spearman correlation.
Seven separate multiple-regression analyses were performed for the 7 continuous DVs
(SBP, DBP, TC, LDL, HDL, non-HDL, and TG). All CVD outcomes were first regressed on
reported history of breastfeeding (model 1) (main independent variable) and then in separate
models BMI percentile was included to assess for its role as a mediator (model 2). For the
outcomes where the association was significant between reported history of breastfeeding and
CVD outcomes (independent of obesity), additional covariates were added in the model (model
3). The decision to include the additional covariates was based on a priori hypotheses, existing
literature, and associations that were found significant with the outcome variable at the bivariate
level using Pearson (for continuous variables) or Spearman (for categorical variables)
correlations.
Ordinary Least Squares (OLS) regression was utilized, which is the most common type of
multiple regression model where: y = a + bx1 + bx2+ bx3+ bx4…bx15, where ‘y’ is the criterion

39

DV, ‘a’ is the constant, ‘b’ is the slope weight values, and x1 through x15 are the values for the
predictors (IVs). The slope ‘b’ gives us the change in the predicted value of Y, on average, for
each unit increase in X. Regression assumptions were assessed for all variables. The regression F
statistic was used to determine the overall significance of the regression model and a
corresponding p-value of ≤0.05 was used for statistical significant. The association of each
independent variable to the outcome variable was also assessed for significance (alpha ≤0.05) by
examining the parameter estimates and their corresponding t-test values in addition to the 95%
confidence intervals (CI) of the t-statistic. The covariates were dropped one at a time from the
regression model if they were not significant (with highest p-value greater than p >0.05).
However, if the main independent variable (reported history of breastfeeding) was not significant
it was retained in the model regardless of its significance.
We report both standardized and unstandardized regression coefficients in order to assist
in interpretation of the findings. The squared multiple correlations, R², and adjusted R² were
interpreted as the effect sizes of the regression model (magnitude of the association). The study
also performed the regression analysis with and without the main predictor variable (i.e., reported
history of breastfeeding) in order to calculate the amount of variance shared between reported
history of breastfeeding and CVD risk factors by calculating the change in R² for outcomes
assessed in model 3 only. Furthermore, the interaction between age and sex was also assessed and
dropped from the model if they were not significant.
For the maternal CVD risk factors (TC, LDL, HDL, non-HDL, and TG), we first assessed
for the bivariate relationship between the binary categorical variable ‘reported history of
breastfeeding’ and maternal CVD risk factors (continuous variables) using Spearman
correlations. Independent samples t-tests were used to compare the means of dependent variables
for the two breastfeeding groups, and the magnitude of this association was calculated using
Cohen’s d effect size for significant differences only. If the bivariate relationships were
significant, then multiple regression analysis was planned to regress the outcome variable on the
reported history of breastfeeding variable adjusting for additional covariates.
Sensitivity analyses. To explore whether there were sex differences we performed chisquare tests on breastfeeding groups, in addition to including the interaction term between sex
and reported history of breastfeeding in the linear regression analysis. Many researchers believe
that preterm and term infants are two separate populations with different rates and risks of
morbidity and mortality in later life.106-110 The percentage of all infants who were reported to
being breastfed was 43.03% in this population overall, and the frequency of reported history of
breastfeeding was similar in full-term (43.17%) and preterm (41.75%) infants. Therefore, we
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performed all the analyses with children born both preterm and full-term combined to determine
if there were any observed differences in the outcomes assessed. We also performed a sensitivity
analysis on the missing data, and used multiple imputation techniques to address the missing data
for the maternal lipid data. Lastly, we performed a post-hoc sensitivity analysis by adjusting for
fasting levels in the regression analysis for children. There is a recent debate on whether to
require prescreening fasting when assessing lipids in children in population based studies. Steiner
and colleagues using data from NHANES 1999-2008 (N= 12,744) found that the lipid and
lipoprotein test results for fasting and non-fasting children were minor and do not have clinical
relevance. They concluded that prescreening fasting should not be required for children in order
to decrease the burden of childhood lipid screening.129 Nearly 20% of our study population in
fifth grade was not fasting before screening.

Results
A total of 11,980 participants were available for analysis with the merged data. After
excluding the infants born preterm (i.e. <37 weeks of gestation: 1,190 (10.2%)), the final number
of participants for this study was 10,457. The study had lipid profiles on only 131 mothers, of
which 127 were biological mothers in the complete dataset. For data restricted to full-term infants
only, the study had lipid profile on 115 mothers, of which 112 were biological mothers.
From the CARDIAC project data, the mean age of the children in fifth grade was 10.97
(±0.47), 55% were female, 94% infants were white. The mean BMI percentile of fifth graders
was 72.58% (±28) and 43.2% of the parents reported breastfeeding the index child at birth. The
CVD risk factor data was available for approximately 93% of children. However, the maternal
lipid data was available for only 1% of the mothers. The detailed population characteristics of the
children as well as the mothers’ characteristic are available in Table 2.
Children who had a reported history of breastfeeding compared to children with no
reported history of breastfeeding had significantly lower mean SBP, DBP, and TG and
significantly higher for mean HDL in fifth grade. The mean difference was -1.3 mmHg (95% CI:
-1.97, -0.81), -0.81 mmHg (95% CI: -1.26, -0.33), -0.08 mg/dL (95% CI: -0.10, -0.05), and 0.9
mg/dL (95% CI: 0.33, 1.56) for SBP, DBP, TG, and HDL cholesterol levels respectively (Table
3). The effect size calculated using the Cohen’s d formula ranged from 0.07 to 0.16 for the
significant outcomes (SBP, DBP, TG and HDL). The mean differences were not significant for
TC, LDL, and non-HDL among children who were reported to be breastfed compared to children
who were not breastfed. For the mothers, none of the mean lipid levels were significantly related
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to mothers who reported to have breastfed as compared to mothers who did not report
breastfeeding the index child.
Consistent with the t-test results, the correlations between reported history of
breastfeeding (yes vs. no) and SBP (N=6647, r = -0.06, p = 0.0001), DBP (N=6648, r = -0.04, p =
0.0007) and TG (N=6435, r = -0.07, p = 0.0001) were significant and negative, whereas the
correlation between reported history of breastfeeding (yes vs. no) and HDL was significant and
positive (N=6647, r = 0.04, p = 0.0011) (Table 4). The correlation between reported history of
breastfeeding and child’s TC, LDL, and non-HDL was not significant. Maternal lipid levels were
not significantly correlated to reported history of breastfeeding (yes vs. no) (Table 4). However
the direction of associations was consistent with the literature that suggests a protective
association between breastfeeding and maternal lipid levels. The results demonstrated a positive
correlation between mothers who reported to have breastfed vs. not breastfed and TC, LDL, nonHDL, and TG and a negative correlation between these two groups and maternal HDL levels.
The unadjusted regression analysis showed that children who had a reported history of
breastfeeding compared to children with no reported history of breastfeeding had significantly
lower SBP (b = -1.39 mmHg; 95% CI: -1.97, -0.81; p <0.0001), DBP (b = -0.79 mmHg; 95% CI:
-1.26, -0.33; p = 0.0009), log-TG (b = -0.08 (95% CI: -0.1, -0.05; p <0.0001), and higher HDL (b
= 0.95 mg/dL (95% CI: 0.33, 1.56; p <0.0001) (Table 5, model 1). However, adjustments for the
child’s current BMI decreased the associations of reported history of breastfeeding to SBP (b = 0.77 mmHg; 95% CI: -1.32, -0.23; p = 0.005) and log-TG (b = -0.05; 95% CI: -0.07, -0.03; p =
0.048), but eliminated the association to DBP (b = -0.44 mmHg; 95% CI: -0.89, 0.02; p = 0.06)
and HDL (b = 0.28mg/dL (95% CI: -0.29, 0.86; p = 0.335) (Table 5, model 2). Adjustments for
additional socio-demographic variables eliminated the association between reported history of
breastfeeding and SBP (b = -0.43 mmHg; 95% CI: -0.98, -0.13; p = 0.1349) and attenuated the
association with log-TG but remained significant (b = -0.04; 95% CI: -0.06, -0.01; p = 0.008)
(Table 5, model 3).
The results of the multiple regression analysis showed that reported history of
breastfeeding was significantly and inversely associated with TG of children with inclusion of
covariates in the model (F (8, 5339) = 118.84; p <0.0001; adjusted R2= 0.1499). Covariates
including BMI percentile in fifth grade, child's age, sex, race, maternal education at birth, number
of previous pregnancies, and family history of cholesterol were statistically significant in
predicting variance in TG of the child at 11 years of age (Table 6). The regression model showed
that among children who had a reported history of breastfeeding there was a 0.04 (b = -0.04; 95%
CI: -0.06, -0.01, t = -2.65, p = 0.008) decrease in the log-transformed TG levels compared to
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children who did not have a reported history of breastfeeding. The amount of variance shared
between reported history of breastfeeding and childhood TG levels was 0.13% (change in R2).
No sex differences were observed in the additional (sensitivity) analysis that examined
the interaction of reported history of breastfeeding by sex on blood pressure and lipid levels of
children (b= -0.03; 95% CI: -0.08, 0.02, t = -1.15, p = 0.2495). The results of the sensitivity
analyses that included all infants (preterm and full term) showed similar findings for both the
children and the mothers’ data. For example, the regression results for children born both preterm
and full-term combined showed that reported history of breastfeeding was significantly and
inversely associated with log-TG of children in fifth grade (-0.03; 95% CI: -0.0513, -0.0005, p =
0.046) with inclusion of covariates in the model (F (8, 6146) = 139.58; p <0.0001; adjusted R2=
0.1527). After multiple imputation for the missing data for the mothers, none of the lipid levels
were significantly correlated with mothers’ reported history of breastfeeding (mothers who
reported to have breastfed compared to mothers who did not) (supplemental files tables S1-5).
We performed a sensitivity analysis (post-hoc) and adjusted for the child’s pre-screening fasting
status. The regression results showed similar findings when adjusted for pre-screening fasting
status vs. not adjusting for fasting status [for e.g. the beta coefficient for the association between
breastfeeding and log-TGs adjusting for fasting was -0.035 (95% CI: -0.06, -0.01; p = 0.0113)
compared to -0.036 without adjusting for fasting status (95% CI: -0.06, -0.01; p = 0.008)].

Discussion
Overall, the results showed that children who had a reported history of breastfeeding (yes
vs. no) had significantly lower SBP, DBP, TG, and higher HDL at the bivariate level (based on
the results of the t-test, Spearman correlation and unadjusted linear regression results). When
adjusted for the child’s current BMI percentile in fifth grade, the association attenuated for SBP
and TG but remained significantly and positively associated with reported history of
breastfeeding. Thus, results suggest that BMI is a potential mediator for the association between
reported history of breastfeeding and DBP and HDL levels. However, adjustments for additional
covariates eliminated the association of reported history of breastfeeding to SBP but remained
significant for TG levels.

Blood Pressure in Children
Our results are consistent with studies that found no differences in the mean SBP and
DBP of children who were breastfed as compared to those not breastfed during infancy.29-36
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However, several studies have found the opposite23-26 including two earlier systematic reviews
with meta-analysis.27,28 These systematic reviews concluded that the pooled mean difference in
SBP (but not DBP) was significantly lower among infants who were breastfed,27 while the later
systematic review with meta-analysis found significant reduction in both SBP and DBP.28
Systematic reviews with meta-analysis occupy the highest levels of evidence in the hierarchy of
study designs.111 The Cochrane Collaboration, an organization dedicated to the conduct of
systematic reviews in healthcare, recommends that reviews on a given topic be updated every two
years.112,113 Our results on both SBP and DBP are consistent with the evidence provided by the
most recent systematic review with meta-analysis published in 2015.37 Horta and colleagues
demonstrated based on 10 studies for age groups 10-19 that SBP was lower but not significant
among those subjects who had been breastfed [mean difference: -1.03mmHg (95%CI: -2.07;
0.02)], whereas no association was observed for DBP based on 8 studies for age groups 10-19
[mean difference: -0.1mmHg (95%CI: -0.65; 0.45)]. Furthermore, this meta-analysis showed that
the mean difference was inversely related to study size. Studies with more than 1000 participants
included the null value. Our study further demonstrated that the association between reported
history of breastfeeding and childhood blood pressure (SBP and DBP) is not independent of
child’s current BMI and socio-demographic variables, thus suggesting the role of child’s current
BMI as a potential mediator. Breastfeeding has shown to be protective for childhood obesity as
demonstrated by several studies18-21,37,114 including our earlier work with WV fifth grade
children.115

Lipid in Children
The results of the current study are also consistent with studies that found no association
between TC,37,42,43 LDL,43 and non-HDL levels among breastfed vs. non-breastfed children. The
results of two systematic reviews with meta-analysis using random effects model showed that the
mean TC and LDL levels in children were not significantly different comparing breastfed infants
to non-breastfed infants [(mean difference TC= 0.00 mmol/L; 95% CI: -0.07, 0.07) and (mean
difference LDL= 0.01 mmol/L; 95% CI: -0.07, 0.08)].43 The most recent meta-analysis also found
no significant difference in the mean TC levels for children ages 10-19 between breastfed and
non-breastfed infants (mean difference TC= 0.01mmol/L; 95% CI: -0.06, 0.08).37
Of greater interest to us were the relationships that proved significant: in particular, HDL
and TG. For HDL our study found a significant positive association among fifth grade children
who were reported to have been breastfed during infancy, with a mean difference of 0.9 mg/dL
(95% CI: 0.33, 1.56). However, the association attenuated after adjustment for the child’s current
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BMI and became non-significant. The non-significant results are consistent with other studies 42,44
that also adjusted for the child’s current BMI.42 This finding also suggests that BMI is a potential
mediator for the association between breastfeeding and HDL levels in this population.
We found a significant association between log-transformed TG levels among fifth grade
children who had a positive history of breastfeeding independent of the child’s BMI, sociodemographic and lifestyle characteristics. To our knowledge very few studies have examined this
association for childhood TG levels. One study found a significant negative association in 17
years old boys but not among girls 116 and another study among 18-year-old boys did not find any
difference in never vs. ever breastfed adolescents.44 Yet, another population based study found
that among 6 year old children this association was not significant after adjusting for age, sex,
family-based socio-demographic, maternal lifestyle-related and childhood factors.117 We did not
find any differences by gender for the association between breastfeeding and TG levels. The
mean difference was significantly lower among children who had a reported history of
breastfeeding (yes vs. no) during infancy -0.08 (95% CI: -0.10, -0.05), and the correlation was
small (r = -0.07, p <0.0001) but also significant. The standardized regression coefficient of the
unadjusted association was -0.07, which attenuated but remained significant after adjusting for
childhood BMI percentile (-0.05) and remained significant after adjusting for additional
covariates as well (-0.03) (covariates included BMI percentile, child's age, sex, race, maternal
education at birth, number of previous pregnancies, family history of cholesterol). Based on these
results, we hypothesize that this association is potentially partially mediated by the child’s current
BMI levels. However, the change in R2 showed that reported history of breastfeeding accounted
for less than 0.2% of unique variance in TG levels of fifth grade children, suggesting a small
effect size.
Interpreting significant covariates included in the study may be of some interest (Table
5). The results suggest that boys have lower TG levels compared to girls in fifth grade. Some
studies have noted that boys have lower TG levels compared to girls at ages 10-14118 and other
studies have found that TG levels in girls and boys are generally similar during early childhood,
but in adolescence girls have lower TG levels than boys.119,120 These studies also noted that TG
values increase sequentially with the increase in pubertal stage. Although this study did not have
information on pubertal status we can hypothesize that perhaps more girls had reached puberty in
fifth grade compared to boys in this cohort, explaining the higher TG levels in girls in fifth grade
WV children. Although the age range in our study was only 5 years (9.3 to 14.14), we observed
that there was a significant increase in the level of TGs with age as observed in other studies as
well.121 The results also showed that white children had higher TG levels compared to other racial
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groups, which is also consistent in the literature as well.121,122 Although most of the previous
research compared whites to blacks, this study collapsed the minority racial groups in one group
based on the population distribution of WV as well as our study (i.e., 94% white). 90 Our study
demonstrates that increasing years of maternal education at time of the child’s birth was
associated with lower child’s TG levels. Although previous studies examining this association
(between maternal education and child’s TG level) have shown inconsistent results.123,124 Our
results also demonstrated that multiparous mothers at birth of the index child had children with
lower TG levels compared to nulliparous mothers, which is also consistent with the literature.100
Lastly, children who had a family history of hypercholesterolemia had significantly higher TG
levels in fifth grade WV children, a finding echoed by previous research as well.125
As mentioned earlier that there were significant differences in TG level by gender but no
significant interaction between gender and reported history of breastfeeding was observed.
Furthermore the results of the sensitively analysis performed on the complete data that included
all infants found similar results to the data restricted to full term birth infants only.

Lipid in Mothers
The results of our study found no significant correlation or significant mean difference in
any of the lipid levels of mothers who reported to have breastfed as compared to mothers who did
not breastfeed. Although the results were not significant it is important to note that the direction
for the association was positive for TC, LDL, non-HDL, and TG and negative for HDL. To our
knowledge very few studies have examined this association. Our results contrast with few studies
that have found a protective association between breastfeeding and maternal lipid profile.11,48,53
However, our results are in concordance with the results of a prospective cohort study that did not
find an association between breastfeeding duration and any of the serum lipid markers (TC, LDL,
HDL, and TG) at 3 years postpartum.56 Several factors may explain our disparate results. The
earlier studies examined lifetime lactation duration of at least 3 month54 or lifetime duration of
lactation of more than 1 or 2 years to demonstrate this protective association.11,48 Our study did
not have information on lactation duration or lifetime duration of lactation, which is the basis of
most previous research. Since our study asked mothers if they breastfed or not, it is possible that
most mothers who initiated breastfeeding, failed to continue to breastfeed for longer durations.
Data from the National Immunization Survey 2011 show that 59% of the mothers ever breastfed
their infant while only 12.2% of the mothers in WV exclusively breastfeed for the first six months
and nearly 16% breastfed for up to one year.13 Additionally, only a small percent of mothers of
participating CARDIAC students took advantage of the free vouchers for lipid testing, resulting
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in very low participation rates among this particular sample. Furthermore, experts in the field also
suggest that no existing study has collected comprehensive data to explain the apparent
association between lifetime lactation and maternal metabolic risk adjusting for several
confounding factors.70 It has been noted in the U.S. as well as in WV that mothers who breastfeed
belong to higher SES and engage in healthy behaviors.126,127 Thus future studies need to collect
wide ranged longitudinal data to examine this association in mothers accounting for several
socio-demographics, genetic and lifestyle factors.

Limitations of the Study
Some of the limitations of the study include lack of information on possible important
confounder variables such as parental adiposity status, maternal pre-pregnancy weight, rapid
weight gain during the first year of life, pubertal status of the child, family history of
hypertension, physical activity, and dietary behaviors. Furthermore, the CARDIAC project only
collects parental lipid data and thus the maternal CVD risk factors were limited to lipid profile
only. Additionally, maternal lipid data was available for a very small sample of the population as
few mothers took advantage of the free vouchers for lipid testing, thus limiting the
generalizability of the maternal sample population. Moreover, information on history of
breastfeeding was obtained retrospectively and thus is subject to recall bias and also to social
desirability bias. The measure also did not inquire about the method, extent, or the lifetime
duration of lactation. Lastly, due to the unique population characteristics of this state, the results
may not be generalizable beyond the participants included in this study.

Strengths of the Study
Despite these limitations, this study afforded the strengths of examining the association
between reported history of breastfeeding and CVD health outcomes in a large dataset,
longitudinally, using linked data from two cross-sectional studies and adjusting for numerous
important covariates. Although all the associations attenuated after adjustment for the child’s
BMI, the association remained significant for TG levels independent of the child’s current BMI,
socio-demographic, genetic and other lifestyle factors. In addition, the results from the regression
analysis showed that although the predictors accounted for nearly 15% of the variance in TG
levels, reported history of breastfeeding uniquely accounted for less than 1% of the variance in
TG levels. Although this effect size is small, it is a novel finding in 11-year-old children. Earlier
studies included 6-year-old children or older adolescents or young adults ranging from ages 1725.116 44,117,128 Lastly, for the maternal CVD risk factors; the current study demonstrates some

47

important preliminary results (i.e., correlations in the correct direction for lipid levels and
breastfeeding). Thus, providing an essential contribution for expanding the research examining
the associations between breastfeeding as a protective perinatal factor and maternal
cardiovascular health in subsequent years.

Conclusion
Breastfeeding has been shown to have numerous health benefits for both the mother and
the child. Our earlier work has shown that breastfeeding is protective for childhood obesity. This
study further adds that breastfeeding is protective for child’s TG levels at 11 years of age after
accounting for several demographic and maternal characteristics, thus adding to the argument of
promoting breastfeeding as a preventive measure against future CVD. The observed effects of
breastfeeding as an early-life determinants or a distal protective factor for the child’s TG lipid
level was small. However, these small changes can impact the burden of CVD risk factors
prevalence in rural Appalachian state of WV. The fact that we were not able to show the
protective effect on blood pressure and other child or maternal lipid levels does not mean that
breastfeeding promotion should be ignored. Future large prospective studies are needed to assess
and understand the association of breastfeeding with both maternal and child CVD risks factors at
various life stages.
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Chapter 4: Childhood obesity and adult cardiovascular disease risk factors: a systematic
review with meta-analysis.

Abstract
Introduction: Previous systematic reviews have led to conflicting findings regarding the
relationship between childhood obesity and adult cardiovascular disease risk factors. The purpose
of this study was to use the aggregate data meta-analytic approach to address this gap.
Methods: Studies were included if they met the following criteria: (1) longitudinal and
cohort studies (including case-cohort), (2) childhood exposure and adult outcomes collected on
the same individual over time, (3) childhood obesity, as defined by the authors, (4) Englishlanguage articles, (5) studies published up to June, 2015, (6) one or more of the following CVD
risk factors [systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC),
high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), non-highdensity lipoprotein cholesterol (non-HDL), and triglycerides (TG)] (7) outcome(s) not selfreported, and (8) exposure measurements (child’s adiposity) assessed by health professionals,
trained investigators, or self-reported. The search strategy included (1) electronic searches in
multiple databases (PubMed (MEDLINE), Web of Science, and Scopus) on June 5, 2015, and (2)
cross-referencing from the reference lists of all retrieved articles (citation tracking). Fisher’s r to z
score was calculated for each study for each outcome. Pooled effect sizes were calculated using
random-effects models while risk of bias was assessed using the STROBE instrument.
Heterogeneity was assessed based on fixed-effect models. In order to try and identify sources of
heterogeneity, random-effects meta-regression was also performed.
Results: Of the 4875 citations reviewed, a total of 23 studies were included in the
systematic review and 21 in the meta-analysis. The findings suggest that childhood obesity is
significantly and positively associated with adult SBP (Zr = 0.11; 95% CI: 0.07, 0.14), DBP (Zr =
0.11; 95% CI: 0.07, 0.14), and TG (Zr = 0.08; 95% CI: 0.03, 0.13), and significantly and
inversely associated with adult HDL (Zr = -0.06; 95% CI: -0.10, -0.02). For 3-6 studies that
adjusted for adult body mass index (BMI), associations were reversed for all outcomes,
suggesting that adult BMI may be a potential mediator. Nine studies had more than 33% of items
that placed them at an increased risk for bias.
Conclusions: Childhood obesity is a risk factor for adult SBP, DBP, HDL, and TG.
Well-designed, longitudinal studies with high quality of reporting as well as data on both
unadjusted and adjusted (for adult adiposity) associations are needed before any definitive
conclusions can be reached
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Introduction

Overview
Overweight and obesity during childhood and adolescence is a major public health
problem. One of the immediate health implications of childhood and adolescent obesity includes
the development of cardiovascular disease (CVD) risk factors during childhood and
adolescence.1-4 According to the World Health Organization, CVD mortality increased globally
from 14.4 million in 1990 to 17.5 million in 2005 and is projected to rise to more than 23.6
million by 2030.5-8 However, in the United States (U.S.), CVD mortality has been decreasing
from 34.3% deaths in 2006 to 30.8% of all deaths in 2013.5,9 Nevertheless, it is still the leading
cause of death.10 According to the 2016 Heart Disease and Stroke Statistics update, more than one
third of U.S. adults have at least one type of CVD,5 which is also projected to rise to more than
40% by 2030.5,11 Several well-established adult CVD risk factors have been found during
childhood. These include, but are not necessarily limited to, high blood pressure (BP), poor lipid
profile, impaired glucose tolerance, and metabolic syndrome.12-14 Importantly, data shows that
these risk factors are amplified in the presence of pediatric obesity, referred to by Ford et al. as
‘obesity-associated risk factors for CVD.’13,14 Most notably, a population-based study estimated
that 70% of obese children and adolescents between the ages of 5 to 17 have at least one risk
factor for CVD.1
Despite the high prevalence of both childhood and adolescence obesity and adult CVD,
studies examining the relationship between childhood obesity and adult CVD have yielded
conflicting results.13,15-18 However, adult adiposity is an established risk factor for developing
adult CVD19,20 and there is much evidence to suggest that overweight adolescents have a 40%80% chance of becoming overweight or obese adults.21-23 Thus, it remains unclear whether
childhood obesity is an independent risk factor for adult CVD risk factors or whether childhood
obesity persists as adult obesity and indirectly increases the risk of adult CVD.24,25

Obesity and CVD Risk Factors
High BP and poor lipid profile are independent risk factors for CVD. However, pediatric
obesity is also an independent risk factor for high BP and poor serum lipid and lipoprotein
concentrations (higher total cholesterol (TC), triglycerides (TG), low-density lipoprotein
cholesterol (LDL) and lower high-density lipoprotein cholesterol (HDL) concentrations) during
childhood and adolescence.26-31 Children and adolescents with less than optimal BP or cholesterol
levels are more likely to develop high BP and less than optimal cholesterol levels during
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adulthood compared to children/adolescents with a normal BP and lipid profile 32-34. Moreover,
abnormal serum lipoprotein concentrations due to pediatric obesity and its correlation with poor
lipid profile during adulthood also remain a controversial topic in the literature 3,35. Data also
shows that childhood CVD risk factors may persist into adulthood, 25 however, the mechanism
from transition from CVD risk factors from childhood to adulthood is still unclear.36 Recent
systematic reviews suggest that the relationship between childhood obesity and adult high BP or
poor lipid profile is weak, possibly because the results are confounded by adult obesity.18,37 Given
that childhood obesity as an independent risk factor for CVD in adults is not well established, we
aim to investigate the association between childhood obesity and select adult CVD risk factors,
i.e., BP, lipids, and lipoproteins.

Critical Evaluation of Existing Knowledge
When proposing to conduct a systematic review (SR) with meta-analysis (MA) on a
topic, it is important to examine previous SRs and MA on this topic. To the best of the
investigative team’s knowledge, four SRs and one MA have been conducted on the relationship
between childhood obesity and adult CVD risk factors.18,37-40 A brief description of these studies
is shown in Table 1. The SRs and MA found were based on a systematic literature search in
PubMed on February 2, 2015, using the following search strategy: ((obes* OR overweight) AND
(child* OR adolesc*) AND (systematic review OR meta-analy*) AND (blood pressure OR
cholesterol OR lipids OR lipoproteins OR cardiovascular) AND adult*). The search strategy can
found in Additional file 1.
To the best of our knowledge, we are not aware of any meta-analytic research that
utilized a systematic way for critically appraising the association between childhood obesity and
adult CVD risk factors based on current guidelines.41 As can be seen in Table 1, four SRs
published on this topic from 2010-2012 provided qualitative evidence but did not show any
quantitative evidence on the association between childhood obesity and adult CVD risk factors
(BP and lipid profile). While one MA was conducted four years ago on this topic, it was limited
to a select four cohorts only, 40 thereby possibly biasing results. Moreover, this MA did not
calculate the association between childhood obesity and TC as well as between childhood obesity
and adult non-high-density lipoprotein cholesterol (non-HDL) levels. This is important since nonHDL (non-HDL = TC minus HDL) has been shown to be better marker of risk for coronary artery
disease and stroke compared to LDL.42,43
Of the four SRs listed in Table 1, two included hypertension as one of the main
outcomes37,38,44 while the other reported results for resting SBP and DBP.37 Another study focused
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on the lipid profile as the main outcome of interest.18 With respect to years covered for those
studies that included hypertension, Park et al, included studies published between 1980-2011,38
Reilly et al. included studies from January 2002 to mid-June 2010,39 while Lloyd et al, searched
online electronic databases, i.e., PubMed (MEDLINE) and ISI Web of Science from their
inception up to July 2008 for the SR with hypertension as the outcome,37 and up to July 2010 for
the SR with serum cholesterol levels as the outcome.18 The Cochrane Collaboration, an
organization dedicated to the conduct of SRs in healthcare, recommends that SRs on a given topic
be updated every two years.45,46 Based on this recommendation, the last SR was published in
2012, thus suggesting that this work needs to be updated. In addition, all previous SRs included
data where adiposity was measured using BMI for both children and adults.18,37-40 However,
research has shown that BMI is not an ideal marker for adiposity47,48 and including other
definitions or classifications of adiposity may help in identifying other potentially eligible studies
that have looked at this association. Finally, the methodological quality of these previous
systematic reviews could have been better.18,37-40 Using the Assessment of Multiple Systematic
Reviews (AMSTAR) Instrument,49 we evaluated the methodological quality of the previously
described SRs. Item-by-item results for these studies are shown in Table 2. As can be seen, the
overall score for each SR ranged from 40% to 80% while scores for each question ranged from
0% to 100%. The questions with the three lowest scores included: (1) status of publication, (2)
including a list of both published and unpublished studies, and (3) assessment for the likelihood
of publication bias. These findings provide further support for an updated, high-quality SR with
MA on the relationship between childhood obesity and selected adult CVD risk factors, i.e., BP,
lipids, and lipoproteins.

Significance of the Topic
SRs with MA occupy the highest levels of evidence in the hierarchy of study designs.50
This structured and standardized approach has been used to make health care decisions and
inform policy makers by analyzing prior findings as well as summarizing, synthesizing and
critically appraising evidence on a specific topic in the literature.51 While several SRs,18,37-39 and
one MA,40 have examined the association between childhood obesity and adult CVD, the
investigative team is not aware of any current and thorough SR with MA on this topic. Thus, the
specific aim of this study was to conduct a SR and MA to critically evaluate the available
evidence regarding the relationship between childhood obesity and selected adult CVD risk
factors. The results of this study can contribute to the planning and implementation of preventive
strategies for promoting cardiovascular health during the various life stages as well as provide
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direction for the future conduct and reporting of research on this topic.

Research Design and Methods

Purpose
The purpose of this study was to conduct a SR and MA of studies that have examined the
association between childhood obesity and the following adult CVD risk factors: (1) resting
systolic blood pressure (SBP), (2) resting diastolic blood pressure (DBP), (3) TC, (4) HDL, (5)
LDL, (6) non-HDL and (7) TG. A secondary aim of the study was to examine whether this
association persists after adjusting for adult obesity.
We conducted a SR with MA by following the Cochrane Collaboration’s
recommendations and guidelines for conducting SRs and MA for observational studies,45,52 as
well as the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)53,54
statement. In addition, we registered this study in PROSPERO, an international registry for SRs
(Protocol number: PROSPERO 2015:CRD42015019763).55

Study Eligibility
The eligibility criteria for the studies included or excluded in the MA need to be well
defined and established a priori.56 The Cochrane acronym PICO(S) (population, intervention,
comparison, outcomes, study design or study setting), was utilized to ensure that all key
components are covered prior to starting the review process. The eligibility criteria for the study
included: (1) longitudinal and cohort studies (including case-cohort), (2) childhood exposure and
adult outcomes collected on the same individual over time, (3) main exposure variable of the
child’s overweight and obesity status (BMI age-and sex-specific percentiles, percent body fat, fat
mass, waist circumference (WC), waist-to-hip ratio, visceral adipose tissue, skin fold thickness,
body weight, BMI z-score, BMI or other measures used to assess overweight and obesity in
populations),57 (4) studies available in English-language, (5) studies published up to June, 2015,
(6) one or more of the following CVD risk factors as the primary outcome measure: (SBP, DBP,
TC, LDL, HDL, non-HDL, and TG), (7) outcome measurements taken by health professionals or
trained investigators but not based on self-report data, (8) exposure measurements (child’s
adiposity) assessed by health professionals, trained investigators, or self-reported. Exclusion
criteria included the following: (1) review articles, (2) cross-sectional study designs, (3) casecontrol study designs, (4) case reports, (5) comments, (6) letters, (7) animal studies, (8) studies
published in non-English language sources, (9) presentations from conference meetings, (10)
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unpublished studies (abstracts, master theses, dissertations, etc.), (11) studies in which the
outcome(s) were self-reported and, (12) studies outside general population.
We utilized a number of various sources and methods to identify the maximum number
of eligible articles. These included electronic database searches as well citation tracking from the
retrieved articles. We also assessed for publication bias, which occurs when the published
literature is systematically unrepresentative of the population of all completed studies.58,59 Grey
literature refers to unpublished reports, conference abstracts, thesis and dissertations, articles in
obscure journals, reports, rejected or un-submitted manuscripts.60 Due to limited resources, we
did not search the grey literature but utilized numerous sources to identify the published
literature. While MA that exclude grey literature may tend to overestimate ESs,60-62 some
researchers have argued that the methodological quality of grey literature is low compared to
published literature due to a lack of formal quality control and peer review, 63,64 and thus, can
jeopardize the quality of MA given that the quality of MA is dependent on the quality of the
studies included in the analysis.65 Alternatively, others have argued that there is limited evidence
that grey literature is of lower quality than published trials.62 However, as previously mentioned,
we excluded grey literature because of limited resources as well as the difficulty to access this
type of literature, the latter of which can also potentially bias results.
In order to control for multiple publication bias (multiple publications from the same
population), only one set of data that included the greatest amount of relevant information on the
participants was included. Given the lack of resources, we also excluded studies that were not
published in the English language. Meta-analyses that restrict studies by language can potentially
overestimate the outcome effects by only 2%, and the percentage of non-English studies
traditionally included in meta-analyses is very small.66

Data Sources
A SR provides a comprehensive search for all potentially relevant literature for a specific
research question.67 For the current study, we searched multiple electronic databases and crossreferenced from the bibliographies of all retrieved articles (citation tracking). An information
retrieval specialist (Health Sciences librarian, JS) assisted in the planning of the literature search
and in identifying and creating correct Boolean operators and search strings for the different
electronic database searches.68 All aspects of the searches were documented with respect to name
of the data source, journal, date of the search, person responsible etc. For this study, we searched
the following electronic databases on June 5, 2015: (1) PubMed (MEDLINE), (2) Web of
Science, and (3) Scopus. We first conducted a preliminary search in PubMed and searched
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forward from the date of the first study that met our search criteria (1975). The PubMed search
string used was as follows: “(obesity OR obese OR overweight OR fat OR adipos* OR “body
mass index” OR BMI) AND (child* or adolesc*) AND (“blood pressure” OR hypertension OR
cholesterol OR lipid OR lipids OR lipoprotein OR lipoproteins OR cardiovascular) AND
(observational OR cohort OR longitudinal) AND adult* AND (human OR humans).” Each search
was conducted separately and then downloaded as a separate file using Endnote X7.69 All
duplicates were removed electronically and then manually.

Study Selection
In order to minimize selection bias, two researchers (AU and CL) independently screened
studies for eligibility by reviewing the titles and abstracts of articles based on the pre-defined
eligibility criteria (see previous section on study eligibility). If the inclusion or exclusion criteria
could not be decided based on the title and abstract, full-text articles were retrieved and the
decision was made accordingly. After independent study selection was performed, the two
reviewers met and reviewed every selection for agreement. Cohen’s kappa statistic70 was used to
measure inter-selection agreement and discrepancies were resolved by consensus. If a decision
could not be achieved, a content area and MA expert (GK) resolved any disagreement(s). Using
Cohen’s kappa statistic, the overall agreement rate prior to correcting discrepancies was 0.75.

Data Abstraction.
Prior to data abstraction, a detailed codebook that could hold up to 200 items per study
was developed by the research team in Microsoft Excel software (version 2011).71 The codebook
included continuous variables, categorical variables, and free text information. The codebook
developed was pilot-tested and revised by the investigative team. In order to avoid data
abstraction bias, two authors (AU and CL) coded or extracted data from each selected article
independently. The researchers then compared every data point for accuracy and consistency until
100% agreement was reached. If agreement could not be reached, a content area and MA expert
(GK) resolved any disagreement(s).

Risk of Bias Assessment
The term ‘risk of bias’ is used to describe “a systematic error or deviation from the truth,
in results or inferences.”45 The Cochrane Collaboration emphasizes that risk of bias assessment
should clearly differentiate between the quality of reporting and the quality of the underlying
conduct of the research.45 Biases similar to randomized controlled trials (RCT) may also be
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present in a non-randomized study (NRS). These include selection bias, attrition bias,
performance bias, detection bias, outcome-reporting bias, publication bias and dissemination bias.
However, the nature and variety of NRS makes it more difficult for the groups to be comparable.
Several of the important biases in longitudinal studies include (1) selective dropout bias, (2)
participation bias, (3) selection bias (sampling frame, recruitment, consent rates, retention, loss to
follow-up, item non-response), (4) interviewer bias, (5) response bias, (6) social desirability bias,
(7) measurement bias, and (8) the role of potential confounders and residual confounding in
explaining the findings from NRS. Numerous tools that have evaluated study quality or risk of
bias of observational studies72 i.e., Downs and Black, 73 Reisch, 74 and Zaza 75 still require
modifications as there is no gold standard for assessing the risk of bias of observational
studies.72,76 However, one tool, Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE), has been cited by several SR and MA for assessing the reporting of
observational studies.77 The STROBE instrument consists of a checklist of 22 items that provides
guidance on the reporting of observational studies to facilitate critical assessment and
interpretation of results.78 For this study, we used the STROBE instrument to assess the quality of
reporting of the included observational studies. This checklist facilitates in assessing the risk of
potential bias in the title and abstract, introduction, methods, results, and discussion sections of
articles. Each item was classified as “yes” (low risk), “no” (high risk), or “unclear”. Two
researchers (AU and CL) conducted all assessments independent of each other and examined the
results at the study level as well as for each item. They then compared their selections for
accuracy and consistency. Inter-rater agreement was assessed using Cohen’s kappa statistic. Any
disagreements were discussed and resolved until 100% agreement was reached. Using Cohen’s
kappa statistic, the overall agreement rate prior to correcting discrepancies ranged from 0.70 to
0.94 (mean =0.89, SD = 0.03).

Statistical Analysis
Descriptive statistics. Using Microsoft Excel 201171 and after data cleaning, descriptive
statistics were generated for continuous [sample sizes, means, medians, standard deviations,
standard errors, 95% confidence intervals (CI)] and categorical (frequencies and percentages)
variables. Seven separate Microsoft excel sheets were generated for all seven outcomes [(1) SBP,
(2) DBP, (3) TC, (4) HDL, (5) LDL, (6) non-HDL, and (7) TG)]. Any outcome with only one
study was excluded from the meta-analysis. Each outcome was further analyzed separately if it
was adjusted for adult adiposity.
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Calculation of effect sizes from each study. The effect size (ES) is the strength of an
association between two variables. The two previous SRs by Lloyd et al. presented the correlation
statistics for the individual studies,18,37 whereas Reilly et al.39 and Park et al.38 presented odds
ratios (OR). However, the one MA on this topic used risk ratios (RR), also known as relative
risks, as their ES measure.40 The a priori plan was to use RR as our ES in order to examine the
association between childhood obesity and selected adult CVD risk factors (SBP, DBP, TC,
HDL, LDL, non-HDL, and TG). However, because most studies reported a correlation between
two continuous variables, a post hoc decision was made to use correlation statistics (Fishers r to z
score) instead of RR to serve as the main ES index.79 All other ESs (OR, mean differences) were
converted to correlation statistics using Comprehensive Meta-Analysis (version 3.0).80 This
software program allows for the automatic calculation of different data into correlation statistics.
Additionally, standardized beta coefficients from individual studies were used as the correlation
statistics. This decision was based on previous research showing that the correlation between the
beta coefficient and correlation coefficient is linear, having a correlation of 0.84 if the coefficients
reside in the interval ±0.50.81 Studies that presented unstandardized beta-coefficients were first
converted to standardized regression coefficients by multiplying the unstandardized coefficient by
the ratio of the standard deviations of the independent variable and the dependent variable.
Studies where unstandardized regression coefficients could not be converted to standardized
regression coefficients and no other ES was provided were excluded from the MA.
Pooling of ES’s. Results for the association between childhood obesity and selected
CVD risk factors (SBP, DBP, TC, HDL, LDL, non-HDL, and TG) were pooled separately using
random-effects, method-of-moments models.82 The correlation metric was converted to Fisher’s z
scale (Fisher's r-to-z transformation), and all analyses performed using the transformed values.79
These results included an overall effect estimate as well as 95% CI.82 If the 95% CI did not
include zero (null=0 for correlation coefficient/Fishers r to z score), we considered our results to
be statistically significant. We chose a random-effects model over a fixed-effect model because
the former incorporates heterogeneity into the model. Random-effects models in MA assume that
the true ESs are normally distributed and that studies are drawn from populations that differ from
each other in ways that could impact the outcome.83 Moreover, several researchers suggest that
when studies are gathered from the published literature, the random-effects model is generally a
more appropriate model.79 This model takes into account both within and between-study variation
while the fixed-effect model only takes into account within-study variation. In other words, a
fixed-effect model assumes that all studies are drawn from a common population84 while a
random-effects model does not. If there is no significant heterogeneity, the random-effects model
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and the fixed-effect model will produce similar results.59 If significant heterogeneity does exist, a
random-effects model usually yields wider CI’s. Forest plots were used to visually display the
estimated ES of each study and their corresponding 95% CI’s. In addition, an overall pooled
effect as well as 95% CI’s was generated. Furthermore, 95% prediction intervals (PI’s) were also
calculated as a measure of dispersion in order to identify how the true value is likely to vary from
one study to the next.
Stability and validity of changes in ES’s. A primary purpose of MA is to investigate
potential sources of heterogeneity of results in existing studies.85 For this study, we estimated
heterogeneity for each outcome using the I2 statistic.86,87 The I2 statistic provides a useful
summary of the impact and extent of heterogeneity, which helps in determining the robustness of
drawing overall conclusions.86,87 I2 is calculated as 100% ×(Q - df)/Q, where Q is Cochran's
heterogeneity statistic and df is the degrees of freedom. Statistical significance for Q was set at an
alpha level of ≤0.10 versus ≤0.05 because the Q statistic suffers from power issues.87 A value of
0% indicates no observed heterogeneity while larger values show increasing heterogeneity.
Negative values of I2 are set to zero.87 For this study, heterogeneity for I2 was classified as trivial
(0%–25%), low (25.1%–50%), moderate (50.1%–75%), or high (75.1%–100%).87 The results
were also interpreted with respect to the clinical implications of the degree of inconsistency as
well as the magnitude and direction across studies, including the strength of evidence for
heterogeneity.87
Publication bias is the tendency for authors to submit, and journals to accept and
publish, manuscripts based on statistically significant findings.88 For this study, we followed the
general guidelines of Sterne et al.,89 for assessing publication bias, one of the potential reasons for
what is known as “small-study effects”, i.e., the tendency for smaller studies to show greater
effects than larger studies. This includes a qualitative test, the funnel plot (inverse of standard
error on the y axis and ES on the x axis) and a quantitative test, Egger’s linear regression test.90
As recommended by Sterne et al.,89 the test for funnel plot asymmetry was not used when there
were fewer than 10 studies because power is usually low in identifying chance from real
asymmetry.89 The Egger regression test is a regression of the standardized effect estimates against
their precision (inverse standard error) and quantifies the funnel plot asymmetry by determining
whether the intercept deviates significantly from zero. If the intercept is not significantly different
from zero there is no evidence of funnel plot asymmetry.90-92 Influence analysis was used to
examine the effects of each study on the overall results. This analysis excludes one study at a time
in order to determine the influence of each study on the overall results.93 Cumulative MA, ranked
by the year the study started, was used to examine the accumulation of findings over time by
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adding one study at a time and the results summarized as each new study is added.94 A sensitivity
analysis was also performed by pooling the ESs from studies that only used childhood BMI as the
exposure. This was performed in order to determine if any differences existed in the pooled
results that included any definition for childhood exposure, including BMI.
Meta-regression. Because of missing data for different predictor variables from different
studies, simple weighted least squares meta-regression (random-effects, method of moments
approach) was used to examine the relationship between each outcome and selected covariates.
Meta-regression is analogous to individual study regression except that the outcome variable is
the effect estimate, i.e., unit of analysis is the study, rather than individual participant scores.59
This analysis is exploratory and used to indicate the magnitude and direction of association
between variables as well as explore which factors, if any, best account for changes in outcomes.
The slope of the regression coefficients along with their 95% CIs were also calculated. CIs that
did not cross zero were considered statistically significant. Planned covariates to examine a priori
included: (1) country in which the study was conducted (USA, other), (2) bias due to loss to
follow up, (3) type of analysis, (4) type of definitions used for adiposity, (5) exposure measure
(self-report or not), (6) subject characteristics (sex, race/ethnicity), (7) studies that examined the
association between childhood obesity and CVD risk factors while controlling or not controlling
for adult adiposity, (8) time to follow up, (9) age categories of adults, (10) age categories of
children, (11) comorbid conditions for both the child and the adult (diabetes, metabolic syndrome,
etc.), (12) lipid lowering medication, (13) hypertensive medication, (14) family history of CVD,
(15) smoking status/alcohol or drug use of both the child and the adult, (16) socio-economic
status related variables, (17) diet, (18) physical activity, (19) fasting vs. non-fasting lipid profile,
(20) child’s pubertal status, (21) perinatal risk factors, and (22) study design. Where there was
insufficient data (fewer than 3 results per group) for potential predictor variables, we performed a
sensitivity analysis without the predictor to see if it had an effect on our overall findings. For
categorical variables, less than three results for any one category were used as the cut-off for
analysis. The results of the meta-regression tests need to be interpreted with caution since they are
considered observational and exploratory inquiries, i.e., non-experimental comparisons, designed
to generate hypotheses about potential sources of heterogeneity to be tested in original studies.59
In addition to statistical significance, the results of our study were also interpreted with respect to
practical significance.
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Results

Study Characteristics
A general description of the characteristics of each study is shown in Table 3. Of the
4875 citations reviewed, a total of 23 were included in the SR4,95-116 and 21 in the MA.4,95-100,102110,112-116

A description of the search process, including the reasons for excluded studies, is shown

in Figure 1. A list of all excluded studies and reasons for exclusion are shown in Additional file 2.
The year that each study started varied considerably, ranging from 1923 to 1989 while the year
that studies were published ranged from 1971 to 2014.
Studies were conducted in eleven different countries; six in the U.S.,4,95,97,98,104,106 three in
United Kingdom (England, Wales, Scotland and Newcastle),107,114,116 three in Finland,96,99,112 two
in Australia,108,113 and one in Sweden,100 India,102 Lithuania,103 Poland,105 the Republic of
Seychelles,109 Japan,110 and Six Solomon Island.115 Most studies used a prospective longitudinal
study design except for two studies that used a retrospective study design.96,104 None of the
studies used a case-cohort study design.
The length of follow-up for the studies ranged from 4.5 to 60 years. As most of the
studies were prospective longitudinal studies, the number of subjects at baseline was often greater
than the number of participants at follow-up due to loss to follow-up. Seven studies included
information on loss to follow-up.4,99,100,102,103,108,113 Reasons for loss to follow-up included the
following: (1) refused to participate, (2) inability to locate, (3) did not respond to contact, (4)
participants out of country or town at time of follow-up, (5) death, (6) difficult to contact married
girls in India who left their native village, (7) social disadvantage (less well educated and having
lower family income). Two studies specified that participants who were lost to follow-up did not
have significantly different childhood BMI’s when compared to those who were available at
follow-up in adulthood.4,116
As for the exposure, most studies used BMI as a measure of adiposity in childhood in
addition to other measures used.4,96-100,102,103,105-110,112-116 However, two studies used relative
overweight95 and sub-scapular skinfold thickness measures only.104 Most studies did not use a
cut-off point to define childhood obesity, but rather, used childhood BMI as a continuous
variable.
Sixteen studies examined the association between childhood obesity and adult SBP,4,95,97100,102-104,106-110,113,116

14 examined the association between childhood obesity and adult DBP,4,95,98-

100,102,103,106-110,113,116

8 examined the association between childhood obesity and adult

TC,4,95,98,110,112,114-116 5 examined the association between childhood obesity and adult
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LDL,4,109,112,114,116 8 examined the association between childhood obesity and adult HDL,
4,98,99,109,112-114,116

TG.

and 9 examined the association between childhood obesity and adult

4,98,99,102,109,112,113,115,116

However, data from one study that assessed TG could not be used for

MA because the study’s main outcome was blood pressure and there was not enough information
provided for TG to calculate an effects size.102 Only one study (Pereira et al., 2013) included data
for the association between childhood adiposity and adult non-HDL cholesterol.111 However, the
study by Pereira et al. was excluded from the MA due to the inability to retrieve data for metaanalytic use for other outcomes as well. Another study by Holland and colleagues was excluded
from the MA for the same reason.101 Of the 21 studies, only six (28.6%) included data on the
association between childhood obesity and adult CVD risk factors while adjusting for adult
BMI.4,96,105,107,109,116 Two of these six studies reported adjusted associations only.96,105

Participant Characteristics
As previously stated, a description of the participant characteristics is shown in Table 3.
The majority of studies included information on both males and females,97,100,103-106,109,110,112,115,116
two were limited to men only,95,102 while 9 included combined data for both men and
women.4,96,98,99,107-109,113,114 No study was limited to women. One study included combined results
as well as results according to sex.109 However, for the current MA, we used the results reported
according to sex.109 Moreover, while one study had data on both males and females, data from
only males was used for the current MA because the regression model for females included
change of BMI over time i.e., from childhood to adulthood.97
The participants’ ages at baseline when the exposure was measured ranged from 2 to 18
years. The age at follow-up when the outcome was measured also varied substantially between
studies, ranging from 19 to 62 years. Some studies used one childhood age or average of a range
of childhood ages as their exposure, while some studies categorized children based on different
age groups. Furthermore, some studies used longitudinal data for the same children over time.
Most of the studies provided some level of information on comorbid conditions of adults.
These included hypertension,95 arteriosclerotic heart disease,95 CV renal disease,95 coronary heart
disease,96 diabetes, insulin or glucose levels,4,99,109 metabolic syndrome,100 medication for heart
diseases,107 medication for hypertension,9,105,107 and uric acid level.109 One study excluded
participants who were on hypertension (HT) medication,104 whereas one study found no
difference in any of the analyses after performing sensitivity analysis and excluding those
subjects who were taking cholesterol-lowering drugs.114 For women, additional information on
the use of oral contraceptives, menstruation, menopausal status, and use of hormonal replacement
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therapy was provided by a five studies.105-107,112,114 Family history of CVD or CVD risk factors
was available in 2 studies.104,106 Information on smoking, alcohol, and drug use was provided by
six studies.100,102,106,107,112,113 Perinatal risk factors such as birth weight and/or gestational age were
presented in approximately one third of the studies.97,99,107,108,110,114,116 Information on diet and
physical activity was provided by 4 studies,100,107,112,113 while information on the child’s pubertal
status was provided by one study.103 It is important to note that these variables were not
necessarily adjusted for in the analyses performed by the individual studies.

Risk of Bias Assessment
Overall study-level risk of bias results are shown in Figure 2 while results for each item
from each study are shown in Additional file 3. More than 50% of the studies did not provide an
adequate description of participant characteristics while almost 70% did not describe any efforts
to address potential sources of bias, explain how loss to follow-up was addressed, or provide
reasons for non-participation at each stage. More than 80% did not explain how missing data was
addressed. At the study level, nine studies had more than one third of items that were at an
increased risk of bias for reporting of items for observational studies.95,97,101,102,104-106,112,116

Primary Outcomes
The results of the random-effects MA for the association between childhood obesity and
adult CVD risk factors are presented below. The forest plots displaying the effect estimates along
with the 95% CI for each outcome is shown in Figures 3-14. The forest plots for influence
analyses, cumulative MA, and funnel plots are shown in Additional file 4. Exploratory randomeffects meta-regression analyses for the association between childhood obesity and adult CVD
risk factors and selected covariates (categorical and continuous) in which adequate data were
available are shown in Additional file 5.

Systolic Blood Pressure (unadjusted for adult adiposity). Overall, there was a
statistically significant and positive association between childhood adiposity and adult SBP
(Table 4 and Figure 3). Heterogeneity was also statistically significant and large. However, 95%
PIs were non-significant. Funnel plot results for small-study effects showed a lack of asymmetry
and were reinforced by a lack of statistical significance based on Egger et al.’s regression
intercept test (p = 0.42). With each study deleted from the model once, results remained
statistically significant across all deletions. The associations ranged from approximately 0.10 to
0.11. Cumulative MA, ranked by the year the study started, demonstrated that results have been
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statistically significant since examining the birth cohort of 1958. Random-effects meta-regression
revealed statistically significant evidence for an association between pooled ES (Fisher’s r to z
score for the association between childhood obesity and adult SBP) and baseline age (β = 0.01, p
= 0.01; I2 reduced from 91% to 88%), studies conducted in the United States versus other
countries (β = 0.07, p = 0.05) and studies that used BMI versus alternative methods for assessing
adiposity (β = 0.05, p = 0.05).

Systolic Blood Pressure (adjusted for adult adiposity). When examining studies that
adjusted for adult BMI, a statistically significant and negative association was observed between
childhood adiposity and adult SBP (Table 4 and Figure 4). Heterogeneity was also statistically
significant and considered large. However, 95% PIs were non-significant. Because there were
less than 10 studies, small-study effects were not assessed. With each study deleted from the
model once, results remained statistically significant across all deletions. The associations ranged
from approximately -0.10 to -0.13. Cumulative MA, ranked by the year the studies started,
demonstrated that results have been statistically significant since the first study was conducted in
1934. Random-effects meta-regression revealed statistically significant evidence for an
association between pooled ES (Fisher’s r to z score for the association between childhood
obesity and adult SBP for studies that adjusted for adult BMI) and follow-up age (β = -0.005, p =
0.002; I2 reduced from 89% to 69%) as well as length of follow-up (follow-up age – baseline age)
(β = -0.004, p = 0.008; I2 reduced from 89% to 76%).

Diastolic Blood Pressure (unadjusted for adult adiposity). Overall, there was a
statistically significant and positive association between childhood adiposity and adult DBP
(Table 4 and Figure 5). Heterogeneity was also statistically significant and large. However, 95%
PIs were non-significant. Funnel plot results for small-study effects showed a lack of asymmetry
and were reinforced by a lack of statistical significance based on Egger et al.’s regression
intercept test (p = 0.37). With each study deleted from the model once, results remained
statistically significant across all deletions. The associations ranged from 0.094 to 0.113.
Cumulative MA, ranked by the year the study started, demonstrated that results have been
significant since examining the birth cohort of 1966. Random-effects meta-regression revealed
statistically significant evidence for an association between pooled ES (Fisher’s r to z score for
the association between childhood obesity and adult DBP) and baseline age (β = 0.01, p = 0.01; I2
reduced from 90% to 87%).
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Diastolic Blood Pressure (adjusted for adult adiposity). When examining studies that
adjusted for adult BMI, a statistically significant and negative association was observed between
childhood adiposity and adult DBP (Table 4 and Figure 6a). Heterogeneity was also statistically
significant and considered large. However, 95% PIs were non-significant. Because there were
less than 10 studies, small-study effects were not assessed. The results of the influence analysis
showed that when two studies (Koziel et al, 2011 and Li et al., 2007) were deleted separately
from the model, results were slightly non-significant.105,107 The results remained statistically
significant when deleting the rest of the studies individually. The associations ranged from
approximately -0.081 to -0.131. Cumulative MA, ranked by the year the studies started,
demonstrated that results have been statistically significant since the first study was conducted in
1947. Random-effects meta-regression revealed statistically significant evidence for an
association between pooled ES (Fisher’s r to z score for the association between childhood
obesity and adult DBP for studies that adjusted for adult BMI) and follow-up age (β = -0.006, p
<0.0001; I2 reduced 92% to 58%), and length of follow-up (β = -0.006, p <0.0001; I2 reduced
from 92% to 56%).

Total Cholesterol (unadjusted for adult adiposity): Overall, there was a positive
association between childhood adiposity and adult TC (Table 4 and Figure 7). However, the
association was not statistically significant. The 95% PIs were also non-significant. The
heterogeneity was statistically significant and large. Because there were less than 10 studies,
small-study effects were not assessed. With each study deleted from the model once, results
remained statistically non-significant across all deletions. The associations ranged from
approximately -0.01 to 0.02. Cumulative meta-analysis, ranked by the year the study started,
demonstrated that results have been negative since the start of the first study in 1923 up to the
sixth study that started in 1970 after which the cumulative results showed a positive association.
Random-effects meta-regression revealed statistically significant evidence for an association
between pooled ES (Fisher’s r to z score for the association between childhood obesity and adult
TC) and follow-up age (β = -0.004, p = 0.04; I2 reduced from 91% to 76%), and length of followup (β = -0.004, p = 0.01; I2 reduced from 91% to 67%).

Total Cholesterol (adjusted for adult adiposity). When examining studies that adjusted
for adult BMI, a negative and non-significant association was observed between childhood
adiposity and adult TC (Table 4 and Figure 8). The 95% PIs were non-significant as well.
Heterogeneity was statistically significant and considered large. Because there were less than 10
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studies, small-study effects were not assessed. With each study deleted from the model once,
results remained statistically non-significant across all deletions except when one study by Barker
et al., 2005 was deleted, resulting in statistically significant results. The associations ranged from
approximately -0.036 to -0.090. Cumulative meta-analysis, ranked by the year the studies started,
demonstrated that results have been negative since examining the birth cohort of 1947. Randomeffects meta-regression revealed statistically significant evidence for an association between
pooled ES (Fisher’s r to z score for the association between childhood obesity and adult TC for
studies that adjusted for adult BMI) and baseline age (β = -0.32, p <0.0001; I2 reduced from 86%
to 0%) and sex (β = -0.32, p <0.0001; I2 reduced from 77% to 35%).

Low-density Lipoprotein (unadjusted for adult adiposity): Overall, there was a
positive association between childhood adiposity and adult LDL (Table 4 and Figure 9).
However, the results were not statistically significant. The 95% PIs were non-significant as well.
Heterogeneity was statistically significant and large. Because there were less than 10 studies,
small-study effects were not assessed. With each study deleted from the model once, results
remained statistically non-significant across all deletions. The associations ranged from
approximately 0.095 to -0.085. Cumulative meta-analysis, ranked by the year the study started,
demonstrated that results have been statistically non-significant since examining the birth cohort
of 1947. The results were negative with the first three studies added and became positive after the
fourth and fifth studies were included. Random-effects meta-regression revealed statistically
significant evidence for an association between pooled ES (Fisher’s r to z score for the
association between childhood obesity and adult LDL) and follow-up age (β = -0.005, p = 0.0001;
I2 reduced from 94% to 39%), and length of follow-up (β = -0.004, p = 0.005; I2 reduced from
94% to 59%).

Low-density Lipoprotein (adjusted for adult adiposity): When examining the three
studies that adjusted for adult BMI, a statistically significant and negative association was
observed between childhood adiposity and adult LDL (Table 4 and Figure 10). Heterogeneity was
also statistically significant and considered large. However, 95% PIs were significant. Because
there were less than 10 studies, small-study effects were not assessed. With each study deleted
from the model once, results remained statistically significant across all deletions. The
associations ranged from approximately -0.07 to -0.09. Cumulative meta-analysis, ranked by the
year the studies started, demonstrated that results have been statistically significant since the first
study was conducted in 1947. Random-effects meta-regression revealed no statistically
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significant evidence for an association between pooled ES (Fisher’s r to z score for the
association between childhood obesity and adult LDL for studies that adjusted for adult BMI) and
sex. None of the other variables were examined because of insufficient data.

High-density Lipoprotein (unadjusted for adult adiposity): Overall, there was a
statistically significant and negative association between childhood adiposity and adult HDL
(Table 4 and Figure 11). Heterogeneity was also statistically significant and large. However, 95%
PIs were non-significant. Because there were less than 10 studies, small-study effects were not
assessed. With each study deleted from the model once, results remained statistically significant
across all deletions except when one study by Schmidt et al., 2011 was deleted. Deleting this
study resulted in a negative non-significant association. The associations ranged from
approximately -0.04 to -0.07. Cumulative meta-analysis, ranked by the year the study started,
demonstrated that results have been statistically significant since examining the birth cohort of
1985. Random-effects meta-regression revealed no statistically significant evidence for an
association between pooled ES (Fisher’s r to z score for the association between childhood
obesity and adult HDL) for all the covariates examined.

High-density Lipoprotein (adjusted for adult adiposity): When examining studies that
adjusted for adult BMI, a positive but non-significant association was observed between
childhood adiposity and adult HDL (Table 4 and Figure 12). Heterogeneity was statistically
significant and considered large. However, 95% PIs were non-significant. Because there were
less than 10 studies, small-study effects were not assessed. With each study deleted from the
model once, results remained statistically non-significant across all deletions. The associations
ranged from approximately -0.009 to 0.079. Cumulative meta-analysis, ranked by the year the
studies started, demonstrated that results have been statistically non-significant since the first
study was conducted in 1947. However, it is important to note that these results are based on only
four studies and the direction of association changed from positive to negative and then positive
over time. Random-effects meta-regression revealed statistically significant evidence for an
association between pooled ES (Fisher’s r to z score for the association between childhood
obesity and adult HDL for studies that adjusted for adult BMI) and follow-up age (β = -0.007, p =
0.004; I2 reduced from 94% to 74%), length of follow-up, (β = -0.007, p = 0.004; I2 reduced from
94% to 76%) and sex (males vs. female, β = -0.13, p = 0.01; I2 reduced from 66% to 59%).

66

Triglycerides (unadjusted for adult adiposity): Overall, there was a statistically
significant and positive association between childhood adiposity and adult TG (Table 4 and
Figure 13). Heterogeneity was also statistically significant and large. However, 95% PIs were
non-significant. Because there were less than 10 studies, small-study effects were not assessed.
With each study deleted from the model once, results remained statistically significant across all
deletions except when Freedman et al., 2001 and Schmidt et al., 2011 were deleted. The
associations ranged from approximately 0.07 to 0.11. Cumulative meta-analysis, ranked by the
year the study started, demonstrated that results have been statistically significant since
examining the birth cohort of 1985. Random-effects meta-regression revealed statistically
significant evidence for an association between pooled ES (Fisher’s r to z score for the
association between childhood obesity and adult TG) and follow-up age (β = -0.001, p <0.0001;
I2 reduced from 83% to 50.35%), and length of follow-up (β = -0.007, p = 0.0001; I2 reduced
from 83% to 50%).

Triglycerides (adjusted for adult adiposity): When examining studies that adjusted for
adult BMI, a negative association was observed between childhood adiposity and adult TG (Table
4 and Figure 14). However, the association was not statistically significant. The 95% PIs were
non-significant as well. Heterogeneity was statistically significant and considered large. Because
there were less than 10 studies, small-study effects were not assessed. With each study deleted
from the model once, results remained statistically non-significant across all deletions. The
associations ranged from approximately -0.05 to -0.13. Cumulative meta-analysis, ranked by the
year the studies started, demonstrated that results have been statistically non-significant since
examining the cohort of 1947. Random-effects meta-regression revealed statistically significant
evidence for an association between pooled ES (Fisher’s r to z score for the association between
childhood obesity and adult TG for studies that adjusted for adult BMI) and follow-up age (β =
0.006, p = 0.05; I2 reduced from 95% to 92%), length of follow-up, (β = 0.004, p = 0.02; I2
reduced from 95% to 90%) and sex (male vs. females, β = 0.05, p = 0.002; I2 reduced from 60%
to 45%).

Non-High-density Lipoprotein. Our study was not able to perform MA on the
association between childhood obesity and non-HDL levels due to lack of data.

Sensitivity Analysis
The results of the sensitivity analysis for all the outcomes using only BMI as the
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exposure showed that childhood obesity is significantly and positively associated with adult SBP
(Zr = 0.10; 95% CI: 0.06, 0.13), DBP (Zr = 0.11; 95% CI: 0.07, 0.14), and TG (Zr = 0.10; 95%
CI: 0.02, 0.17), and significantly and inversely associated with adult HDL (Zr = -0.06; 95% CI: 0.11, -0.01) (Table 5).

Discussion

Findings
The purpose of this study was to conduct a SR and MA of studies that have examined the
association between childhood obesity and adult CVD risk factors (SBP, DBP, TC, HDL, LDL,
non-HDL, and TG). The overall, unadjusted findings suggest that childhood obesity is
significantly and positively associated with adult SBP, DBP, and TG and significantly and
negatively associated with adult HDL. This interpretation is supported by: (1) 95% CI for
overall results that do not include the null, (2) consistency of overall results when each study was
deleted from the model once (influence analysis), (3) significance of results over a long time
period in which the included studies were conducted (cumulative meta-analysis), and (4) nonsignificant small study effects.
When examining studies that adjusted for adult obesity, the overall findings suggest that
the association was significant and negative for SBP, DBP, and LDL while the associations
between childhood obesity and adult HDL and TG became non-significant when adult BMI was
accounted for. However, it is important to point out that less than one third of studies adjusted for
adult adiposity measures.4,96,105,107,109,116 For the studies that adjusted for adult BMI, the
associations became reversed, suggesting that the association between childhood adiposity and
adult CVD risk factors is potentially mediated by adult adiposity. The correlation coefficient for
childhood adiposity from childhood to adulthood ranged from 0.3 to 0.8 (mean = 0.6, SD = 0.1),
demonstrating a medium to strong tracking of adiposity across the lifespan. This is also consistent
with previous research suggesting that children who are obese have a 40%-80% chance of
becoming overweight or obese adults.21-23
Several factors need to be taken under consideration when examining the results of this
study. First, we used random-effects models that incorporate heterogeneity into the analysis.
However, based on the fixed-effect model, we observed a moderate to large amount of
heterogeneity in all the outcomes assessed. While a random-effects model incorporates
heterogeneity into the analysis, it does not explain the sources of heterogeneity. Second, the 95%
PIs were not statistically significant as they overlapped the null (0). As previously noted, the 95%
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CI are centered around the point estimate of the between study variation. A 95% PI is based on
the random mean effect, and is an interval/range in which 95% of the true study’s expected
effects are found. This is the area where the true effect measure of the new study lies, or
simultaneously the predicted parameter value in a new study can be deduced, thus giving more
confidence in the overall results of the study.117,118 Third, many studies were considered to be at
an increased risk of bias for the quality of reporting on several items of the STROBE instrument
(Figure 2 and Additional file 3). More specifically, nearly 70% of the studies were considered to
be at a high risk of bias for the following elements: (1) describing any efforts to address potential
sources of bias, (2) explaining how missing data were addressed, (3) explaining how loss to
follow-up was addressed, (4) describing any sensitivity analyses, (5) providing reasons for nonparticipation at each stage, (6) considering the use of a flow diagram, (7) considering translating
estimates of relative risk into absolute risk for a meaningful time period, and (8) not providing
adequate information on participants characteristics. Fourth, loss to follow-up is one of the main
sources of bias in longitudinal studies. The potential bias occurs when the participants who are
lost to follow-up are different from participants who remain in the study.119 Research suggests
that more than a 20% loss to follow-up is a potential threat to the internal validity of the study.120
Only seven studies included information on loss to follow-up.4,99,100,102,103,108,113 Lastly, some of
the associations observed in the exploratory covariates from the results of the meta-regression
analyses suggest that some factors may potentially impact the overall conclusions. These include
different factors for different outcomes. The significant factors included: (1) baseline age for
adult SBP and DBP, (2) follow up age for TC, LDL, and TG (3), length of follow-up for TC,
LDL, and TG, (4) country study was conducted for SBP, and (5) type of exposure used to assess
adiposity for SBP. For the studies that adjusted for adult BMI, the factors included (1) baseline
age for TC, (2) follow up age for SBP, DBP, HDL, and TG (3) length of follow-up for SBP,
DBP, HDL, and TG and (4) sex for TC, HDL, and TG. The statistically significant findings of the
meta-regression are discussed below.
The results from the meta-regression analysis revealed that the association between
childhood obesity and adult SBP and DBP increases as the baseline age increases. For TC, LDL,
and TG the association decreases as the follow-up age and length of follow-up increases. The
association was higher in U.S. compared to other countries, and higher for studies that used BMI
to measure the exposure compared to other measures of adiposity for SBP only. For studies that
adjusted for adult BMI the association between childhood obesity and adult TC increases as the
baseline age increases. For SBP, DBP, and HDL the association decreases as the follow-up age
and length of follow-up increases. The association was lower in males compared to females for
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TC and HDL, and higher in males compared to females for TGs. However, the results found one
unusual finding for the association between childhood obesity and adult TG (adjusted for adult
BMI) that increased with the increase in the follow-up age/length of follow-up. We hypothesize
that this odd finding could have been due to the play of chance given all the tests that were
conducted. However, the results of the meta-regression tests should be interpreted with caution
since they are considered observational and exploratory in nature, i.e., non-experimental
comparisons, designed to generate hypotheses about potential sources of heterogeneity.59 Thus,
these would need to be tested and confirmed in original studies.

Critical Evaluation of Results compared to Previous Systematic Reviews and Meta-analysis
on the Topic
As discussed earlier, four SRs published on this topic from 2010-2012 provided
qualitative evidence but did not provide any quantitative evidence on the association between
childhood obesity and adult CVD risk factors (BP and lipid profile). While one quantitative
analysis was conducted four years ago on this topic, it was limited to a select four cohorts only
and thus, not considered a true MA.40 The results of our study as well as similarities and
differences from these previously conducted SRs and MA are discussed below.
Previous systematic reviews18,37-39 The SR by Lloyd and colleagues37 found little
evidence that childhood obesity is an independent risk factor for adult SBP and DBP. They
concluded that the relationships observed are dependent on the tracking of BMI from childhood
to adulthood. They found that the positive association between childhood BMI and adult blood
pressure was attenuated or became negative when taking into account adult BMI. The results of
our study are in congruence with the findings of this SR. Notably, the second SR by Lloyd and
colleagues18 also found little evidence that childhood obesity is an independent risk factor adult
TC, LDL, HDL, and TG. They found that the association between childhood BMI and adult lipid
levels was attenuated or inversed when taking into account adult BMI. The results of our study
are also consistent with the findings of this SR.
The SR by Reilly and colleagues39 reported a significant and positive association between
childhood adiposity and adult HT. However, the SR did not mention if the studies included in the
review adjusted for adult adiposity. The SR by Park and colleagues38 also found a significant and
positive association between childhood adiposity and adult HT. Two out of five studies described
in this SR38 that adjusted for adult BMI found no association. We believe that the present study is
perhaps answering a different research question (SBP and DBP versus HT). However, since HT is

70

based on both SBP and DBP, it appeared important to mention these differences in findings.38,39
Along those lines, Park and colleagues suggested in their SR that since adult BMI is on the causal
pathway for the association between childhood obesity and adult disease, adjusting for adult BMI
has methodological limitations. One of the main limitations being that adjusting for variables on
the casual pathway can lead to spurious associations (over-adjustment biases) that can draw
estimates towards the null. The study also cited a simulation study that showed that a true positive
association between birth weight and adult BP was diminished after adjusting for current adult
weight status, something that could be reversed if the correlation between birth weight and
current weight was increased.121 As childhood adiposity and adult adiposity are strongly
correlated, this can be a potential issue. However, this debate has been both criticized by other
researchers as well as supported.122-124 Some of the main differences of our study from these
earlier SRs include: (1) combining the ESs of the included studies using the meta-analytic
approach, (2) using SBP and DBP instead of HT,38,39 (3) performing MA on systematically
finding 16 studies for SBP and 14 studies for DBP, 8 studies each for TC, HDL, and TG, and 5
studies for LDL, (4) including additional studies published up to June, 2015, (5) utilizing
numerous definitions for childhood adiposity (exposure), (6) excluding studies that examined
change of exposure from childhood to adulthood,18,37 (7) excluding special populations,18,37 (8)
excluding gestational hypertension39 and, (9) excluding studies that used self-reported
outcomes.39
Previous Meta-analysis40 The MA by Juonala and colleagues used data from four
cohorts: the Bogalusa Heart Study (BHS) the Muscatine Study (MS), the Childhood Determinants
of Adult Health (CDAH) study, and the Cardiovascular Risk in Young Finns Study (YFS). The
results from the random effects MA showed a significant association between childhood obesity
in predicting the following adult CVD outcomes using risk ratios: HT = 2.1 (95% CI: 1.8, 2.5),
LDL = 1.6 (95% CI: 1.3, 2.0), high risk HDL = 1.7 (95% CI: 1.5, 1.9), and TG = 1.8 (95% CI:
1.5, 2.2). The direction of effect for the association between childhood obesity and adult CVD
risk factors in the current MA is consistent with the previous meta-analytic work by Juonala et
al.40 Juonala and colleagues used pooled data from all 4 studies and showed that childhood
obesity was significantly associated with HT even after adjustment for adult obesity (relative risk,
1.5; 95% CI: 1.1, 2.1; P = 0.009). For dyslipidemias, the effect of childhood adiposity was
reduced and became non-significant when adult obesity was taken into account. The results of our
MA are consistent with the pooled results for dyslipidemias. However, this previous study was
not a true MA.40 Some of the main differences in our study compared to this previous
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investigation include: (1) using a systematic approach to find studies published until June 2015
that have examined these selected associations, (2) using SBP and DBP instead of HT, (3)
examining the association for TC, (4) finding a positive but non-significant association for LDL,
(5) performing MA on systematically finding 16 studies for SBP and 14 studies for DBP, 8
studies each for TC, HDL and TG and 5 studies for LDL, (6) performing MA on studies that
adjusted for BMI, and (7) utilization of numerous definitions for childhood adiposity (exposure).

Implications for Research
The results of the current SR with MA have several implications for reporting of future
longitudinal studies. First, based on the STROBE instrument, it is recommended that future
longitudinal studies improve their reporting with respect to several potential sources of bias.
These include: (1) describing any efforts to address potential sources of bias, (2) explaining how
missing data were addressed, (3) explaining how loss to follow-up was addressed, (4) describing
any sensitivity analyses conducted, (4) reporting the numbers of individuals at each stage of the
study, (5) providing reasons for non-participation at each stage, (6) considering the use of a flow
diagram, (7) describing the characteristics of study participants, and (8) considering translating
estimates of relative risk into absolute risk for a meaningful time period. Because longitudinal
studies have a criterion for initially selecting participants that chose to participate or not, have
varied response rates, different numbers of participants at baseline and follow-up, as well as
varied participation and response rates at follow-up time point(s), it is important to demonstrate
this information using a flow diagram. However, only one study used a flow diagram. Therefore,
it is suggested that future longitudinal studies include a flow diagram in order to clearly
demonstrate their study design, participation and response rates. Second, complete information on
the population characteristics should be presented (usually in Table 1 of most articles).
Unfortunately, more than 50% of the studies did not provide adequate information on the
population characteristics. Third, as loss to follow-up is a potential threat to the internal validity
of the study,120 this information should also be provided. Only seven studies included information
on loss to follow-up. Fourth, only one study reported on the association between childhood
obesity and adult non-HDL. This is important since non-HDL has been shown to be better marker
of risk for coronary artery disease and stroke compared to LDL.42,43 It is suggested that future
studies collect and report this information. Fifth, only one third of the studies adjusted for adult
adiposity. Given the former, it would appear prudent to suggest that future studies collect this
information and present both crude and adjusted associations. Sixth, some studies presented
results with unstandardized regression coefficients only. Among those studies that only provided
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unstandardized regression coefficients, we were able to calculate standardized regression
coefficients using the standard deviations of the exposure and the outcome. However, there were
some studies where the standard deviations were not provided. As a result, we were unable to use
data from these studies for our MA. Given the former, it is suggested that future studies provide
information for both standardized and unstandardized regression coefficients. Seventh, while the
majority of studies included information on males and females,97,100,103-106,109,110,112,115,116 two were
limited to men only 95,102 while 9 combined data for both men and women.4,96,98,99,107-109,113,114
Given biological differences between men and women, it would appear plausible to suggest that
future studies include separate as well as combined results for both men and women. Eighth, only
one study provided information on the pubertal status of children. It is important to collect and
adjust for pubertal status in future studies as previous studies have shown an association between
childhood obesity and pubertal developmental,125 as well as between pubertal timing and adult
cardio-metabolic risk factors.126 Ninth, most studies used BMI as a measure of adiposity for the
childhood exposure.4,96-100,102,103,105-110,112-116 However, since prior research has shown that BMI is
not an ideal marker for adiposity,47,48 it is suggested that future studies collect information on
additional markers for adiposity, for example percent body fat, in addition to BMI. Lastly, the
negative associations in the adjusted analysis for all outcomes, and a positive association for HDL
provides the basis for future research to explore whether children at the lower end of BMI during
childhood are at a higher risk for developing CVD risk factors compared to children at the higher
end of the BMI spectrum during childhood and after adjusting for adult BMI.

Implications for Practice
The results of the current MA have relevant implications for practice. Overall, it appears
that childhood obesity is positively associated with adult SBP, DBP, and TG and negatively
associated with adult HDL. Given the former, prevention of childhood obesity should remain a
priority for public health interventions for preventing negative health outcomes during childhood
as well as reducing the burden of adult obesity. Furthermore, this study adds to the argument that
obese children who become normal weight adults are probably not at any higher risk of CVD risk
factor development if they become non-obese in adulthood. However, these findings need to be
interpreted with caution given that only one third of the studies adjusted for adult BMI.

Strengths of the Study
To the best of our knowledge, this is the first MA and most recent SR that has
systematically appraised studies examining these associations. The present study is based on a
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greater number of studies (published up to June 2015) that included both the crude associations as
well as studies that adjusted for adult adiposity. This study also included any definition of
adiposity measure that was utilized for the exposure. Research has shown that BMI is not an ideal
marker for adiposity47,48 and including other definitions or classifications of adiposity helped us in
identifying other potentially eligible studies that have looked at this association. Although we
performed the main MA using studies that utilized varied childhood adiposity measure, the results
of our sensitivity analysis using only BMI as the exposure showed similar findings (Table 5). In
addition, we also used SBP and DBP instead of HT to examine for independent associations
between childhood obesity and components of HT (i.e. high SBP and/or DBP). Lastly, we
performed meta-regression analysis on covariates that may potentially impact this association and
to inform future research on these factors.

Limitations of the Study
The results of the current MA should be viewed with respect to the following potential
limitations. First, only one third of the included studies adjusted for adult BMI. Second, some of
the pre-planned analyses to identify sources of heterogeneity were not performed due to lack of
data. Third, the sample sizes for many of the analyses were probably underpowered to find a true
effect. Fourth, due to the small sample sizes for some analyses, small-study effects (e.g. potential
publication bias) were not conducted. Fifth, the a priori plan of the current study did not include
an age range for childhood exposure. A post hoc decision was made to limit the age range from 219. However, due to including this age range the investigative team faced an additional challenge
i.e. some outcomes were assessed where the mean age of the participants at the follow-up time
point was greater than 19 but the age range included less than 19 year old participants as well.
There were four studies in our review where the mean age was 27 but the age ranged from 1837,4 mean age 24 and age ranged from 18-26,102 mean age 21 and age ranged from 18-24,108 and
mean age 20 and age ranged from 18-21.109 Sixth, MA cannot make up for the poor quality of the
original studies and is inherently vulnerable to the biases in the original studies. Seventh, in order
to retrieve information on missing data, we contacted the corresponding authors via email in
order to obtain necessary information. Nearly 30% of the corresponding authors replied but no
author provided any additional information. Eighth, we excluded studies that were not published
in the English language, which could potentially introduce language bias. However, we do not
believe that this was a major problem since previous research has shown that meta-analyses that
restrict studies by language overestimate the effect of the outcomes by only 2%.66 Ninth, like any
SR, literature search bias is a potential problem where some relevant literature is not identified

74

during the search process. However, we performed an exhaustive search according to pre-defined
criteria examining nearly 5000 citations. Thus, we expect this bias to be minimal. Finally, given
the large number of analyses we conducted, one or more of our findings may have been due to the
play of chance. However, no adjustment for multiple tests were made given that we did not want
to miss potentially important findings that could be tested in future original studies.127 Though the
study had several limitations, to the best of the investigative team’s knowledge, this is the first
MA to examine the association between childhood obesity and adult CVD risk factors as well as
examine this association in studies that adjusted for adult BMI.

Conclusion
The results of the current MA suggest that childhood obesity is significantly and
positively associated with adult SBP, DBP, and TG and negatively associated with adult HDL.
However, additional, well-designed, longitudinal studies with improved reporting as well as data
analysis that includes both unadjusted and adjusted associations for adult adiposity are needed
before any definitive conclusions can be reached.
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Chapter 5: Discussion

Summary of Key Findings

Overview
The current set of studies aimed to examine three distinctive distal determinants of
cardiovascular (CVD) risk factors during childhood and adulthood. We focused on two distal
perinatal factors (birth weight of the infant and reported history of breastfeeding) and later
childhood and maternal CVD risk factors for the first two studies. For the third study we focused
on childhood obesity as the distal determinant of adult CVD risk factors. The CVD risk factors
included: (1) blood pressure including both systolic blood pressure (SBP) and diastolic blood
pressure (DBP), (2) lipids including total cholesterol (TC), high-density lipoprotein cholesterol
(HDL), non-high-density lipoprotein cholesterol (non-HDL), low-density lipoprotein cholesterol
(LDL), and triglycerides (TG), and (3) obesity as assessed by body mass index (BMI). Previous
studies that have examined these distal exposures and CVD risk factors at various life stages
typically have shown inconsistent results. Thus, the overall objective of this project as a whole
was to determine the associations between perinatal risk factors (birth weight and breastfeeding)
and childhood and maternal cardiovascular health, and determine the relationship between
childhood obesity and adult CVD risk factors.
For the first two studies we used data from three projects, including West Virginia (WV)
Birth Certificates, the Working in Appalachia to Track High Birth Score, Critical Congenital
Heart Disease and Hearing Loss (WATCH)/Birth Score project, and the Coronary Artery Risk
Detection in Appalachian Communities (CARDIAC) project. For the first study, children
participating in the Birth-Score project (all of whom are merged with the Birth Certificate data)
born in 1994-2000 were merged with data collected by the CARDIAC project in years 2004-2010
and restricted to full-term birth infants only (N=19,583). For the second study, children
participating in the WATCH/Birth-Score project at birth (all of whom are merged with the Birth
Certificate data) born between in 1997-2004 were merged with data collected by the CARDIAC
project in years 2008-2014 (N=10,457). For the third study we conducted a systematic review and
meta-analysis to critically evaluate the evidence regarding the relationship between childhood
obesity and adult CVD risk factors. A total of 4,840 citations were reviewed utilizing numerous
resources. The inclusion criteria were: (1) longitudinal study-design, (2) childhood exposure and
adult outcomes collected on the same individual over time, (3) childhood obesity, as defined by
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the authors, (4) English language articles, (5) studies published by June, 2015, (6) the primary
outcome measures included SBP, DBP, TC, HDL, LDL, non-HDL, TG, and (7) outcome not selfreported. The search strategy included (1) electronic searches in multiple databases (PubMed
(MEDLINE), Web of Science, and Scopus) on June 5, 2015, and (2) cross-referencing from the
reference lists of all retrieved articles (citation tracking). The summaries of the key findings from
all three studies are discussed below.

Birth Weight and CVD Risk Factors
The aim of the first study was to investigate the association between infant’s birth weight
and childhood CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL, and TG) at 11 years of
age (controlling for child’s current BMI), and the subsequent risk of developing maternal CVD
risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post partum in infants born full-term
only.
The final study sample after excluding infants born pre-term (i.e., <37 weeks of gestation:
N=2,097, 9.67%) was 19,583. In this sample, nearly 3% of the infants were low birth weight
(LBW) and 11% were high birth weight (HBW). Whereas current literature on the association
between birth weight and CVD risk factors shows inconsistent results, the results of this current
study were generally consistent with the Barker’s hypothesis for all outcomes except for DBP.
The results showed a linear inverse association between birth weight and SBP, TC, LDL, nonHDL, and TG, and a positive association with HDL at 11 years of age after adjusting for child
BMI and additional covariates. However, the associations were not statistically significant for
SBP and TC in the adjusted models. Although the direction of the association between SBP and
birth weight was consistent with previous studies,1-5 unlike most studies the adjusted association
was not significant (b = -0.02 mmHg; 95% CI: -0.06, 0.03; p = 0.5295 for 1,000 g increase in
birth weight). The findings suggest that the negative association between birth weight and SPB is
most likely not independent of the child’s current BMI. The direction of the association between
birth weight and DBP was not consistent with the Barker’s hypothesis for both the crude and the
adjusted analysis (b = 0.01 mmHg; 95% CI: -0.02, 0.04; p = 0.4913 for 1,000g increase in birth
weight). However, the results for DBP are consistent with other studies that also found a
significant positive association between birth weight and childhood DBP for the unadjusted
analysis6,7 that became non-significant after adjusting for the child’s current BMI.8 Our results
found a significant positive association between birth weight and childhood HDL (b = 0.06
mg/dL; 95% CI: 0.02, 0.09; p = 0.0035 for 1,000 g increases in birth weight), and a negative
association with TG levels (b = -0.003 mg/dL; 95% CI: -0.05, -0.001; p = 0.0005 for 1,000 g
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increases in birth weight) which is are also consistent with other studies for HDL2,9 and TG levels
respectively.10 When adjusted for the child’s current BMI the direction of association for HDL (b
= 0.14 mg/dL; 95% CI: 0.11, 0.18; p <0.0001 for 1,000 g increases in birth weight) and log-TG (b
= -0.007; 95% CI: -0.008, -0.005; p <0.0001 for 1,000 g increases in birth weight) remained the
same and the magnitude of the association increased. LDL and non-HDL were not significant in
the unadjusted analysis but became significant and negatively associated with birth weight after
accounting for the child’s BMI and additional covariates [LDL (b = -0.1 mg/dL; 95% CI: -0.19, 0.16; p = 0.0196 for 1,000 g increases in birth weight; and for non-HDL (b = - 0.18 mg/dL; 95%
CI: -0.28, -0.09; p = 0.0002 for 1,000 g increases in birth weight)], consistent with the findings of
other studies.2,5
The results from the current study are consistent with the Barker’s hypothesis, as LBW is
associated with higher LDL, non-HDL, and TGs and lower mean HDL levels independent of the
child’s current BMI and additional covariates. The results of the sensitivity analysis using spline
regression model further verified that the association between birth weight and lipid levels was
linear in our population and not U-shaped as demonstrated by some studies.10-12 Based on these
results, we hypothesize that the association between birth weight and lipids is independent of the
child’s current BMI levels. Although the observed effect of birth weight as a distal risk factor for
the child’s lipid levels was small but significant during childhood, this can have a potential
amplified impact as these children enter adulthood.
The association between birth weight and maternal CVD risk factors is an active area of
research. Only one study conducted in India that examined the relationship between birth weight
and maternal lipid levels 8 years post partum found a significant positive association for maternal
TG levels only, after adjusting for additional covariates including maternal BMI.13 Our study
found no significant mean differences in the any of the lipid levels of mothers by birth weight
categories of the infant. However, the unadjusted association between birth weight and maternal
TC was significant and positive but became non-significant when adjusted for additional
covariates in the regression analysis. None of the other lipid levels were significant in either the
unadjusted or the adjusted models. However, the direction of association in our study suggests
that mothers who give birth to HBW infants seemed to demonstrate a trend towards poor
maternal lipid levels 11 years post-partum and is consistent with the previous study.13 Whether
maternal lipid levels are associated with giving birth to LBW or HBW infants, or whether the
birth weight of the infant is a potential risk factor for maternal lipid level in later years, or
whether the mother’s own birth weight impacted their lipid profile is difficult to establish at this
point. The research on this topic is still in its infancy and needs further exploration.
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Breastfeeding and CVD Risk Factors
The aim of the second study was to investigate the association between infants who were
breastfed during infancy and childhood CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL,
and TG) at 11 years of age (controlling for child’s current BMI), and the subsequent risk of
developing maternal CVD risk factors (TC, LDL, HDL, non-HDL, and TG) 11 years post partum.
The final study sample after excluding infants born pre-term (i.e. <37 weeks of gestation:
N=1,190, 10.2%) was 10,457. Nearly 43% of the mothers self-reported that they breastfed their
index child during infancy. The results showed that children whose mother reported to have
breastfed compared to children who were not breastfed in infancy had significantly lower SBP (b
= -1.39 mmHg; 95% CI: -1.97, -0.81; p <0.0001) and DBP (b = -0.79 mmHg; 95% CI: -1.26, 0.33; p = 0.0009) in unadjusted models. However, adjustments for the child’s current BMI
attenuated the association between report of breastfeeding and DBP (b = -0.44 mmHg; 95% CI: 0.89, 0.02; p = 0.06). Adjustment for the child’s current BMI also slightly attenuated the
association of breastfeeding to SBP (b = -0.77 mmHg; 95% CI: -1.32, -0.23; p = 0.005), but
adjustments for additional socio-demographic variables eliminated the association of
breastfeeding to SBP (b = -0.43 mmHg; 95% CI: -0.98, -0.13; p = 0.1349). The results of the
current study for both SBP and DBP are consistent with the evidence provided by the most recent
systematic review with meta-analysis published in 2015.14 Horta and colleagues demonstrated
that SBP and DBP were lower but not significant in children and adolescents aged 10-19 years
who had been breastfed [SBP mean difference= -1.03 (95%CI: -2.07; 0.02) and DBP mean
difference= -0.1 (95%CI: -0.65; 0.45)]. Our study further demonstrated that the child’s current
BMI is a potential mediator for the association between breastfeeding and childhood blood
pressure. Breastfeeding has shown to be protective for childhood obesity as demonstrated by
several studies,14-19 including earlier work with WV fifth grade children.20 The results of this
current study are also consistent with individual studies as well as with systemic reviews and
meta-analyses that found no association between infants who were breastfed vs. non-breastfed
and TC,14,21,22 LDL,22 and non-HDL levels in childhood. However, the results of this current study
showed that children whose mother reported to have breastfed compared to children who were
not breastfed in infancy had significantly lower TG. The regression coefficient of the unadjusted
association was -0.07 (95% CI: -0.1, -0.05; p <0.0001). Adjustment for the child’s current BMI in
fifth grade attenuated the association of reported history of breastfeeding to TG (b= -0.05; 95%
CI: -0.07, -0.03; p = 0.048), which further diminished in magnitude but remained significant after
adjusting for additional covariates as well (b= -0.04; 95% CI: -0.06, -0.01; p = 0.01). The final
model for TG included, the child’s BMI percentile in fifth grade, age, sex, race, maternal
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education at birth, number of previous pregnancies, and family history of cholesterol. However,
previous research on this association remains inconclusive with one study finding a significant
association only among boys only23 or no association at all.24,25 This study did not find any
differences by gender for the association between breastfeeding and childhood TG levels. Based
on the results for TGs, we hypothesize that this association is independent of the child’s current
BMI. Although the associations were partially attenuated by childhood BMI but remained
significant suggests that childhood BMI may be a potential partial mediator. Additionally the
unique amount of variance shared between reported history of breastfeeding and TG levels of
fifth grade WV children was less than 0.2%, suggesting a small effect size.
The association between maternal history of breastfeeding their infants and maternal
CVD risk factors is also an active area of research. Our results are not consistent with studies that
found a protective association between breastfeeding and maternal lipid profile.26-28 However, it is
important to note that for the current study the direction of association was positive for TC, TG,
non-HDL, and LDL and negative for HDL, which is consistent with the hypothesis that
breastfeeding is protective for maternal cardiovascular health. Some of the potential reasons for
the contrasting results could be lack of information on lactation duration or lifetime duration of
lactation, which is the basis of most previous research.26,27,29 Furthermore, the exposure was
assessed retrospectively via parental recall and is subject to self-report bias. It is also possible that
most mothers who initiated breastfeeding, failed to continue to breastfeed for longer durations.
Additionally, the sample size for the maternal outcomes was small due to very low participation
rates. However, Stuebe and colleagues suggest that currently there is no study that has collected
comprehensive data to explain the apparent association between breastfeeding and maternal CVD
risk factors.30 Thus, future studies are needed to collect longitudinal data with wide-ranging
information on several socio-demographics, genetic and lifestyle factors in order to examine and
understand these associations in mothers.

Childhood Obesity and Adult CVD Risk Factors
The purpose of the third study was to conduct a comprehensive systematic review (SR)
and meta-analysis (MA) to critically evaluate the available evidence regarding the relationship
between childhood obesity and adult CVD risk factors (SBP, DBP, TC, LDL, HDL, non-HDL,
and TG).
The final number of studies included in the SR was 2331-53 and 21 studies were included
in the MA.31-37,39-47,49-53 The findings suggest that childhood obesity is significantly and positively
associated with adult SBP (Zr = 0.11; 95% CI, 0.07, 0.14), DBP (Zr = 0.11; 95% CI, 0.07, 0.14),
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and TG (Zr =0.08; 95% CI, 0.03, 0.13), and significantly and inversely associated with adult
HDL (Zr =-0.06; 95% CI, -0.10, -0.02). However, the pooled results of studies that adjusted for
adult BMI32,35,42,44,46,53 showed that these associations were significant but negative for SBP (Zr =
-0.13; 95% CI, -0.07, -0.14), DBP (Zr = -0.11; 95% CI, -0.17, -0.04), and LDL (Zr = -0.08; 95%
CI, -0.12, -0.05). Furthermore, the associations between childhood adiposity measure and adult
HDL and TG became non-significant when pooling studies that adjusted for adult BMI. However,
it is important to point out that less than one third of studies adjusted for adult adiposity measures.
The results of our study are consistent with two systematic reviews by Lloyd and
colleagues.54,55 Lloyd and colleagues found little evidence that childhood obesity is an
independent risk factor for adult blood pressure55 and adult lipid levels.54 The SR by Park and
colleagues56 and by Reilly and colleagues,57 which focused on hypertension and not individual
components of hypertension (i.e. SBP and DBP), also found a significant and positive association
between childhood adiposity and adult hypertension. However, two out of five studies that
adjusted for adult BMI found no association.56 The results from the random effects MA by
Juonala and colleagues using data from four cohorts showed a significant association between
childhood obesity and adult hypertension, LDL, high risk HDL, and TG. When the study adjusted
for adult obesity, hypertension remained significant but the effect of childhood adiposity was
reduced and became non-significant for dyslipidemias.58 The direction of effect for the
association between childhood obesity and adult CVD risk factors in the current MA is consistent
with the meta-analytic work by Juonala et al.58
The results also demonstrated that more rigorous science is needed. For example, the risk
of bias assessment was performed using the ‘Strengthening the Reporting of Observational
studies in Epidemiology’ (STROBE) instrument. The results showed that at the study level, nine
studies had more than one third of items that were at an increased risk of bias.31,33,38,39,41-43,49,53
Other differences between studies may be driven by geographic, gender, or time related
covariates. For example, results from the meta-regression analysis revealed that the association
between childhood obesity and adult SBP and DBP increases as the baseline age increases. For
SBP, DBP, TC, HDL, and LDL the association decreases as the follow-up age and length of
follow-up increases. For TC and HDL (for studies that adjusted for adult BMI) the association
was lower in males compared to females. For SBP only, the association was higher in United
States compared to other countries.
To the best of the investigative team’s knowledge, this is the first MA to examine the
association between childhood obesity and adult CVD risk factors as well as examine this
association in studies that adjusted for adult BMI. The results of the current MA suggest that
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childhood obesity is significantly and positively associated with adult SBP, DBP, and TG and
negatively associated with adult HDL. However, additional, well-designed, longitudinal studies
are needed before any definitive conclusions can be reached.

Limitations of the Dissertation
Some of the limitations of the first two studies include lack of information on potential
factors that are known to influence the relationship between perinatal exposures and childhood
and maternal CVD risk factors. These include but are not limited to: parental adiposity status,
maternal pre-pregnancy weight, maternal lipid status at before and during pregnancy, maternal
birth weight, rapid weight gain during the first year of life, pubertal status of the child, family
history of hypertension, physical activity, and dietary behaviors. Secondly, maternal CVD risk
factors were limited to lipid profile only, which was available for a small sample of the
population thus limiting the generalizability of the sample. Although the childhood data can be
generalizable to WV children, the results may not be generalizable beyond the participants
included in this study due to the unique population characteristics of this state. Lastly, for the
second study information on actual breastfeeding was obtained retrospectively via parental recall
and did not inquire about the method, extent, or the lifetime duration of maternal lactation.
Some of the main limitations of the third study included having a small sample size for
most of the outcomes assessed. Due to the small number of included studies we were not able to
assess for small-study effects (e.g. potential publication bias) for all the lipid outcomes, and were
perhaps underpowered to find a true effect for many of the analyses. Some of the pre-planned
analyses to identify sources of heterogeneity were not performed due to the small sample size as
well. Lastly, less than one third of the included studies adjusted for adult BMI, which further
decreased the sample size of the pooled analysis for the outcomes that examined the relationship
between childhood obesity and adult CVD risk factors adjusting for adult adiposity.

Strengths of the Dissertation
One of the main strengths of the first two studies included using a large longitudinal
dataset with information available for important covariates. To our knowledge this is the first
study that has examined these associations in Appalachia, as an initial step to reduce the CVD
burden by identifying the linkages between perinatal risk factors and later CVD risk factors.
Other strengths include the use of directly measured distal exposure (birth weight) and all study
outcomes (i.e., they were not based on recall or self-report). Furthermore, the effect size of
breastfeeding and childhood TGs levels is a novel finding in 11-year-old children as earlier
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studies included younger or older adolescent populations.23-25,59 For the third study, to the best of
our knowledge this is the first MA to examine the association between childhood obesity and
adult CVD risk factors as well as examine this association in studies that adjusted for adult BMI.
Earlier SRs54-57 on the topic included studies published up to 2011, thus this SR provides a more
updated review of studies examining this association in studies published up to 2015. The current
SR also included any definition or classification used in individual studies to measure childhood
adiposity, which facilitated in identification of additional eligible studies that examined these
associations.

Potential Public Health Implications and Future Recommendations
CVD is the leading cause of death globally, nationally as well in the state of WV.60-62
According to the 2016 Heart Disease and Stroke Statistics update, more than one third of
American adults have ≥1 types of CVD62 and it is projected that 43.9% of the US population will
have some form of CVD by 2030.62 For 2011-12, the estimated cost of CVD (direct and indirect)
was $316.6 billion, which is also projected to increase to $918 billion by 2030.62 High blood
pressure and poor cholesterol are well-established risk factors for CVD.63-67 Hypertension in
children is linked to end-organ damage and poor cholesterol is associated with preclinical
atherosclerosis during childhood.68-71 These risk factors also track from childhood into
adulthood.49,72-78 Childhood adiposity is another risk factor for developing CVD risk factors 35,79-81
and obese children have a higher risk of becoming overweight/obese adults,82-84 which is an
independent predictor of adult CVD and its risk factors.85-89 Over weight and obesity is prevalent
in one third of the youth in the U.S. and nearly two third of the adult population.90 Research
shows that early prevention of CVD risk factors such as obesity, high blood pressure, and
cholesterol levels can reduce the risk of CVD in subsequent years.64,91
The current set of studies was able to explore the association between perinatal factors
(birth weight and breastfeeding) and childhood and maternal CVD risk factors in the state of WV.
This rural Appalachian population has one of the highest prevalence of CVD and CVD risk
factors in the nation. Thus, there is vital need to first and foremost identify these determinants and
their long-term cardiovascular impact in this state as a first step geared towards health promotion
and implementation of early preventative interventions for reducing the burden of CVD.
The findings revealed that perinatal exposures such as LBW in full-term infants was
associated with worse lipid levels, and breastfeeding as a protective early life exposure was
associated with lower lipid levels during childhood. Childhood BMI was a potential mediator
between perinatal factors (birth weight and breastfeeding) and childhood CVD risk factors.
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Though the association between perinatal factors as the distal determinant of CVD risk factors
was small, these risk factors have the ability to track and potentially amplify, as these children
become adults. The results of the study can guide future research to identify early life exposures
that may potentially restrict fetal growth resulting in LBW babies in full-term infants in this state.
Moreover, biomedical research should focus on identifying complex mechanisms, which underlie
the physiological changes in infants who were not breastfed or who were born with LBW that are
responsible for less than optimal cardiovascular health in later life. The results from this study can
guide future interventions to create targeted prevention or screening programs for children who
are born LBW for less than optimal levels of lipids and lipoproteins. Considering the role of BMI
as a potential mediator the study can also serve a guide to targeted screening interventions for
children who are born LBW and are overweight or obese during childhood for high blood
pressure and less than optimal levels of lipids and lipoproteins. Furthermore, future research
should focus on establishing different birth cut-offs for diverse populations to increase the
sensitivity of identifying infants with higher risk of future CVD as suggested by a recent
systematic review as well.92 The observed impact of breastfeeding as a distal protective factor for
the child’s CVD risk factors was small; nonetheless it adds to the argument of promoting
breastfeeding practices in this rural Appalachian state of WV. For the maternal CVD risk factors,
the current study demonstrates some important preliminary results. The direction of association in
the first study suggested that mothers who give birth to HBW babies have higher risk of poor
lipid levels and for the second study the direction of correlations suggested breastfeeding to be
protective for maternal lipid levels 11 years post-partum. Thus, providing an essential
contribution for expanding the research examining the associations between perinatal factors and
maternal CVD health in subsequent years.
The results of the current SR with MA have several implications as well. Some of the
main implications for research include recommendation for future longitudinal studies to improve
their reporting with respect to several potential sources of bias. Additionally, it is recommended
that future studies examining the association between childhood obesity and adult CVD risk
factors to also report their findings for non-HDL level. This is important because non-HDL has
been shown to be better marker of risk for CVD compared to LDL.93,94 Moreover, less than one
third of the studies included in the SR adjusted for adult adiposity. It is suggested that future
studies collect this information and present both crude and adjusted associations. The inverse
associations in the adjusted analysis provides the basis for future research to explore whether
children at the lower end of the BMI are at a higher risk for developing CVD risk factors
compared to children at the higher end of the BMI spectrum during childhood after adjusting for
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adult BMI. Furthermore, this finding adds to the argument that perhaps obese children who
become normal weight adults are probably not at any higher risk of CVD risk factor development
if they become non-obese in adulthood. However, future robust studies are needed to confirm
these results in diverse populations. Overall childhood obesity was a risk factor for select adult
CVD risk factors (SBP, DBP, HDL, and TG). These findings can guide future interventions to
create screening programs for high blood pressure and less than optimal levels of lipids and
lipoproteins in adults who were overweight or obese during childhood and adolescence.
Prevention of childhood obesity should remain a priority for public health interventions for
preventing negative health outcomes during childhood as well as reducing the burden of adult
obesity.

Conclusion
The main findings of the study demonstrated that LBW is a risk factor for poor lipid levels in
childhood (LDL, HDL, non-HDL, and TG) and breastfeeding is a protective factor for childhood
lipid level (TG) in fifth grade West Virginian children born full term. No significant associations
were observed for perinatal factors (birth weight and breastfeeding) and maternal lipid profile.
Well-designed longitudinal studies are needed to understand the complex pathways examining
these associations at different life stages. The results of the systematic review with meta-analysis
suggest that childhood obesity is significantly and positively associated with adult SBP, DBP, and
TG and negatively associated with adult HDL. However, additional, well-designed longitudinal
studies with improved reporting as well as data on both unadjusted and adjusted associations for
adult adiposity are needed before any definitive conclusions can be reached.
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Tables
Chapter 2
Table 1: Maternal and child characteristics at birth and in fifth grade using merged data from the
Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were
born Full-Term (N=19583)
Variable

N

Missing

Sex

19583

0

Female
Male

10713 (54.71)
8870 (45.29)
19049

Race (child in fifth grade)

534

Others
White

931 (4.89)
18118 (95.11)
19583

Race (mother at birth)

0

Others
White

482 (2.46)
19101 (97.54)
19583

Marital Status (at birth)

0

Single
Married

5072 (25.9)
14511 (74.1)
10657

Health Insurance

8926

Medicaid
Non-Medicaid
Maternal Education at Birth
Less than or equal to 12 years
Greater than 12 years
Maternal Education when child in 5 grade
Less than or equal to 12 years
Greater than 12 years
Family History of Cholesterol
No
Yes
Family History of CVD
No
Yes
Family History of Diabetes
No
Yes
Smoking during Pregnancy (maternal)
Yes
No
Smoking in the house when child in 5 grade

Frequency (%)/
Mean (SD)

5937 (55.71)
4720 (44.29)
19516

67
12642 (64.78)
6874 (35.22)

17820

1763
7769 (43.6)
10051 (56.4)

15781

3802
10055 (63.72)
5726 (36.28)

19583

0
13098 (66.88)
6485 (33.12)

17897

1686
8513 (47.57)
9384 (52.43)

19428

155
4839 (24.91)
14590 (75.09)

18564

1019

120

No
Yes

12316 (66.34)
6248 (33.66)
19239

No. of Prenatal care visits

344

<12
≥12

7453 (38.74)
11786 (61.26)
19015

Month prenatal care visits

568

<3months
≥3months

11772 (61.91)
7243 (38.09)
19583

No. of Previous pregnancy
0
≥1

0
6893 (35.2)
12690 (64.8)

19583
0
Breastfeeding Intention
Both (Breast or Bottle)
11201 (57.2)
Breastfed
8382 (42.8)
Birth weight (grams)
0
515 (2.63)
<2500 19583
2500 - 4000
16963 (86.62)
>4000
2105 (10.75)
19583
0
10.95 (0.48)
Age of Child
19558
25
25.35 (5.5)
Maternal Age at Birth
19555
28
36.3 (5.49)
Maternal Age when child in 5 grade
19517
66
12.58 (2.06)
Maternal Education at Birth
18105
1478
30.43 (13.93)
Weight Gain during Pregnancy (lbs)
19583
0
39.25 (1.16)
Gestational Age (weeks)
19397
186
108.85 (11.96)
Child SBP
19344
239
68.8 (9.31)
Child DBP
16122
3461
160.3 (28.13)
Child TC
15964
3619
92.92 (24.7)
Child LDL
16066
3517
49.98 (12.05)
Child HDL
16066
3517
110.3 (28.45)
Child NON-HDL
15951
3632
91.79 (54.46)
Child TG
15951
3632
4.39 (0.5)
Child log TG
19281
302
73.05 (27.84)
BMI-Percentile
19583
0
3414.05 (483.33)
Birth Weight (grams)
1121
18462
189.18 (34.67)
Maternal TC
1082
18501
113.38 (30.22)
Maternal LDL
1116
18467
52.65 (13.28)
Maternal HDL
1116
18467
136.59 (35.94)
Maternal NON-HDL
1115
18468
119.15 (82.99)
Maternal TG
1115
18468
4.62 (0.54)
Maternal log TG
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TCtotal cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; nonHDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Table 2: Results one-way analysis of variance (ANOVA) for the mean difference in blood
pressure and lipid levels in both fifth grade children and mothers by low birth weight (<2500g)
normal birth weight (2000-4000g) and high birth weight (>4000g) groups using merged data from
the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who
were born Full-Term (N=19583)

Child CVD risk factors
Birth weight
categories
(grams)
BMI (N)
Mean (SD)*

>2500

2500-4000

>4000

504
66.04
(30.64)
510
108.3
(11.75)

16707
72.51
(28.07)
16800
108.79
(11.98)

2070
79.14
(24.13)
2087
109.58
(11.89)

509
68.44
(9.14)
437
161.33
(30.21)

16754
68.74
(9.34)
13982
160.21
(28.18)

LDL (N)
Mean (SD)

433
94.08
(26.63)

HDL (N)
Mean (SD)
Non-HDL (N)
Mean (SD)

SBP (N)
Mean (SD)*
DBP (N)
Mean (SD)*
TC (N)
Mean (SD)

Mother CVD risk factors
>2500

25004000

>4000

2081
69.36
(9.14)
1703
160.8
(27.17)

26
188.74
(28.92)

970
188.52
(35.27)

120
194.71
(30.47)

13844
92.79
(24.63)

1687
93.74
(24.81)

26
188.74
(28.92)

970
188.52
(35.27)

120
194.71
(30.47)

436
49.61
(11.99)

13933
49.97
(12.08)

1697
50.18
(11.89)

25
51.4
(11.55)

970
52.79
(13.41)

121
51.82
(12.61)

436
111.66
(29.62)

13933
110.23
(28.47)

1697
110.58
(27.97)

25
138.4
(30.15)

970
135.84
(36.63)

121
142.2
(30.85)

432
13841
1678
25
969
121
4.4
4.39
4.36
4.57
4.62
4.67
(0.52)
(0.5)
(0.51)
(0.51)
(0.54)
(0.58)
*P <0.05 (omnibus F-test)
Post hoc test (Tukeys) were performed where the omnibus F-test was significant to explore which
means were significantly different between groups. All comparisons were significant for BMI.
For SBP and DBP only high birth weigh (>4000g) was significantly greater than normal birth
weigh (2500-4000g) (p <0.05)
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TCtotal cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; nonHDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
Log-TG (N)
Mean (SD)
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Table 3: Pearson correlation between birth weight and CVD risk factors for mothers and children
using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (20042010) for all infants who were born Full-Term (N=19,583)
Childhood CVD risk factors
BMI percentile
SBP
DBP
TC
LDL
HDL
Non-HDL
Log-TG

N

Correlation Coefficient r

P-value

19281
19397
19344
16122
15964
16066
16066
15951

0.10284
0.02647
0.03224
0.00568
0.00336
0.02305
-0.00565
-0.02768

<0.0001
0.0002
<0.0001
0.4704
0.6709
0.0035
0.4742
0.0005

Maternal CVD risk factors
1116
0.0386
TC
0.06193
1082
0.04892
0.1078
LDL
1116
-0.00539
0.8574
HDL
1116
0.04932
0.0996
Non-HDL
1115
0.03763
0.2093
Log-TG
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TCtotal cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; nonHDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Table 4a: Results of the multiple regression analysis for the association between birth weight and CVD risk factors of fifth-grade WV children
using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were born Full-Term
(N=19,583)

N

SBP
Birth weight

1939
7

LBW
HBW
DBP
Birth weight

1934
4

LBW
HBW
TC
Birth weight

1612
2

LBW
HBW
LDL
Birth weight

LBW

1596
4

Model 1
Unstandardized
regression
coefficients (95%
CI)
0.0007
(0.0003- 0.001)**
-0.49
(-1.54 - 0.56)
0.80
(0.25 - 1.34)**
0.0006
(0.0003 - 0.0008)**
-0.31
(-1.13 - 0.52)
0.62
(0.19 - 1.04)**
0.0003
(-0.0006 - 0.001)
1.12
(-1.56 - 3.80)
0.59
(-0.82 - 2.00)
0.0002
(-0.0006 - 0.001)
1.29
(-1.08 - 3.65)

Standardiz
ed (Beta)

N

0.026

1911
3

-0.007
0.021
0.032

1906
3

-0.005
0.021
0.006

1606
6

0.006
0.006
0.003

0.008

1590
8

Model 2
Unstandardized
regression
coefficients (95%
CI)
-0.0002
(-0.0005 - 0.0001)
0.55
(-0.44 - 1.56)
-0.13
(-0.64 - 0.39)
0.00009
(-0.0001 - 0.0004)
0.35
(-0.45 - 1.15)
0.034
(-0.38 - 0.45)
-0.0002
(-0.001 - 0.0007)
1.83
(-0.84 - 4.49)
-0.02
(-1.44 - 1.39)
-0.0006
(-0.001 - 0.0002)
2.20
(-0.14 - 4.54)

Standardiz
ed (Beta)

N

-0.009

8289

0.007
-0.003
0.005

1501
8

0.006
0.001
-0.004

1327
1

0.011
0
-0.011

0.014
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1313
9

Model 3
Unstandardized
regression
coefficients (95%
CI)
-0.0002
(-0.0006 - 0.0003)
0.48
(-0.91 - 1.86)
0.05
(-0.71 - 0.82)
0.00010
(-0.0002 - 0.0004)
0.38
(-0.52 - 1.29)
0.13
(-0.33 - 0.59)
-0.0007
(-0.0017 - 0.0002)
1.71
(-1.23 - 4.64)
-0.36
(-1.90 - 1.19)
-0.0010
(-0.0019- 0.00016)*
2.61
(0.05 - 5.18)*

Standar
dized
(Beta)
-0.007
0.007
0.001
0.005
0.007
0.004
-0.013
0.01
-0.004
-0.02

0.017

HBW
HDL
Birth weight

1606
6

LBW
HBW
Non-HDL
Birth weight

1606
6

LBW
HBW
Log-TG
Birth weight

LBW

1595
1

0.95
(-0.30 - 2.2)
0.0006
(0.0002 - 0.0009)**
-0.36
(-1.50 - 0.79)
0.21
(-0.39 - 0.82)
-0.0003
(-0.001 - 0.0006)
1.43
(-1.28 - 4.15)
0.35
(-1.08 - 1.78)
-0.00003
(-0.00004 –
- 0.00001)**
0.014
(-0.033 - 0.062)
-0.02
(-0.05 - 0.005)

0.012
0.023

1601
0

-0.005
0.005
-0.006

1601
0

0.008
0.004
-0.028

0.005
-0.013

1589
6

0.10
(-1.14 - 1.34)
0.0014
(0.0011 - 0.0018)**
-1.25
(-2.34 - -0.17)*
1.19
(0.62 - 1.77)**
-0.0017
(-0.0026- 0.0008)**
3.02
(0.38 - 5.67)*
-1.25
(-2.65 - 0.16)
-0.00007
(-0.00008 –
-0.00005)**
0.054
(0.009 - 0.099)*
-0.065
(-0.089 - -0.042)**

0.001
0.057

1549
1

-0.017
0.03
-0.029

1541
9

0.017
-0.013
-0.064

0.018
-0.04

1277
6

0.08
(-1.27 - 1.43)
0.0009
(0.0005 - 0.0012)*
-0.85
(-1.95 - 0.26)
0.71
(0.12 - 1.30)*
-0.0018
(-0.0028 - 0.0009)**
3.18
(0.27 - 6.08)*
-1.07
(-2.60 - 0.45)
-0.00005
(-0.00006 - 0.00003)**
0.046
(-0.003 - 0.097)
-0.05
(-0.08 - -0.02)*

0.001
0.036
-0.011
0.018
-0.032

0.018
-0.012
-0.048

0.015
-0.031

HBW
* <0.05; ** <0.01
LBW (<2,500 grams), HBW (>4000grams), Referent: normal birth weight (2500-4000grams).
Variables included in the model: Model 1: All the outcomes were regressed on birth weight (both linear and categorical). Model 2: All the
outcomes were regressed on birth weight variable and the child's BMI percentile in fifth grade. Model 3: All the outcomes were regressed on birth
weight and the child's BMI percentile and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in
the multiple regression analysis. Each non-significant covariate was deleted from the regression model one at a time. Variables retained in model
for SBP: child's age, race (white vs. other), maternal health insurance status at time of delivery (non-Medicaid vs. Medicaid), and family history of
cholesterol (yes vs. no); DBP: child's age, race (white vs. other), and family history of cholesterol (yes vs. no); TC: child's age, race (white vs.
other), and family history of cholesterol (yes vs. no); LDL: child's age, gender, interaction between age*gender, and family history of cholesterol
(yes vs. no); HDL: child's age, gender, race (white vs. other), family history of CVD (yes vs. no), maternal smoking status during pregnancy (yes
vs. no), and maternal age at time of delivery; Non-HDL: child's age, family history of cholesterol (yes vs. no), and breastfeeding intention
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(breastfeed vs. both); TG: child's age, sex, race (white vs. other), family history of cholesterol (yes vs. no), family history of CVD (yes vs. no), and
maternal education at birth.
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Table 4b: Table 4a: Results of the multiple regression analysis for the association between birth weight and CVD risk factors of mothers using
merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were born Full-Term
(N=19583)

Model 1
N

TC
Birth weight

1116

LBW
HBW
LDL
Birth weight

1082

LBW
HBW
HDL
Birth weight

1116

LBW
HBW
Non-HDL
Birth weight
LBW

1116

Model 2

Unstandardized
regression coefficients
(95% CI)
0.005
(0.0002 – 0.00904)
0.22
(-13.29 – 13.73)
6.19
(-0.38 – 12.77)
0.003
(-0.0007 – 0.007)

Standa
rdized
(Beta)
0.062

PValue

Adj-R2

N

0.039

0.0029

1115

0.001

0.975

0.0013

0.055

0.065

0.049

0.108

0.1078

3.69
(-8.56 – 15.94)
5.39
(-0.46 – 11.25)
-0.0002
(-0.002 – 0.002)
-1.38
(-6.66 – 3.90)
-0.96
(-3.48 – 1.55)
0.004
(-0.001 - 0.008)
2.56
(-11.71 - 16.83)

0.018

0.555

0.0014

0.055

0.071

-0.005

0.857

-0.0009

-0.015

0.608

-0.0011

-0.023

0.453

0.049

0.100

0.0015

0.011

0.725

0.0013

1060

1016

1093

Unstandardized
regression
coefficients (95% CI)
0.004
(-0.0001 – 0.0087)
-0.87
(-14.25 – 12.50)
5.74
(-0.78 – 12.27)
0.003
(-0.0007 – 0.0072)

Standar
dized
(Beta)
0.057

PValue

Adj-R2

0.0553

0.0246

-0.004

0.898

0.0231

0.051

0.0845

0.050

0.1019

0.0191

1.602
(-10.74 – 13.94)
5.49
(-0.36 – 11.35)
-0.001
(-0.003 – 0.0004)
1.73
(-3.60 – 7.06)
-1.55
(-4.09 – 0.98)
0.00426
(-0.0003 – 0.0088)
0.48
(-14.20 – 15.17)

0.008

0.7989

0.0188

0.056

0.0662

-0.045

0.1444

0.0563

0.019

0.5252

0.0551

-0.037

0.2297

0.054

0.07

0.0226

0.002

0.9486

0.0221
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0.055
0.067
6.66
0.058
0.0555
6.35
(-0.44 - 13.14)
(-0.156 – 13.48)
1115
0.00004
0.038
0.209
0.0005 1114
0.00005
0.044
0.139
0.005
(-0.00002 - 0.0001)
(-0.000017 – 0.00012)
-0.016
0.604
-0.0008
-0.062
-0.017
0.5675 0.0034
-0.06
(-0.27 – 0.16)
(-0.275 – 0.151)
LBW
0.04
0.026
0.391
0.051
0.030
0.3171
HBW
(-0.06 - 0.15)
(-0.049 – 0.153)
LBW (<2,500 grams), HBW (>4000grams), Referent: normal birth weight (2500-4000grams).
Variables included in the model: Model 1: All the outcomes were regressed on birth weight (both linear and categorical). Model 2: All the
outcomes were regressed on birth weight and additional covariates. Only covariates that were significant in the Spearman’s correlation were used
in the multiple regression analysis. Each non-significant covariate was deleted from the regression model one at a time. Variables retained in
model for TC: mothers age when child in fifth grade, and breastfeeding intention (breastfeed vs. both); LDL: mothers age when child in fifth
grade, breastfeeding intention (breastfeed vs. both), and smoking in the house (yes vs. no); HDL: mothers age when child in fifth grade, smoking
in the house (yes vs. no), family history of CVD (yes vs. no), family history of diabetes (yes vs. no), number of previous pregnancies (≥1 vs. 0);
Non-HDL: mothers age when child in fifth grade, breastfeeding intention (breastfeed vs. both), and smoking in the house (yes vs. no); TG:
mothers age when child in fifth grade and breastfeeding intention (breastfeed vs. both).
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
HBW
Log-TG
Birth weight

128

Table 5a: Results of the multiple regression analysis for the association between birth weight (continuous) and LDL, HDL, non-HDL, and TG
levels of fifth-grade WV children born full term using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (20042010) for all infants who were born Full-Term (N=19583)

LDL

Intercept

N

Unstandardized
regression coefficients
and 95% CI

Standardiz
ed (Beta)

t
Value

Pvalue

AdjR2

Reduce
d model
Adj-R2

13139

142.72 (128.72 - 156.71)

0

19.99

0.0001

0.036
5

0.0361

Chan
ge in
AdjR2
0.0004

-5.23 (-6.47 - -3.995)
-23.32 (-42.57 - -4.07)
2.25 (0.49 - 3.992)
5.38 (4.52 - 6.25)

-0.11
-0.47
0.5
0.11

-8.3
-2.37
2.51
12.21

0.0001
0.0176
0.0122
0.0001

0.12 (0.11 - 0.14)

0.14

15.61

0.0001

-0.0011 (-0.0019 - 0.0002)
68.8 (64.25 - 73.35)
-0.97 (-1.35 - -0.59)
2.18 (1.82 - 2.54)
-2.71 (-3.53 - -1.89)
-0.75 (-1.12 - -0.38)
-0.74 (-1.17 - -0.32)

-0.02

-2.33

0.0196

0
-0.04
0.09
-0.05
-0.03
-0.03

29.66
-5.02
11.75
-6.48
-3.93
-3.41

0.0001
0.0001
0.0001
0.0001
0.0001
0.0007

0.124

0.1228

0.0012

0.05 (0.02 - 0.09)
-0.15 (-0.16 - -0.14)

0.03
-0.34

2.86
-43.96

0.0042
0.0001

0.001 (0.0006 - 0.0013)
137.4 (125.8-148.99)

0.04
0

4.59
23.22

0.0001
0.0001

0.066
8

0.0659

0.0009

Child's age in fifth grade
Sex (male vs. female)
Child's sex*age
Family history of
cholesterol
BMI percentile in fifth
grade
Birth weigh (grams)
HDL

NonHDL

Intercept
Child's age in fifth grade
Sex (male vs. female)
Race (white vs. other)
Family history of CVD
Maternal smoking
(pregnancy)
Maternal age at birth
BMI percentile in fifth
grade
Birth weigh (grams)
Intercept

15491

13221
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Log-TG

Child's age in fifth grade
Family history of
cholesterol
Feeding intention
BMI percentile in fifth
grade
Birth weigh (grams)
Intercept
Child's age in fifth grade
Sex (male vs. female)
Race (white vs. other)
Family history of
cholesterol
Family history of CVD
Maternal education at birth
BMI percentile in fifth
grade
Birth weigh (grams)

12776

-3.57 (-4.56 - -2.57)
6.45 (5.47 - 7.43)

-0.06
0.11

-7.04
12.91

0.0001
0.0001

-0.99 (-1.94 - -0.03)
0.23 (0.22 - 0.25)

-0.02
0.23

-2.02
26.31

0.0435
0.0001

-0.002 (-0.003 - -0.001)
3.7 (3.49 - 3.92)

-0.032
0

-3.75
33.85

0.0002
0.0001

0.04 (0.02 - 0.06)
-0.11 (-0.13 - -0.1)
0.15 (0.11 - 0.19)
0.06 (0.04 - 0.08)

0.04
-0.11
0.07
0.06

4.03
-12.9
7.67
6.38

0.0001
0.0001
0.0001
0.0001

0.02 (0.01 - 0.04)
-0.01 (-0.02 - -0.01)
0.006 (0.0059 - 0.0065)

0.02
-0.04
0.35

2.18
-4.18
41.98

0.0296
0.0001
0.0001

0.142
1

0.1401

0.002

-0.00005 (-0.00007 - -0.05
-5.66 0.0001
0.00004)
Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis. Each non-significant covariate
was deleted from the regression model one at a time. Variables retained in model for LDL: child's age, gender, interaction between age*sex, and
family history of cholesterol (yes vs. no); HDL: child's age, gender, race (white vs. other), family history of CVD (yes vs. no), maternal smoking
status during pregnancy (yes vs. no), and maternal age at time of delivery; Non-HDL: child's age, family history of cholesterol (yes vs. no), and
breastfeeding intention (breastfeed vs. both); TG: child's age, sex, race (white vs. other), family history of cholesterol (yes vs. no), family history
of CVD (yes vs. no), and maternal education at birth.
CVD-Cardiovascular Disease; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein
cholesterol; cholesterol; TG-triglycerides
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Table 5b: Results of the multiple regression analysis for the association between birth weight (categorical) and LDL, HDL, non-HDL, and TG
levels of fifth-grade WV children born full term using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (20042010) for all infants who were born Full-Term (N=19583)
N

LDL

HDL

Intercept
Child's age in fifth grade
Sex (male vs. female)
Child's sex*age
Family history of
cholesterol
BMI percentile in fifth
grade
LBW (<2500 gram)
HBW (>4000 grams)
Intercept
Child's age in fifth grade
Sex (male vs. female)
Race (white vs. other)
Family history of CVD
Maternal smoking
(pregnancy)
Maternal age at birth
BMI percentile in fifth
grade
LBW (<2500 gram)
HBW (>4000 grams)

13139

15491

Unstandardized
regression
coefficients and 95%
CI
138.95 (125.41 152.49)
-5.21 (-6.44 - -3.97)
-23.54 (-42.79 - -4.29)
2.25 (0.5 - 4.01)
5.39 (4.53 - 6.25)

Standardiz
ed (Beta)

t
Value

P-value

Adj-R2

Reduce
d model
Adj-R2

Change
in AdjR2

0

20.12

<0.0001

0.0363

0.0361

0.0002

-0.11
-0.48
0.51
0.11

-8.26
-2.4
2.52
12.23

<0.0001
0.0166
0.0118
<0.0001

0.12 (0.11 - 0.14)

0.14

15.46

<0.0001

2.62 (0.05 - 5.18)
0.09 (-1.27 - 1.44)
71.93 (67.59 - 76.27)
-1 (-1.37 - -0.62)
2.26 (1.9 - 2.62)
-2.66 (-3.47 - -1.84)
-0.75 (-1.13 - -0.38)
-0.88 (-1.3 - -0.46)

0.02
0.01
0
-0.04
0.1
-0.05
-0.03
-0.04

2
0.12
32.5
-5.15
12.25
-6.35
-3.94
-4.09

0.046
0.9022
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

0.1232

0.1228

0.0004

0.06 (0.02 - 0.09)
-0.15 (-0.15 - -0.14)

0.03
-0.34

3.01
-43.77

0.0026
<0.0001

-0.85 (-1.96 - 0.26)
0.72 (0.13 - 1.31)

-0.02
0.02

-1.5
2.37

0.1327
0.0177
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Non-HDL

Intercept

13221

130.81 (119.82 141.8)
-3.53 (-4.52 - -2.54)
6.46 (5.48 - 7.44)

0

23.33

<0.0001

0.0662

0.0659

0.0003

Child's age in fifth grade
-0.06
-6.97
<0.0001
Family history of
0.11
12.92 <0.0001
cholesterol
Feeding Intention
-1.07 (-2.02 - -0.12)
-0.02
-2.2
0.0281
BMI Percentile in fifth
0.23 (0.21 - 0.25)
0.23
26.14 <0.0001
grade
LBW (<2500 gram)
3.19 (0.28 - 6.09)
0.02
2.15
0.0316
HBW (>4000 grams)
-1.08 (-2.61 - 0.46)
-0.02
-1.38
0.1671
Intercept
12776
3.54 (3.34 - 3.75)
0
33.5
<0.0001 0.1411
0.1401
0.001
Log-TG
Child's age in fifth grade
0.04 (0.02 - 0.06)
0.04
4.17
<0.0001
Sex (male vs. female)
-0.12 (-0.13 - -0.1)
-0.12
-13.4
<0.0001
Race (white vs. other)
0.15 (0.11 - 0.19)
0.07
7.52
<0.0001
Family history of
0.06 (0.04 - 0.08)
0.06
6.42
<0.0001
cholesterol
Family history of CVD
0.02 (0.01 - 0.04)
0.02
2.17
0.0302
Maternal education at birth
-0.01 (-0.02 - -0.01)
-0.04
-4.66
<0.0001
BMI percentile in fifth
0.006 (0.0059 0.35
41.8
<0.0001
grade
0.0065)
LBW (<2500 gram)
0.05 (-0.01 - 0.1)
0.02
1.82
0.0684
HBW (>4000 grams)
-0.06 (-0.08 - -0.03)
-0.04
-3.77
0.0002
Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis. Each non-significant covariate
was deleted from the regression model one at a time. Variables retained in model for LDL: child's age, gender, interaction between age*gender,
and family history of cholesterol (yes vs. no); HDL: child's age, gender, race (white vs. other), family history of CVD (yes vs. no), maternal
smoking status during pregnancy (yes vs. no), and maternal age at time of delivery; Non-HDL: child's age, family history of cholesterol (yes vs.
no), and breastfeeding intention (breastfeed vs. both); TG: child's age, sex, race (white vs. other), family history of cholesterol (yes vs. no), family
history of CVD (yes vs. no), and maternal education at birth.
CVD-Cardiovascular Disease; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein
cholesterol; cholesterol; TG-triglycerides
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Supplemental Tables Chapter 2
Supplemental Table S1: Results of the Spline regression analysis for the association between birth weight and CVD risk factors of fifth-grade
WV children using merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were born
Full-Term (N=19,583)

CVD risk
factors

BTW
(grams)

Child
SBP

< 2500
2500 4000
> 4000

DBP

< 2500
2500 4000
> 4000

TC

LDL

< 2500
2500 4000
> 4000
< 2500

Model 1
Unstandardized
regression
coefficients and
95% CI
-0.00009
(-0.004 - 0.004)
0.0006
(-0.0031 -0.0043)
0.00156
(-0.0003 - 0.0033)
-0.0009
(-0.0037 -0.0019)
0.002
(-0.001 - 0.004)
0.0006
(-0.0008 - 0.002)
-0.00935
(-0.0184 -0.00021)
0.01011
(0.00061 -0.0196)
-0.0008
(-0.005 - 0.004)
-0.005

Model 2

Pvalue

Adjus
tedR2

0.961
6
0.771
2
0.092
8
0.512
5
0.302
9
0.422
2

0.000
7

0.045
0.036
8
0.728
0.187

0.001

0.000
1

0

Unstandardized
regression
coefficients and
95% CI
-0.00105
(-0.0045 - 0.0023)
0.00072
(-0.0028 - 0.0042)
0.00103
(-0.0007 - 0.0028)
-0.00171
(-0.004 - 0.001)
0.0018
(-0.001 - 0.005)
0.0002
(-0.0012 - 0.002)
-0.0098
(-0.019 - -0.0007)
0.01008
(0.0006 - 0.0195)
-0.0012
(-0.006 - 0.004)
-0.006

Model 3

Pvalue

Adju
stedR2

0.543
7
0.687
1
0.239
1
0.218
2

0.115
6

0.204
0.752
8
0.034
2
0.036
4
0.623
5
0.137

0.068
5

0.009
3

0.021
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Unstandardized
regression
coefficients and
95% CI
0.00395
(-0.0006 - 0.0085)
-0.0045
(-0.009 - 0.0002)
0.00157
(-0.0001 - 0.004)
-0.0008
(-0.004 - 0.002)
0.0009
(-0.003 - 0.004)
0.0003
(-0.001 - 0.002)
-0.012
(-0.022 - -0.0017)
0.0119
(0.0011 - 0.02264)
-0.0012
(-0.006 - 0.004)
-0.009

Pvalue

Adjus
ted-R2

0.087
4
0.063
6
0.224
5
0.628
7

0.140
3

0.073
2

0.601
0.722
0.022
4
0.030
7
0.649
0.044

0.025
8

0.036

(-0.013 - 0.0026)
4
(-0.014 - 0.0019)
9
7
6
(-0.018 - -0.0002)
5
0.0055
0.193
0.005
0.008
0.083
(-0.0028 - 0.0139)
4
(-0.002 - 0.013)
0.195
(-0.001 - 0.017)
8
0.00164
0.438
0.0012
0.002
0.473
> 4000
(-0.00251 0.0058)
4
(-0.003 - 0.005)
0.585
(-0.003- 0.006)
3
-0.002
0.000
-0.002
0.110
-0.0005
0.806
< 2500
(-0.006 - 0.002)
0.369
7
(-0.005 - 0.003)
0.527
9
(-0.004 - 0.003)
8
0.124
HDL
2500 0.0028
0.184
0.0029
0.138
0.0016
0.419
4000
(-0.0013 - 0.0068)
9
(-0.0009 - 0.0067)
4
(-0.0023 - 0.0054)
5
-0.00225
-0.0012
0.108
-0.0013
0.190
(-0.0043 0.029
(-0.003 - 0.0004)
8
(-0.003 - 0.0006)
5
> 4000
0.00023)
1
-0.007
0.123
-0.008
0.068 0.055
-0.0117
0.024 0.066
< 2500
(-0.016 - 0.002)
3
0
(-0.017 - 0.0007)
9
8
9
Non-HDL
(-0.022 - -0.0015)
8
2500 0.0069
0.157
0.00674
0.156
0.01007
0.063
4000
(-0.0027 - 0.0165)
1
(-0.0026 - 0.0161)
8
(-0.0006 - 0.0207)
3
0.0017
0.474
0.0007
0.762
0.0008
0.748
> 4000
(-0.003 - 0.0065)
3
(-0.0039 - 0.0054)
5
(-0.004 - 0.006)
3
-0.00006
-0.00009
-0.0001
(-0.00023 0.450 0.000
(-0.00024 0.254 0.126
(-0.0003 0.128 0.142
<
2500
0.0001)
8
7
0.00006)
7
4
0.00004)
8
9
Log-TG
0.00003
0.00002
0.00009
2500 (-0.00014 0.745
(-0.00014 0.804
(-0.00009 0.331
4000
0.0002)
6
0.00018)
1
0.00027)
3
0.00005
0.00003
0.000004
(-0.00003 0.209
(-0.00005 0.518
(-0.00009 0.927
> 4000
0.00014)
8
0.00011)
8
0.00008)
5
Spline Knots at LBW <2,500 grams and HBW >4000grams
Variables included in the model: Model 1: All the outcomes were regressed on birth weight. Model 2: All the outcomes were regressed on birth
weight variable and the child's BMI percentile in fifth grade. Model 3: All the outcomes were regressed on birth weight and the child's BMI
percentile and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in the multiple regression
analysis. Each non-significant covariate was deleted from the regression model one at a time. Variables retained in model for SBP: child's age,
race (white vs. other), maternal health insurance status at time of delivery (non-Medicaid vs. Medicaid), and family history of cholesterol (yes vs.
2500 4000
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no); DBP: child's age, race (white vs. other), and family history of cholesterol (yes vs. no); TC: child's age, race (white vs. other), and family
history of cholesterol (yes vs. no); LDL: child's age, gender, interaction between age*gender, and family history of cholesterol (yes vs. no); HDL:
child's age, gender, race (white vs. other), family history of CVD (yes vs. no), maternal smoking status during pregnancy (yes vs. no), and
maternal age at time of delivery; Non-HDL: child's age, family history of cholesterol (yes vs. no), and breastfeeding intention (breastfeed vs.
both); TG: child's age, sex, race (white vs. other), family history of cholesterol (yes vs. no), family history of CVD (yes vs. no), and maternal
education at birth.
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Supplemental Table S2: Results of the Spline regression analysis for the association between birth weight and maternal CVD risk factors using
merged data from the Birth Score Project (1994-2000) and the CARDIAC Project (2004-2010) for all infants who were born Full-Term
(N=19,583)

Model 1
Mothers’
CVD risk
factors

BTW
(grams)

TC

< 2500
2500 - 4000
> 4000

LDL

< 2500
2500 - 4000
> 4000

HDL

< 2500
2500 - 4000
> 4000

NonHDL

< 2500
2500 - 4000

Beta-coefficient
unstandardized
(95%CI)
-0.04
(-0.107 - 0.027)
0.046
(-0.022 - 0.115)
-0.005
(-0.03 - 0.02)
-0.045
(-0.106 - 0.015)
0.049
(-0.012 - 0.111)
0.001
(-0.021 - 0.023)
0.007
(-0.019 - 0.033)
-0.006
(-0.033 - 0.02)
-0.006
(-0.016 - 0.003)
-0.047
(-0.116 - 0.023)
0.052
(-0.02 - 0.123)

Model 2

Standardi
zed (Beta)

P-value

Adjust
ed-R2

-0.537

0.239

0.0027

0.608

0.186

-0.014

0.701

-0.689

0.141

0.738

0.118

0.003

0.938

0.24

0.601

-0.219

0.635

-0.048

0.195

-0.599

0.191

0.652

0.157

0.002

0.007

0.0016

Beta-coefficient
unstandardized
(95%CI)
-0.031
(-0.098 - 0.035)
0.037
(-0.031 - 0.105)
-0.004
(-0.029 - 0.02)
-0.036
(-0.096 - 0.023)
0.04
(-0.021 - 0.101)
0.001
(-0.02 - 0.023)
0.001
(-0.025 - 0.026)
-0.001
(-0.028 - 0.025)
-0.004
(-0.013 - 0.006)
-0.038
(-0.109 - 0.033)
0.044
(-0.029 - 0.116)

136

Standard
ized
(Beta)

P-value

Adjuste
d-R2

-0.418

0.356

0.0238

0.483

0.289

-0.012

0.731

-0.554

0.234

0.603

0.198

0.005

0.901

0.02

0.965

-0.05

0.916

-0.028

0.458

-0.494

0.289

0.551

0.24

0.0189

0.055

0.0221

-0.001
-0.001
(-0.027 - 0.024)
-0.004
0.91
(-0.026 - 0.024)
-0.003
0.942
-0.000104
(-0.00115 -0.000145
< 2500
0.000941)
-0.08978
0.8446
0.0012
(-0.00119 - 0.0009)
-0.12458
0.7857
0.0033
Log-TG
0.000151
0.0002
(-0.000921 (-0.000872 2500 - 4000
0.00122)
0.12706
0.7829
0.00127)
0.16901
0.7142
0.000006
0.000006
(-0.000375 (-0.000374 > 4000
0.000387)
0.00113
0.9755
0.000386)
0.00109
0.9763
Spline Knots at LBW <2,500 grams and HBW >4000grams
Variables included in the model: Model 1: All the outcomes were regressed on birth weight. Model 2: All the outcomes were regressed on birth
weight and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis.
Each non-significant covariate was deleted from the regression model one at a time. Variables retained in model for TC: mothers age when child
in fifth grade, and breastfeeding intention (breastfeed vs. both); LDL: mothers age when child in fifth grade, breastfeeding intention (breastfeed vs.
both), and smoking in the house (yes vs. no); HDL: mothers age when child in fifth grade, smoking in the house (yes vs. no), family history of
CVD (yes vs. no), family history of diabetes (yes vs. no), number of previous pregnancies (≥1 vs. 0); Non-HDL: mothers age when child in fifth
grade, breastfeeding intention (breastfeed vs. both), and smoking in the house (yes vs. no); TG: mothers age when child in fifth grade and
breastfeeding intention (breastfeed vs. both).
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
> 4000
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Chapter 3
Table 1: 2011 National Immunization Survey (NIS) and Pediatric Nutrition Surveillance System
(PedNSS) breastfeeding rates nationally and in the state of WV.13,14
NIS

Ever breastfed
Breastfed at least 6 months
Breastfed at least 12 months
Exclusive breastfeeding 3 months
Exclusive breastfeeding 6 months

National
(%)
79.2
49.4
26.7
40.7
18.8

PedNSS
WV
(%)
59.3
29.3
15.9
28.3
12.2

National
(%)
66.3
26.0
17.9
10.8
6.3

WV
(%)
44.7
13.5
10.2
2.9
0.3

WV Rank
41
38
30
27
28
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Table 2: Maternal and child characteristics at birth and in fifth grade using merged data from the
Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013) for all infants who were
born Full-Term (N=10457)

Variable
Sex

N
10457

Missing

Female
Male

5740 (54.89)
4717 (45.11)
10070

Race

387

Others
White
Marital Status (at birth)
Single
Married
No. of previous pregnancy (at
birth)
0
≥1
Health Insurance of mother (at
birth)
Medicaid
Non-Medicaid
Family History of Cholesterol
No
Yes
Family History of CVD
No
Yes
Smoking during Pregnancy
Yes
No
No. of Prenatal care visits
<12
≥12
Breastfeeding
No
Yes
Age of Child (years)
Maternal Age at Birth (years)
Maternal Education at Birth
Weight Gain during Pregnancy

Frequency
(%)/Mean (SD)

630 (6.26)
9440 (93.74)
10457
2788 (26.66)
7669 (73.34)
10457
3651 (34.91)
6806 (65.09)
10457
4841 (46.29)
5616 (53.71)
8879

1578
6119 (68.92)
2760 (31.08)

10457
6114 (58.47)
4343 (41.53)
10395

62
2580 (24.82)
7815 (75.18)

10457
4641 (44.38)
5816 (55.62)
6833

10457
10424
10405
9597

3624

0
33
52
860

3883 (56.83)
2950 (43.17)
10.97 (0.47)
25.79 (5.5)
12.87 (2.12)
30.79 (14.66)
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(lbs)
10457
0
39.07 (1.12)
Gestational Age (weeks)
10452
5
3352.64 (481.55)
Birth Weight (grams)
10444
13
72.58 (28)
BMI-Percentile
10254
203
108.43 (11.75)
Child SBP (mmHg)
10255
202
67.49 (9.53)
Child DBP (mmHg)
9740
717
157.7 (27.51)
Child TC (mg/dL)
9725
732
89.99 (24.41)
Child LDL (mg/dL)
9740
717
50.14 (12.37)
Child HDL (mg/dL)
9740
717
107.56 (27.86)
Child NON-HDL (mg/dL)
9739
718
92.28 (54.99)
Child TG (mg/dL)
9739
718
4.38 (0.52)
Child log TG
112
10345
182.67 (33.62)
Maternal TC (mg/dL)
109
10348
110.64 (27.87)
Maternal LDL (mg/dL)
112
10345
51.55 (12.73)
Maternal HDL (mg/dL)
112
10342
131.12 (33.64)
Maternal NON-HDL (mg/dL)
112
10342
106.47 (73.95)
Maternal TG (mg/dL)
112
10342
4.47 (0.61)
Maternal log TG
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TCtotal cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; nonHDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Table 3: Results of the Independent Sample T-test for the mean difference in blood pressure and lipid levels in both fifth grade children who were
breastfed vs. not breastfed and mothers who breastfed vs. did not breastfed for children born Full-Term using merged data from the Birth Score
Project (1998-2003) and the CARDIAC Project (2010-2013)
Childhood CVD risk factors

BMI
(N)
(Percentile)
Mean (SD)
SBP

DBP

TC

LDL

HDL

Non-HDL

Log-TG

(N)
Mean (SD)
(N)
Mean (SD)
(N)
Mean (SD)
(N)
Mean (SD)
(N)
Mean (SD)
(N)
Mean (SD)
(N)

Breastfed

Not
Breastfed

2948

3877

70.2
(28.6)
2866
107.3
(11.8)
2867
66.4
(9.5)
2792
157.5
(27.8)
2788
89.4
(24.6)
2792
51.0
(12.4)
2792
106.4
(27.9)
2791

74.2
(27.5)
3781
108.6
(11.9)
3781
67.2
(9.7)
3644
157.8
(27.9)
3639
89.3
(24.8)
3644
50.1
(12.5)
3644
107.7
(28.5)
3644

Maternal CVD risk factors

Mean
Difference
(95% CI)

P-value

Cohen's
d effect
size

-3.95*
(-5.29, -2.62)

<0.0001

0.14

-1.3*
(-1.97, -0.81)

<0.0001

0.11

-0.8*
(-1.26, -0.33)

0.0009

0.08

-0.3
(-1.71, 1.04)

0.6285

0.1
(-1.12, 1.31)

0.8868

0.9*
(0.33, 1.56)

0.0026

-1.3
(-2.70, 0.11)

0.0705

0.07

Breastf
ed

Not
Breastfed

31
182
(34.1)
31
108.5
(27.3)
31
52.7
(11.1)
31
129.3
(36.0)
31

21
187
(41.2)
20
114.8
(31.2)
21
50.4
(12.7)
21
136.5
(36.3)
21
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Mean
Difference
(95% CI)

Pvalue

-4.9
(-26, 16.09)

0.6385

-6.3
(-22.92, 10.35)

0.4515

2.3
(-4.37, 8.99)

0.49

-7.3
(-27.77, 13.24)

0.4799

4.43
0.4697
<0.0001
-0.16
4.4 (0.7) 4.5 (0.7)
-0.1
-0.08*
(0.5)
(-0.53, 0.24)
(0.33, 1.56)
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
Mean (SD)

4.35 (0.5)
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Table 4: Correlation between Breastfeeding and CVD risk factors for infants born Full-Term
using merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (20102013)
Childhood CVD risk

N

factors

Correlation

P-value

Coefficient r
BMI percentile

6825

-0.08

<0.0001

SBP

6647

-0.06

<0.0001

DBP

6648

-0.04

0.0007

TC

6436

-0.008

0.4941

LDL

6427

0.004

0.7731

HDL

6436

0.04

0.0011

Non-HDL

6436

-0.02

0.0632

Log-TG

6435

-0.07

<0.0001

TC

52

-0.05

0.7406

LDL

51

-0.08

0.5743

HDL

52

0.12

0.3958

Non-HDL

52

-0.11

0.4554

Log-TG

52

-0.08

0.5935

Maternal CVD risk
factors

CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TCtotal cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; nonHDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Table 5: Results of the multiple regression analysis for the association between reported history of breastfeeding and CVD risk factors of FifthGrade WV Children born Full-Term using merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013)
Risk
factor
s

SBP
DBP
TC
LDL
HDL
NonHDL
Log
TG

Model 1

Model 2

Model 3

Unstandardiz
ed Regression
Coefficient
(95% CI)

P-value

Stand
ardize
d
Beta

R2

Unstandardiz
ed Regression
Coefficient
(95% CI)

P-value

Standar
dized
Beta

Adjuste
d R2

-1.39
(-1.97 - -0.81)
-0.79
(-1.26 - -0.33)
-0.34
(-1.71 - 1.04)
0.09
(-1.13 - 1.31)
0.95
(0.33 - 1.56)
-1.29
(-2.68 - 0.11)

<0.0001

-0.06

-0.032

0.1188

-0.04

0.06

-0.022

0.0633

0.6285

-0.006

0.999

0.002

0.000

0.3164

0.00001
0.012

0.0069

0.8868

0.0231

0.0026

0.04

0.001

0.335

0.011

0.1378

0.0705

-0.02

0.000
5
0.005
3

-0.77
(-1.32 - -0.23)
-0.44
(-0.89 - 0.02)
-0.001
(-1.37 - 1.37)
0.62
(-0.59 - 1.83)
0.28
(-0.29 - 0.86)
-0.28
(-1.64 - 1.07)

0.0052

0.0009

0.003
3
0.001
7
0.000

0.6824

-0.005

0.0611

Unstandardi
zed
Regression
Coefficient
(95% CI)
-0.43
(-0.98 - 0.13)

Pvalue

Stan
dard
ized
Beta

Adjus
ted R2

0.134
9

-0.02

0.1311

<0.0001 -0.07
<0.0001
-0.048
0.1302
0.008 -0.03 0.1499
-0.04
-0.08
-0.05
(-0.06 - (-0.1 - -0.05)
(-0.07 - -0.03)
0.01)
Variables included in the model: Model 1: All the outcomes were regressed on breastfed variable (yes vs. no). Model 2: All the outcomes were
regressed on breastfed variable and the child's BMI percentile in fifth grade. Model 3: All the outcomes were regressed on breastfed variable and
the child's BMI percentile and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in the multiple
regression analysis. Covariates included child's age, gender, race, infant birth weight in grams, maternal education status at birth (1–17 years of
education), maternal health insurance status at time of delivery (non-Medicaid vs. Medicaid), family history of hypercholesterolemia (yes vs. no),
number of previous pregnancies assessed at birth (>=1 vs. 0), maternal smoking status during pregnancy (yes vs. no), weight gain during
pregnancy in lbs. Covariates that were not significant in the Spearman’s correlation and were excluded: maternal age at birth of the index child,
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infant birth weight in grams, marital status of the mother at birth, number of prenatal care visits. Each non-significant covariate was deleted from
the regression model one at a time. Variables retained in model for SBP: child's age, maternal education at birth. For TG: Child's age, sex, race,
maternal education at birth, number of previous pregnancies, and family history of cholesterol.
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Table 6: Results of the multiple regression analysis for all the variables in the model to predict Triglyceride of Fifth-Grade WV Children born Full
Term using merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013)

Full Model
Standa
t
rdized Value
Beta

Covariate Model
Unstandardized Stand
t
P-value
regression
ardiz Value
coefficients
ed
(95% CI)
Beta
3.17
0
22.56 <0.0001
(2.89 -3.44)
0.072
0.06
6.08
<0.0001
(0.05 - 0.10)
-0.11
-0.11 -10.48 <0.0001
(-0.13 - -0.09)
0.12
0.06
5.58
<0.0001
(0.08 - 0.17)
0.07
0.06
6.16
<0.0001
(0.05 - 0.10)
-0.03
-0.03
-3.01
0.0026
(-0.06 - -0.01)
-0.008
-0.04
-3.43
0.0006
(-0.014 - -0.004)
0.0065
0.35
33.72 <0.0001
(0.006 - 0.007)

Unstandardized
P-value Adjusted
Adjus
regression
R2
ted R2
coefficients
(95% CI)
3.31
0.00
19.3
<0.0001
0.1499
0.1486
Intercept
(2.97 - 3.64)
0.06
4.4
<0.0001
0.06
Age (Years)
(0.04 - 0.09)
-0.11
-0.10
-8.24 <0.0001
Gender
(-0.14 - -0.08)
(Male vs. Female)
0.14
0.07
5.3
<0.0001
Race
(0.09 - 0.19)
(White vs. Others)
0.07
0.06
5.04
<0.0001
History of
(0.04 - 0.10)
hypercholesterolemia
-0.04
-0.04
-3.12
0.0018
Number of Previous
(-0.07 - -0.02)
pregnancies (≥1 vs. 0)
-0.010
-0.04
-3.16
0.0016
Maternal education
(-0.017 - -0.004)
(Years)
0.0065
0.35
27.45 <0.0001
BMI percentile
(0.006 - 0.007)
-0.03
-2.65
0.008
Breastfed
-0.04
(Yes vs. No)
(-0.06 - -0.01)
Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis. Covariates included child's age,
gender, race, infant birth weight in grams, maternal education status at birth (1–17 years of education), maternal health insurance status at time of
delivery (non-Medicaid vs. Medicaid), family history of hypercholesterolemia (yes vs. no), number of previous pregnancies assessed at birth (≥1
vs. 0), maternal smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs. Covariates that were not significant in the
Spearman’s correlation and were excluded: maternal age at birth of the index child, infant birth weight in grams, marital status of the mother at
birth, number of prenatal care visits. Each non-significant covariate was deleted from the regression model one at a time. These included infant
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birth weight in grams, family history of hypercholesterolemia (yes vs. no), number of previous pregnancies assessed at birth (≥1 vs. 0), maternal
smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs. WV, West Virginia; CI, confidence interval.
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Supplemental Table Chapter 3
Supplemental Table S1: Maternal and Child Characteristics at Birth and in Fifth Grade using
merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013)
for All infants (N=11980)
Variable

N

Sex

11980

Missing

Female
Male

6553 (54.7)
5427 (45.3)
11531

Race

449

Others
White
Marital Status (at birth)
Single
Married
No. of previous pregnancy (at birth)
0
≥1
Health Insurance of mother (at birth)
Medicaid
Non-Medicaid
Family History of Cholesterol
No
Yes
Family History of CVD
No
Yes
Smoking during Pregnancy
Yes
No
No. of Prenatal care visits
<12
≥12
Breastfeeding
No
Yes
Age of Child (years)
Maternal Age at Birth (years)
Maternal Education at Birth
Weight Gain during Pregnancy (lbs)
Gestational Age (weeks)

Frequency
(%)/Mean (SD)

729 (6.32)
10802 (93.68)
11980
3181 (26.55)
8799 (73.45)
11981
4193 (35)
7787 (65)
11982
5619 (46.9)
6361 (53.1)
10166

1814
6940 (68.27)
3226 (31.73)

11980
6978 (58.25)
5002 (41.75)
11901

79
2960 (24.87)
8941 (75.13)

11980
5486 (45.79)
6494 (54.21)
7861

11980
11945
11919
10907
11647

4119

0
35
61
1073
333

4478 (56.96)
3383 (43.04)
10.97 (0.47)
25.84 (5.54)
12.87 (2.12)
30.58 (14.67)
38.59 (1.91)
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11975
5
3259.34 (569.19)
Birth Weight (grams)
11967
13
72.31 (28.19)
BMI-Percentile
11741
239
108.44 (11.85)
Child SBP (mmHg)
11742
238
67.46 (9.52)
Child DBP (mmHg)
11133
847
157.87 (27.65)
Child TC (mg/dL)
11114
866
90.06 (24.54)
Child LDL (mg/dL)
11133
847
50.18 (12.42)
Child HDL (mg/dL)
11133
847
107.69 (28.1)
Child NON-HDL (mg/dL)
11132
848
92.54 (55.46)
Child TG (mg/dL)
11132
848
4.38 (0.53)
Child log TG
127
11853
181.1 (32.81)
Maternal TC (mg/dL)
123
11857
109.0 (27.59)
Maternal LDL (mg/dL)
127
11853
51.28 (13.13)
Maternal HDL (mg/dL)
127
11853
129.77 (33.24)
Maternal NON-HDL (mg/dL)
127
11853
106.0 (74.54)
Maternal TG (mg/dL)
127
11853
4.47 (0.62)
Maternal log TG
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TCtotal cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; nonHDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Supplemental Table S2: Results of the Independent Sample T-test for the mean difference in blood pressure and lipid levels in both fifth grade
children who were breastfed vs. not breastfed and mothers who breastfed vs. did not breastfed for all children (both pre-term and full-term) using
merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (2010-2013)
Childhood CVD risk factors
Maternal CVD risk factors
Breastfed
Not
Mean
P-value Breastfed
Not
Mean
P-value
Breastfed
Difference
Breastfed
Difference
(95% CI)
(95% CI)
3286
4357
SBP
(N)
107.4
108.7
<0.0001
Mean (SD)
-1.3
(12.0)
(11.9)
(-1.8 - -0.8)
3287
4357
DBP
(N)
66.4
67.2
0.0005
Mean (SD)
-0.8
(9.6)
(9.6)
(-1.2 - -0.3)
3199
4194
34
25
TC
(N)
157.6
157.9
-0.3
0.5845
180.0
186.0
-6.0
0.527
Mean (SD)
(27.8)
(27.8)
(-1.6 – 0.6)
(33.1)
(39.3)
(-25.0 – 12.0)
3193
4188
34
24
LDL
(N)
89.3
89.4
-0.1
0.864
106.5
113.0
-6.5
0.3961
Mean (SD)
(24.6)
(24.7)
(-1.2 – 1.0)
(27.0)
(30.7)
(-21.8 – 8.7)
3199
4194
34
25
HDL
(N)
51.0
50.2
0.0066
52.5
51.1
1.4
0.6593
Mean (SD)
0.8
(12.3)
(12.7)
(11.8)
(12.4)
(-4.9 – 7.7)
(0.2 – 1.4)
3199
4194
34
25
Non-HDL
(N)
106.5
107.7
-1.2
0.0812
127.5
134.9
-7.4
0.4327
Mean (SD)
(28.1)
(28.4)
(-2.5 – 0.1)
(35.3)
(36.1)
(-26.2 – 11.4)
3198
4194
36
25
Log-TG
(N)
<0.0001
4.4
4.5
-0.12
0.5152
4.36
4.42
Mean (SD)
-0.06
(0.7)
(0.7)
(-0.49 – 0.25)
(0.5)
(0.5)
(-0.08 - -0.04)
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Supplemental Table 3S: Correlation between breastfeeding and maternal and childhood CVD risk
factors for all infants using merged data from the Birth Score Project (1998-2003) and the
CARDIAC Project (2010-2013) as well examining the association for maternal variables using
imputed dataset.
Childhood
CVD risk factors
N

Correlation P-value
Coefficient
r
7853
<0.0001
-0.08

Maternal
CVD risk factors
N

Correlation
Coefficient
r

Pvalue

Maternal CVD risk
factors
(Imputed Dataset)
Correlation
Coefficient
r

Pvalue

BMI
percentile
<0.0001
7643
SBP
-0.05
0.0007
7644
-0.04
DBP
7393
-0.01
0.496
59
-0.06
0.6276
-0.13
0.2571
TC
7381
0.00
0.9336 58
-0.08
0.5323
-0.16
0.1649
LDL
0.0013 59
7393
0.05
0.6878
0.07
0.4093
0.04
HDL
7393
-0.02
0.0692 59
-0.11
0.4209
-0.16
0.18
NonHDL
<0.0001 59
-0.06
0.6493
-0.08
0.3499
7392
-0.06
Log-TG
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TCtotal cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein; nonHDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Supplemental Table S4: Results of the multiple regression analysis for the association between reported history of breastfeeding and CVD risk
factors of Fifth-Grade WV Children for All infants (Preterm and Full term) using merged data from the Birth Score Project (1998-2003) and the
CARDIAC Project (2010-2013)
CVD
risk
factors

Model 1
Unstandar
dized
Regression
Coefficient

Pvalue

Standar
dized
Beta

Model 2
R2

Unstandar
dized
Regression
Coefficient

Pvalue

Standar
dized
Beta

Model 3
Adjusted
R2

Unstandar
dized
Regression
Coefficient

Pvalue

Stan
dardi
zed
Beta

Adjust
ed R2

0.0001
-0.054
0.003
0.0046
-0.031
0.1195
-0.34
0.2042 -0.01
0.132
SBP
-1.39
-0.73
0.0007
-0.039
0.0015
-0.41
0.0557
-0.021
0.0669
DBP
-0.75
-0.36
0.5845
-0.006
0.000
-0.03
0.9666
0.000
0.0078
TC
-0.10
0.864
0.002
0.000
0.42
0.4663
0.008
0.0256
LDL
0.0066
0.032
0.001
0.17
0.5402
0.007
0.1438
HDL
0.80
-1.16
0.0812
-0.020
0.0004
-0.28
0.762
-0.003
0.0657
NonHDL
0.0001
-0.059
0.0034
0.0015
-0.035
0.1328
0.046
-0.02 0.1527
Log-TG
-0.06
-0.04
-0.03
Variables included in the model: Model 1: All the outcomes were regressed on breastfed variable. Model 2: All the outcomes were regressed on
breastfed variable and the child's BMI percentile in fifth grade. Model 3: All the outcomes were regressed on breastfed variable and the child's
BMI percentile and additional covariates. Only covariates that were significant in the Spearman’s correlation were used in the multiple regression
analysis. Covariates included child's age, gender, race, infant birth weight in grams, maternal education status at birth (1–17 years of education),
maternal health insurance status at time of delivery (non-Medicaid vs. Medicaid), family history of hypercholesterolemia (yes vs. no), number of
previous pregnancies assessed at birth (>=1 vs. 0), maternal smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs.
Covariates that were not significant in the Spearman’s correlation and were excluded: maternal age at birth of the index child, infant birth weight
in grams, marital status of the mother at birth, number of prenatal care visits. Each non-significant covariate was deleted from the regression model
one at a time. Variables retained in model for SBP: child's age, maternal education at birth. For TG: Child's age, sex, race, maternal education at
birth, number of previous pregnancies, and family history of cholesterol. Additionally gestational age was adjusted for but was not significant.
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides
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Supplemental Table S5: Results of the multiple regression analysis for all the variables in the model to predict Triglyceride of Fifth-Grade WV
Children for All infants (Preterm and Full term) using merged data from the Birth Score Project (1998-2003) and the CARDIAC Project (20102013)
Full Model
Covariate Model

Intercept
Age
Gender
(Male vs. Female)
Race
(White vs. Others)
History of
hypercholesterolemia
(Yes vs. No)
Number of Previous
pregnancies (>=1 vs. 0)
Maternal education
(Years)
BMI percentile
Breastfed
(Yes vs. No)

Unstandardize
d regression
coefficients
(95% CI)
3.33
(3.02, 3.65)
0.06
(0.03, 0.08)
-0.11
(-0.13, -0.08)
0.14
(0.09, 0.19)
0.08
(0.06, 0.11)

Standa
rdized
Beta

t Value

P-value

Adjust
ed R2

0.00

20.82

<0.0001

0.1527

0.05

4.28

<0.0001

-0.10

-8.50

<0.0001

0.07

5.72

<0.0001

0.07

6.07

<0.0001

-0.04
(-0.06, -0.01)
-0.01
(-0.01, -0.003)
0.01
(0.01, 0.01)
-0.03
(-0.05, -0.0005)

-0.03

-2.79

0.0053

-0.04

-2.94

0.0033

0.36

30.22

<0.0001

-0.02

-2.00

0.0460

Unstandardize
d regression
coefficients
(95% CI)
3.184
(2.928, 3.44)
0.068
(0.046, 0.089)
-0.113
(-0.133, -0.093)
0.135
(0.094, 0.176)
0.08
(0.058, 0.101)

Standar
dized
Beta

t
Value

P-value

Adjust
ed R2

0.00

24.38

<0.0001

0.1518

0.06

6.16

<0.0001

-0.11

-11.06

<0.0001

0.06

6.46

<0.0001

0.07

7.29

<0.0001

-0.031
(-0.052, -0.011)
-0.008
(-0.013, -0.003)
0.007
(0.006, 0.007)

-0.03

-2.94

0.0032

-0.03

-3.24

0.0012

0.35

36.60

<0.0001
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Only covariates that were significant in the Spearman’s correlation were used in the multiple regression analysis. Covariates included child's age,
gender, race, infant birth weight in grams, maternal education status at birth (1–17 years of education), maternal health insurance status at time of
delivery (non-Medicaid vs. Medicaid), family history of hypercholesterolemia (yes vs. no), number of previous pregnancies assessed at birth (>=1
vs. 0), maternal smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs. Covariates that were not significant in the
Spearman’s correlation and were excluded: maternal age at birth of the index child, infant birth weight in grams, marital status of the mother at
birth, No. of prenatal care visits. Each non-significant covariate was deleted from the regression model one at a time. These included infant birth
weight in grams, family history of hypercholesterolemia (yes vs. no), number of previous pregnancies assessed at birth (>=1 vs. 0), maternal
smoking status during pregnancy (yes vs. no), weight gain during pregnancy in lbs. WV, West Virginia; CI, confidence interval.

154

Chapter 4
Table 1: Previous SRs and MA examining the association between childhood obesity and selected adult CVD risk factors
Authors, year study
published

Type of
study
design

No. of studies included
and outcome of interest

Park et al., 201238

SR

5 studies for HT107,128-131

Lloyd et al., 201218

SR

Lloyd et al., 201037

SR

Reilly et al., 201139

SR

5 studies for lipids (TC,
TG, LDL, and
HDL)4,116,132-134
8 studies for blood
pressure (SBP and
DBP)4,107,116,131,133,135-137
4 studies for
HT107,131,138,139

Juonala et al., 201140

MA

Studies from 4-cohortsBHS, MS, CDAH, and
YFS

Conclusion

Increase in BMI/overweight in childhood was associated with increased risk of
HT. 2 out of 5 studies that adjusted for adult BMI found no association. The
review was unable to confirm the presence of long-term health effects of
childhood obesity independent of its effects on adult BMI. This conclusion was
not made for HT exclusively but the authors made a general statement.
Little evidence that childhood obesity is an independent risk factor for adult
blood lipid status.
Little evidence that childhood obesity is an independent risk factor for CVD
risk (SBP and DBP). The relationships observed are dependent on the tracking
of BMI from childhood to adulthood.
Significant increase in adult HT with overweight and obesity during childhood
and adolescence. The SR did not mention if the studies included controlled for
adult weight status.
Childhood obesity was significantly associated with HT even after adjustment
for adult obesity (relative risk, 1.5; 95% CI: 1.1, 2.1; P = 0.009). For
dyslipidemias, the effect of childhood adiposity was reduced and became nonsignificant when adult obesity was taken into account.

MA-Meta-analysis; SR-Systematic Review; CVD-Cardiovascular Disease; HT-hypertension; SBP-systolic blood pressure; DBP-diastolic blood
pressure; TC-total cholesterol; TG-triglycerides; LDL-low-density lipoprotein cholesterol; HDL-high-density lipoprotein cholesterol; BHSBogalusa Heart Study; MS-Muscatine Study; CDAH-Childhood Determinants of Adult Health; YFS-Cardiovascular Risk in Young Finns Study
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Table 2: Item-by-item results using the AMSTAR assessment instrument for previous SRs and MA

Authors

Year

1

2

3

4

5*

6

7

8

9

10

11

12

Total score Row
(%)

Park et al. 38

2012

SR

Yes

Yes

Yes

No

Yes

Yes

Yes

No

NA

Yes

Yes

8/10=80%

18

Lloyd et al.

2012

SR

Yes

Yes

Yes

No

No

Yes

Yes

Yes

NA

No

Yes

7/10=70%

Lloyd et al.37

2010

SR

Yes

Yes

Yes

No

No

Yes

Yes

Yes

NA

No

No

6/10=60%

Reilly et al. 39

2011

SR

Yes

No

Yes

No

No

Yes

No

No

NA

No

Yes

4/10=40%

Juonala et al. 40

2011

MA Yes

No

NA

NA

NA

Yes

No

Yes

Yes

NA

Yes

5/7=71%

Total score column (%)

5/5=

3/5= 4/4=

0/4= 1/4= 5/5=

100% 60% 100% 0%

3/5= 3/5= 1/1=

1/4= 4/5=

25% 100% 60% 60% 100% 25% 80%

Note: NA is “Not Applicable” is chosen when item is not relevant. Scores are adjusted for NA responses.
A Measurement Tool to Assess Systematic Reviews (AMSTAR) instrument:
1-Type of study design
2-Was a priori design provided?
3-Was there duplicate study selection and data extraction?
4-Was a comprehensive literature search performed?
5-Was the status of publication (i.e. grey literature) used as an inclusion criterion? *
6-Was a list of studies (included and excluded) provided?
7-Were the characteristics of the included studies provided?
8-Was the scientific quality of the included studies assessed and documented?
9-Was the scientific quality of the included studies used appropriately in formulating conclusions?
10-Were the methods used to combine the findings of studies appropriate?
11-Was the likelihood of publication bias assessed?
12-Was the conflict of interest included?
*This question was modified and is asking if the authors included grey literature as their inclusion criteria. ‘Yes’ means they did and ‘No’ means
they did not.
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Table 3: Study and participants characteristics:
Study
start
year
1923

Country

Study
design*

N
(Baseline)

USA

1087

1934

Finland

Berkey et al.,
1998
(LSCHD)97

1929

USA

Prospective
Cohort
Retrospective
longitudinal
study
Prospective
longitudinal
study

Eisenmann et
al., 2005
(ACLS)98

1970

USA

Freedman et al., 1973
2001 (BHS)4

USA

Graversen et
al., 2014
(NFBC 1966)99
Gustafsson et
al., 2011
(NSC)100
Holland et al.,
1993
(NSHD)101
Kanade et al.,
2011 (CBCI)102

1966

Finland

1981

Sweden

Prospective
cohort study

1946

England,
Wales,
Scotland
India

Prospective
longitudinal
study
Community
base

Study-cohort
name
Abraham et al.,
1971 (HMS)95
Barker et al.,
2005 (HBCS)96

1979

Longitudinal,
prospective
epidemiologi
cal study
Cross panel
design later
longitudinal
component
Population
based cohort

Age
exposure
assessed
9-12

Age
outcome
assessed
48

67

2 – 11 (age
used in our
study 2)
17

48

Exposure

Outcome

62

Relative over
weight
BMI

SBP,
DBP, TC
SBP, TC,
TG

30

BMI

16

27

2617

10

4111

2-5 (age used
in our study
5)
16

2003

1083;
F=506
M=577
3332 at
birth
387

Adj.
adult
BMI
No

Sex

Male

Yes
(only)

Overall

SBP

No

BMI, WC,
%BF

SBP,
DBP, TC,
HDL, TG

No

Male
(this
study)
Female
Overall

27

BMI, Triceps
ST

Yes

Overall

31

BMI

No

Overall

BMI

No

Male
Female

4-7, 11-14

21 (this
study),
30, 43
36

SBP,
DBP, TC,
LDL,
HDL, TG
SBP,
DBP,
HDL, TG
SBP, DBP

BMI

SBP, DBP

No

Male
Female

3, 15

24

BMI

SBP,
DBP, TG#

No

Male
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prospective
cohort study
Longitudinal
cohort

Klumbiene et
al., 2000
(JHL)103

1977

Lithuania

Kneisley et al.,
1990 (BPSTM)104
Koziel et al.,
2011 (WGS)105

1959

USA

Retrospective
Cohort Study

1961

Poland

Lauer et al.,
1993 (MS)106

1971

USA

Li et al., 2007
(BBC- 1958)107

1958

England,
Wales
and
Scotland
Australia

Liddle et al.,
2012
(MUSP)108
Lyngdoh et al.,
2013
(SCDC)109

1981

1989

Seychelle
s

Miura et al.,
2001 (YAJS)110

1965

Japan

505
M=217
F=288

12-13

32-33

BMI, Triceps
ST, Subscapular ST

SBP, DBP

No

Male
Female

7

32

Sub-scapular
ST

SBP

No

Male
Female

Longitudinal
Study

576
M=271
F= 305
M=124
F= 139

50

BMI

SBP

Yes
(only)

Male
Female

Longitudinal
Cohort

M=677
F= 748

20 – 25,
26 – 30

BMI

SBP, DBP

No

Male
Female

M=492
F= 528
9297

8, 9, 10, 11,
12, 13, 14,
15, 16, 17, 18
7-8, 9-10, 1112, 13-14,
15-16, 17-18:
13-14, 15-16,
17-18
7, 11, 16

33, 45
(this
study)

BMI

SBP, DBP

Yes

Overall

Longitudinal
Birth Cohort
study
Longitudinal
cohort

1755

5

21

BMI, Triceps
ST

SBP, DBP

No

Overall

390
M=175
F=215

12-15

19-20

BMI

Yes

Overall
Male
Female

20-year FU
data using
record
linkage of a
Birth cohort

M=2198
F= 2428

3

20

BMI

SBP,
DBP,
LDL,
HDL, TG
SBP,
DBP, TC

No

Male
Female

Longitudinal,
Birth Cohort
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Pereira et al.,
2013 (BBC1958)111

1958

Porkka et al.,
1994 (YFS)112
Schmidt et al.,
2011 (ASHFSCDAHS)113

1980

England,
Wales
and
Scotland
Finland

Large
Population
based Birth
Cohort
Longitudinal
Cohort
Prospective
cohort study

1985

Australia

Skidmore et al.,
2007
(NSHD)114

1946

England,
Wales
and
Scotland

Prospective
longitudinal
birth cohort
study

Weitz et al.,
2014 (LS-MidTC)115

1966

Six
Solomon
Island

Longitudinal

Wright et al.,
2001
(NTFCS)116

1947

M=3927
F=3897

7, 11, 16

23, 33,
42, 45

BMI

TC, LDL,
HDL, TG,
non-HDL

No

Male
Female

3596

3-9, 12-18
(this study)
7-15

24-30

TC, LDL,
HDL, TG
SBP,
DBP,
HDL, TG

No

26-32

No

Male
Female
Overall

2, 4, 7, 11, 15

53

BMI, Subscapular ST
BMI, WC,
WHR, weight
to height
ratio, sum ST
BMI

TC, LDL,
HDL

No

Overall

0-5, 6-11, 1219 (6-11, 1219 for this
study)
9, 13

25

TC, TG

No

Male
Female

2188

5362
births
(2311 for
the
analysis)
540
M=169
F=219

BMI, Subscapular ST

50
SBP,
Yes
Male
1142 at
birth, 2/3rd
DBP, TC,
Female
LDL,
followed
till age 15
HDL, TG
CVD-Cardiovascular Disease; SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein
cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides; BMI-body mass
index; WC-waist circumference; WHR-waist to hip ratio; ST-skinfold thickness; BF-body fat; M-male; F-female; USA-United States of America;
UK-United Kingdom; FU- follow up; HMS-Hagerstown Morbidity Study; LSCHD-Longitudinal Study of Child Health and Development; HBCSHelsinki Birth Cohort Study; ACLS-Aerobics Center Longitudinal Study; BHS-Bogalusa Heart Study; NSC-Northern Swedish Cohort; NFBC
1966- Northern Finland Birth Cohort 1966 Study; NSHD-Medical Research Council National Survey of Health and Development; CBCICommunity Based Cohort study India; JHL-Study of Juvenile Hypertension in Lithuania; BPS-TM-Blood Pressure Study in Tecumseh, Michigan;
WGS-Wroclaw Growth Study; MS- The Muscatine Study; BBC 1958-British Birth Cohort 1958; MUSP-The Mater-University of Queensland
Study of Pregnancy (MUSP); SCDC-Seychelles Child Development Study; YAJS- Young Adult Japanese Study; YFS-Cardiovascular Risk in
Young Finns; ASHFS-CDAHS-Australian Schools Health and Fitness Survey-Childhood Determinants of Adult Health Study; NSHD-Medical
Research Council National Survey of Health and Development; LS-Mid-TC-Longitudinal Study of the Mid-20th Century; NTFCS-Thousand
UK

Prospective
birth cohort
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Families Cohort Study
Holland et al., 1993 and Pereira et al., 2013 were not included in the meta-analysis.
#
Kanade et al., 2011-TG could not be used for meta-analysis because the study’s main outcome was blood pressure and there was not enough
information provided for TG to calculate an effects size.
*Terminologies used by the authors
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Table 4: Changes in primary outcomes using any definition for adiposity

Studies (#)

Participants (#)

Zr (95% CI)

Q (P)

I2 (%)

95% PI

SBP

16

27487

0.11 (0.07, 0.14)

162.44 (<0.001)

90.77

-0.03, 0.23

SBP (adjusted)

6

15156

-0.13 (-0.18, -0.07)

43.05 (<0.001)

88.39

-0.31, 0.01

DBP

14

27153

0.11 (0.07, 0.14)

135.95 (<0.001)

90.44

-0.01, 0.23

DBP (adjusted)

5

13356

-0.11 (-0.17, -0.04)

51.75 (<0.001)

92.27

-0.37, 0.06

TC

8

10420

0.01 (-0.05, 0.06)

79.69 (<0.001)

91.22

-0.16, 0.18

TC (adjusted)

4

7272

-0.06 (-0.12, 0.01)

21.72 (<0.001)

86.19

-0.32, 0.19

LDL

5

5462

0.02 (-0.06, 0.10)

63.07 (<0.001)

93.66

-0.25, 0.27

LDL (adjusted)

3

3365

-0.08 (-0.12, -0.05)

0.25 (0.879)

0

-0.08, -0.08

HDL

8

7915

-0.06 (-0.10, -0.02)

57.22 (<0.001)

87.77

-0.18, 0.06

HDL (adjusted)

4

5854

0.04 (-0.08, 0.15)

51.65 (<0.001)

86.44

-0.47, 0.47

TG

8

5919

0.08 (0.03, 0.13)

42.0 (<0.001)

83.33

-0.05, 0.25

TG (adjusted)

5

5854

-0.08 (-0.19, 0.02)

76.20 (<0.001)

94.75

-0.39, 0.31

Variable

SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-low-density lipoprotein cholesterol; HDL-high-density
lipoprotein; non-HDL-non-high-density lipoprotein cholesterol; cholesterol; TG-triglycerides;
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Table 5: Changes in primary outcomes using BMI measures only for the childhood exposure

Studies
Variable

(#)

Zr (95% CI)

Q (P)

I2 (%)

95% PI

SBP

14

0.10 (0.06, 0.13)

97.56 (<0.001)

86.68

0, 0.23

DBP

13

0.11 (0.07, 0.14)

100.19 (<0.001)

88.02

0, 0.24

TC

7

0.01 (-0.05, 0.07)

54.28 (<0.001)

88.95

-0.17, 0.16

LDL

5

0.02 (-0.06, 0.10)

63.07 (<0.001)

93.66

-0.28, 0.28

HDL

8

-0.06 (-0.11, -0.01)

39.61 (<0.001)

82.33

-0.19, 0.09

TG

7

0.10 (0.02, 0.17)

42.0 (<0.001)

83.33

-0.13, 0.34

SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-lowdensity lipoprotein cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density
lipoprotein cholesterol; cholesterol; TG-triglycerides.
All the studies that used that adjusted for adult BMI used BMI as the exposure during childhood.
The results of the adjusted analysis are same as in table 4.
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Figures
Chapter 4

Figure 1: Flow diagram for the selection of studies

SBP-systolic blood pressure; DBP-diastolic blood pressure; TC-total cholesterol; LDL-lowdensity lipoprotein cholesterol; HDL-high-density lipoprotein; non-HDL-non-high-density
lipoprotein cholesterol; cholesterol; TG-triglycerides.
Non-HDL was not analyzed because there were less than 3 studies to pool.
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Figure 2: Risk of bias assessment using STROBE instrument for each study

Low Rsik

High Risk

Unclear Risk

100
90
80
70
60
50
40
30
20
10
0

STROBE-Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
consists of a checklist of 22 items related to the title, abstract, introduction, methods, results and
discussion sections of the articles. Each study was assessed for the items. NA is “Not Applicable”
is chosen when item is not relevant. Scores are adjusted for NA responses. The STROBE
checklist is available at: http://strobe-statement.org/index.php?id=available-checklists
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Figure 3. Forest plot for the association between childhood obesity and adult SBP

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 4. Forest plot for the association between childhood obesity and adult SBP (adjusted
for adult BMI)

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 5. Forest plot for the association between childhood obesity and adult DBP

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 6. Forest plot for the association between childhood obesity and adult DBP (adjusted
for adult BMI)

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 7. Forest plot for the association between childhood obesity and adult TC

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 8. Forest plot for the association between childhood obesity and adult TC (adjusted
for adult BMI)

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 9. Forest plot for the association between childhood obesity and adult LDL

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 10. Forest plot for the association between childhood obesity and adult LDL
(adjusted for adult BMI)

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 11. Forest plot for the association between childhood obesity and adult HDL

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 12. Forest plot for the association between childhood obesity and adult HDL
(adjusted for adult BMI)

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 13. Forest plot for the association between childhood obesity and adult TG

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Figure 14. Forest plot for the association between childhood obesity and adult TG (adjusted
for adult BMI)

The common metric for the effect size for each study is the Fisher’s r to z transformation of the
correlation statistics. The vertical lines represent the represent the Fishers Zr while the left and
right extremes of the vertical lines represent the corresponding 95% CI. The middle of the black
diamond represents the overall Fishers Zr while the left and right extremes of the diamond
represent the corresponding 95%CI. Combined measures represent those studies in which male
and female were combined, or different age cohorts from each study were combines, or multiple
readings from the same cohort were combined or one study using more than one exposure
definition.
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Additional Files
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Additional File 1- Search Strategy for Databases (June 5, 2015)
PubMed Database Search:

Web of Science Database Search

177

Scopus Database Search

Search Strategy for Databases (February 2, 2015) to find existing systematic reviews and metaanalysis on the topic:
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Additional file 2: List of excluded studies with reasons.
Approximately 5000 citations
Available upon request: Contact amnaumer@gmail.com
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Additional file 3: Strobe Checklist

STROBE items
Abraham et al., 1971
Berkey et al., 1998
Barker et al., 2005
Eisenmann JC et al.,
2005
Freedman DS et al.,
2001
Gustafsson et al.,
2011
Graversen et al, 2014
Holland et al., 1993
Kanade et al., 2011
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Kneisley et al., 1990
Koziel et al., 2011
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Li et al., 2007
Liddle et al., 2012
Lyngdoh et al., 2013
Miura et al., 2001
Pereira et al., 2013
Porkka et al., 1994
Schmidt et al., 2011
Skidmore et al., 2007
Weitz et al., 2014
Wright et al., 2001
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Freedman DS et al.,
2001
Gustafsson et al.,
2011
Graversen et al, 2014
Holland et al., 1993
Kanade et al., 2011
Klumbiene et al.,
2000
Kneisley et al., 1990
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Schmidt et al., 2011
Skidmore et al., 2007
Weitz et al., 2014
Wright et al., 2001
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NA-Not Applicable
L- Low Risk
H- High Risk
UN- Unclear
STROBE Statement—checklist of items that should be included in reports of observational studies
1 a. Indicate the study’s design with a commonly used term in the title or the abstract
1 b. Provide in the abstract an informative and balanced summary of what was done and what was found
2. Explain the scientific background and rationale for the investigation being reported
3. State specific objectives, including any pre-specified hypotheses
4. Present key elements of study design early in the paper
5. Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection
6 a. Give the eligibility criteria, and the sources and methods of selection of participants. Describe methods of follow-up
6 b. For matched studies, give matching criteria and number of exposed and unexposed-Not Applicable for any study therefore this item is not
shown in the figure below
7. Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable
8. For each variable of interest, give sources of data and details of methods of assessment. Describe comparability of assessment methods if there
is more than one group
9. Describe any efforts to address potential sources of bias
10. Explain how the study size was arrived at.
11. Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why
12 a. Describe all statistical methods, including those used to control for confounding
12 b. Describe any methods used to examine subgroups and interactions
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12 c. Explain how missing data were addressed
12 d. Cohort study—If applicable, explain how loss to follow-up was addressed
12 e. Describe any sensitivity analyses
13 a. Report numbers of individuals at each stage of study
13 b. Give reasons for non-participation at each stage
13 c. Consider use of a flow diagram
14 a. Give characteristics of study participants
14 b. Indicate numbers of participants with missing data for each variable of interest
14 c. Summaries follow-up time
15. Report numbers of outcome events or summary measures over time
16 a. Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision. Make clear which confounders were adjusted
for and why they were included
16 b. Report category boundaries when continuous variables were categorized
16 c. If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period
17. Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses
18. Summaries key results with reference to study objectives
19. Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss both direction and magnitude of any
potential bias
20. Give a cautious overall interpretation of results considering objectives, limitations, and multiplicity of analyses, results from similar studies,
and other relevant evidence
21. Discuss the generalizability (external validity) of the study results
22. Give the source of funding and the role of the funders for the present study and, if applicable, for the original study on which the present article
is based

Risk of Bias Assessment:
Figure: Risk of bias assessment for each item of the STROBE instrument
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Additional File 4:
Influence meta-analysis, Cumulative meta-analysis and Funnel plots

Influence Analysis
Figure 1a. Influence analysis for the association between childhood obesity and adult SBP

Influence analysis for point estimate changes in SBP with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 1b. Influence analysis for the association between childhood obesity and adult SBP
adjusted for adult BMI

Influence analysis for point estimate changes in SBP with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 2a. Influence analysis for the association between childhood obesity and adult DBP

Influence analysis for point estimate changes in DBP with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 2b. Influence analysis for the association between childhood obesity and adult DBP
adjusted for adult BMI

Influence analysis for point estimate changes in DBP with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 3a. Influence analysis for the association between childhood obesity and adult TC

Influence analysis for point estimate changes in TC with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 3b. Influence analysis for the association between childhood obesity and adult TC
adjusted for adult BMI

Influence analysis for point estimate changes in TC with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.

191

Figure 4a. Influence analysis for the association between childhood obesity and adult LDL

Influence analysis for point estimate changes in LDL with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 4b. Influence analysis for the association between childhood obesity and adult LDL
adjusted for adult BMI

Influence analysis for point estimate changes in LDL with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 5a. Influence analysis for the association between childhood obesity and adult HDL

Influence analysis for point estimate changes in HDL with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 5b. Influence analysis for the association between childhood obesity and adult HDL
adjusted for adult BMI

Influence analysis for point estimate changes in HDL with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 6a. Influence analysis for the association between childhood obesity and adult TG

Influence analysis for point estimate changes in TG with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Figure 6b. Influence analysis for the association between childhood obesity and adult TG
adjusted for adult BMI

Influence analysis for point estimate changes in TG with each corresponding study deleted from
the model once. The vertical lines represent the represent the Fishers Zr while the left and right
extremes of the squares represent the corresponding 95% confidence intervals. The middle of the
black diamond represents the overall mean difference while the left and right extremes of the
diamond represent the corresponding 95% confidence intervals. Results are ordered from smallest
to largest reductions. Combined measures represent those studies in which male and female were
combined, or different age cohorts from each study were combines, or multiple readings from the
same cohort were combined or one study using more than one exposure definition.
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Cumulative Meta-Analysis:

Figure 1a. Cumulative meta-analysis for the association between childhood obesity and
adult SBP

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 1b. Cumulative meta-analysis for the association between childhood obesity and
adult SBP adjusted for adult BMI

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 2a. Cumulative meta-analysis for the association between childhood obesity and
adult DBP

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 2b. Cumulative meta-analysis for the association between childhood obesity and
adult DBP adjusted for adult BMI

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 3a. Cumulative meta-analysis for the association between childhood obesity and
adult TC

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 3b. Cumulative meta-analysis for the association between childhood obesity and
adult TC adjusted for adult BMI

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 4a. Cumulative meta-analysis for the association between childhood obesity and
adult LDL

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.

204

Figure 4b. Cumulative meta-analysis for the association between childhood obesity and
adult LDL adjusted for adult BMI

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 5a. Cumulative meta-analysis for the association between childhood obesity and
adult HDL

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 5b. Cumulative meta-analysis for the association between childhood obesity and
adult HDL adjusted for adult BMI

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 6a. Cumulative meta-analysis for the association between childhood obesity and
adult TG

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Figure 6b. Cumulative meta-analysis for the association between childhood obesity and
adult TG

Cumulative meta-analysis, ordered by the year the study started. The vertical lines represent the
represent the Fishers Zr while the left and right extremes of the vertical lines represent the
corresponding 95% confidence intervals. The results of each corresponding study are pooled with
all studies preceding it. The middle of the black diamond represents the overall Fishers Zr while
the left and right extremes of the diamond represent the corresponding 95% confidence intervals.
Combined measures represent those studies in which male and female were combined, or
different age cohorts from each study were combines, or multiple readings from the same cohort
were combined or one study using more than one exposure definition.
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Funnel plots:

Figure 1: Funnel plot for the association between childhood obesity and adult SBP
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Figure 1: Funnel plot for the association between childhood obesity and adult DBP
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Additional File 5
Meta-Regression results for the association between childhood adiposity and adult cardiovascular disease (CVD) risk factors

Table 1: Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)
CVD risk factors
SBP
Covariate

Baseline Age
Follow-up Age
Length of FU
Type of Analysis
Country
*Sex
*Exposure

# of
Studies

Beta ± SE

16
16
16
16
16

0.0104 ± 0.004
-0.0006 ± 0.002
-0.0024 ± 0.002
0.0218 ± 0.0421
0.0741 ± 0.0386
0.0303 ± 0.029
0.0476 ± 0.0245

DBP
CI (95%)

P-value

# of
Studies

Beta ± SE

CI (95%)

0.0025, 0.0183
0.0096
14
0.0019, 0.0173
0.0096 ± 0.0039
-0.0045, 0.0033
0.7559
14
-0.0011 ± 0.0016
-0.0042, 0.0021
-0.0063, 0.0014
0.216
14
-0.0028 ± 0.0017
-0.0062, 0.0006
-0.0607, 0.1043
0.6046
14
0.0176 ± 0.0393
-0.0594, 0.0946
-0.0015, 0.1497
0.0548
14
0.014 ± 0.0412
-0.0668, 0.0948
-0.0265, 0.0871
0.2964
-0.0304 ± 0.0294
-0.0879, 0.0272
-0.0005, 0.0956
0.0524
0.0156 ± 0.0258
-0.0351, 0.0662
CVD risk factors adjusted for adult BMI
SBP
DBP
Baseline Age
6
0.0055 ± 0.0084
-0.011, 0.0221
0.5118
5
0.0072 ± 0.0249
-0.0416, 0.0559
Follow-up Age
6
-0.0075,
-0.0017
0.0017
5
-0.0087,
-0.0032
-0.0046 ± 0.0015
-0.006 ± 0.0014
Follow-up Time
6
-0.0066, -0.001
0.0078
5
-0.0089, -0.0034
-0.0038 ± 0.0014
-0.0061 ± 0.0014
*Sex
0.0409 ± 0.0432
-0.0438, 0.1256
0.3435
0.0165 ± 0.045
-0.0717, 0.1047
Type of Analysis: Correlation/Beta coefficient vs. Mean Difference/OR/RR
Country: USA vs. Others
Sex: Male vs. Female
Exposure: BMI vs. Other Measures of Adiposity
*Factors assessed using sub-group as the study of analysis instead of study as the unit of analysis
For categorical variables, less than three results for any one category were used as the cut-off for analysis
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Pvalue
0.0145
0.5116
0.1076
0.6535
0.7342
0.3008
0.5465

0.7723
0.0001
0.0001
0.7141

Table 2: Total cholesterol (TC) and Low-density lipoprotein cholesterol (LDL):
CVD risk factors
TC
Covariate

Baseline Age
Follow-up Age
Length of FU
Type of Analysis
Country
*Sex
*Exposure

LDL

# of
Studies

Beta ± SE

CI (95%)

P-value

# of
Studies

Beta ± SE

CI (95%)

Pvalue

8
8
8

-0.0017 ± 0.0086
-0.0035 ± 0.0017
-0.0036 ± 0.0014

-0.0186, 0.0153
-0.0068, -0.0002
-0.0064, -0.0008

0.8477
0.0379
0.0124

5
5
5

0.0108 ± 0.0159
-0.0049 ± 0.0013
-0.0041 ± 0.0015

-0.0204, 0.042
-0.0073, -0.0024
-0.007, -0.0013

0.4965
0.0001
0.0047

8

0.0599 ± 0.0465
0.0055 ± 0.0464
-0.0584 ± 0.0408

0.0163 ± 0.0833

-0.147, 0.1795

0.8453

-0.0479, 0.2072

0.2208

-0.0313, 0.1511
0.1978
-0.0853, 0.0964
0.905
-0.1383, 0.0216
0.1526
CVD risk factors adjusted for adult BMI
TC

LDL

Baseline Age
4
0.0001
-0.0125 ± 0.0027 -0.0179, -0.0071
Follow-up Age
4
0.0023 ± 0.0028
-0.0031, 0.0077
0.4002
Length of FU
4
0.0025 ± 0.0019
-0.0012, 0.0062
0.1903
-0.4022, -0.228
0.0001
0.0797 ± 0.0651
*Sex
-0.3151 ± 0.0444
Type of Analysis: Correlation/Beta coefficient vs. Mean Difference/OR/RR
Country: USA vs. Others
Sex: Male vs. Female
Exposure: BMI vs. Other Measures of Adiposity
*Factors assessed using sub-group as the study of analysis instead of study as the unit of analysis
For categorical variables, less than three results for any one category were used as the cut-off for analysis
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Table 3: High-density lipoprotein cholesterol (HDL) and triglycerides (TG)

CVD risk factors
HDL
Covariate

Baseline Age
Follow-up Age
Length of FU
Type of Analysis
Country
*Sex
*Exposure

TG

# of
Studies

Beta ± SE

CI (95%)

P-value

# of
Studies

Beta ± SE

CI (95%)

Pvalue

8
8
8

-0.0072 ± 0.0079
0.0014 ± 0.0016
0.0013 ± 0.0014

-0.0227, 0.0083
-0.0017, 0.0045
-0.0015, 0.0041

0.3622
0.3754
0.3507

8
8
8

-0.0041 ± 0.0095
-0.0091 ± 0.0016
-0.0073 ± 0.0019

-0.0227, 0.0146
-0.0122, -0.006
-0.011, -0.0037

0.6699
0.0001
0.0001

0.0144 ± 0.0517
0.0231 ± 0.0232

-0.0868, 0.1157
-0.0224, 0.0685

0.7798
0.3197

0.0141 ± 0.0964
-0.0237 ± 0.0329

-0.1749, 0.2031
-0.0882, 0.0408

0.884
0.4715

-0.0427, 0.0011
0, 0.0109
0.0008, 0.0091
0.0546, 0.2334

0.0622
0.0493
0.0205
0.0016

CVD risk factors adjusted for adult BMI
HDL

TG

Baseline Age
4
0.0104 ± 0.0438
-0.0755, 0.0963
0.8123
5
-0.0208 ± 0.0112
Follow-up Age
4
0.0036
5
-0.0069 ± 0.0024 -0.0115, -0.0022
0.0055 ± 0.0028
Length of FU
4
0.0041
5
-0.0068 ± 0.0024 -0.0115, -0.0022
0.0049 ± 0.0021
-0.2381, -0.031
0.0109
*Sex
-0.1345 ± 0.0528
0.144 ± 0.0456
Type of Analysis: Correlation/Beta coefficient vs. Mean Difference/OR/RR
Country: USA vs. Others
Sex: Male vs. Female
Exposure: BMI vs. Other Measures of Adiposity
*Factors assessed using sub-group as the study of analysis instead of study as the unit of analysis
For categorical variables, less than three results for any one category were used as the cut-off for analysis
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